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Background 
Epidemiology of chronic musculoskeletal pain in Switzerland 
In a large survey with 46,394 respondents from fifteen European countries, including 
Switzerland and Israel, Breivik et al. reported that chronic pain of moderate to severe 
intensity occurred in 19% of adult Europeans (Numeric Rating Scale = 5-10), seriously 
affecting the quality of their social and working lives. In-depth interviews showed that 
59% had suffered from pain for two to fifteen years, 21% had been diagnosed with 
depression because of their pain, 61% were less able or unable to work outside their 
home, 19% had lost their job, and 13% had changed jobs because of their pain. The 
daily activities that chronic pain sufferers were no longer or less able to do consisted of 
exercising, 73%; household chores, 54%; attending social activities, 48%; maintaining an 
independent lifestyle, 30%; and maintaining relationships with family and friends, 27%. 
Very few were managed by pain specialists and nearly half of the chronic pain sufferers 
reported inadequate pain management (e.g. Switzerland, 54%; the Netherlands, 56%) 
[1]. The results of this survey were largely replicated by another survey in a sample of 
the populations from the United Kingdom, France, Spain, Germany and Italy [2]. Alto-
gether, the prevalence and consequences of chronic pain represented a substantial 
burden to individuals and their family and friends, employers, health care systems and 
society in general.  
 The economic burden of musculoskeletal pain is huge because of medical treat-
ment cost, it complicates treatment of other ailments, and it lowers worker productivi-
ty. In 2010 in the United States the total costs ranged from $560 to $635 billion. The 
annual cost of pain was greater than the annual cost of heart disease ($309 billion), 
cancer ($243 billion), and diabetes ($188 billion) [3]. After the United States Switzerland 
has the most expensive health care system worldwide. Therefore, the costs of total 
musculoskeletal pain in the United States may be translated to the situation in Switzer-
land. The Breivik survey showed that the most common body location of chronic pain 
was the spine with 44% (18% lower back, 24% back, unspecified) [1]. A survey in 2005 
with a sample of 2,507 German-speaking respondents showed that the total economic 
burden of back pain to Swiss society varied between 1.6 and 2.3% of gross domestic 
product (€4.8 to €6.6 billion) with indirect productivity losses of €4.6 billion mainly 
through absenteeism [4].  
 Moreover, musculoskeletal pain disorders do not solely affect function, activities, 
and health-related quality of life, but are also associated with risk of mortality. In a 
cohort study with 4,515 adults in North West England, McBeth et al. described a long-
term increase of 20 to 30% in the risk of cancer and cardiovascular-related mortality 
[5]. In a former study with subjects with widespread and regional pain syndromes simi-
lar associations with both cancer onset (incidence) and subsequent reduced survival 
were reported [6]. The strongest relationship was with breast and prostate cancer, with 
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smaller effects for gastrointestinal and lung cancer. These relationships persisted after 
adjustment for age, gender, social class and smoking. 
Current evidence-based practice 
Exercise therapy appears to be slightly effective at decreasing pain and improving func-
tion in adults with chronic low back pain [7]. There is little or no difference between 
behavioral therapy and group exercises for chronic back pain or depressive symptoms 
[8]. In trials with patients with chronic, nonspecific back pain, comparing exercise ther-
apy, behavioral therapy or multidisciplinary treatment with no-treatment, modest ef-
fects were measured [9, 10]. In trials comparing two interventions, often no differences 
were found [9]. Relative to a host of widely used conventional medical treatment, com-
prehensive interdisciplinary pain management programs offer the most efficacious and 
cost-effective, evidence-based treatment for patients with chronic back pain [11, 12]. 
Accordingly, several international clinical guidelines recommend multidisciplinary (bio-
psychosocial) treatment (e.g. [13]. When looking at inpatient rehabilitation in Germany, 
summarized in a systematic review of thirty studies, both controlled and uncontrolled, 
a multitude of positive somatic and psychological changes were reported. However, 
methodological quality was often poor [14]. To the knowledge of the author, only one 
randomized controlled trial with chronic back pain patients in a rehabilitation setting 
has been conducted in Switzerland [15]. This study evaluated the effect of function-
centred compared with pain-centred inpatient rehabilitation in chronic nonspecific low 
back pain. Function-centred rehabilitation increased the number of work days, self-
efficacy, and lifting capacity. 
 However, back pain is nonspecific in about 90% of cases, which means that no 
relevant physical cause of the pain can be identified, and its origins remain unclear [12, 
16]. Chronic back pain is a heterogeneous condition, and this affects the way it is diag-
nosed, classified, treated, and studied [17]. The search for homogeneous subgroups of 
patients with nonspecific low back pain who respond best to subgroup-specific pain 
management interventions – repeatedly described as the Holy Grail of low back pain 
research – has been on the international research agenda for many years [12, 13, 18-
20]. Lack of prospective specification, inadequate sample size, inability to maintain 
power, and the cumulative effect of sampling error in trials designed to detect overall 
treatment effects complicate the interpretation of a posteriori subgroup analyses [21, 
22]. Among other recommendations, studies investigating treatment effect modifiers 
should limit their analyses to a small number of plausible predictors (subgroups) that 
are nominated prior to the conduct of the trial [23, 24]. Several, mainly physiotherapy 
movement based classification systems to subgroup low back pain patients with the 
intent to guide treatment, have been developed (for overview: reference [25]). Some 
are descriptive, some prognostic, and some, as in this thesis, attempt to direct treat-
ment. So far, the effects of a few classification-based interventions have been tested in 
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different settings [26-31]. These trials showed large variations in categorization meth-
od, therapeutic interventions and outcome.  
Why this research? 
According to the recommendations by the COST B13 Working Group on Guidelines for 
Chronic Low Back Pain more research is needed to develop tools to improve the classi-
fication and identification of specific clinical subgroups of chronic back pain patients 
[13]. Subsequent good quality randomized controlled trials are needed to determine 
the effectiveness of specific interventions aimed at those specific target groups. More 
emphasis should be placed on identifying the right treatment for the right patient. The 
Multidimensional Pain Inventory (MPI) Classification System, which classifies back pain 
patients into three predominantly psychosocial subgroups, has been used by several 
research groups to show a posteriori significant differences in score changes for pain, 
mental health, disability and coping [32, 33]. The three unique MPI profiles or sub-
groups have a high recognition value for both chronic pain patients and health profes-
sionals. However, no randomized controlled trial has been conducted to evaluate the 
effects of tailored pain interventions to a priori classified MPI subgroups of patients 
with chronic back pain in a rehabilitation setting. 
Rehabilitation 
Admission criteria to inpatient musculoskeletal rehabilitation in Switzerland 
Biopsychosocial multidisciplinary rehabilitation in Switzerland is available in rehabilita-
tion centres and to a lesser extent as outpatient rehabilitation, or in pain clinics. Pa-
tients in Switzerland are mainly referred by general practitioners, rheumatologists, 
psychiatrists, and hospitals (mainly departments of rheumatology and anaesthesiology) 
to the multimodal, interdisciplinary pain programs and are screened for possible partic-
ipation. The condition for recruitment to inpatient treatment programs is a history of 
failed or insufficient efficacy of outpatient treatment, as a rule, after at least three 
series of nine ambulatory physiotherapy sessions (each lasting 30 minutes to one hour). 
This criterion has been established by the Swiss Association of Rheumatologists in con-
sensus with the association of health insurance companies [34]. Basically, this means 
that pain patients can start inpatient rehabilitation within three months after the onset 
of symptoms. Early identification of patients at risk of developing a chronic pain condi-
tion and early admission to inpatient pain programs is very much supported by the 
Swiss rehabilitation clinics. Compared to most Western countries, this difference in 
referral policy in Switzerland possibly reflects differences in cultural background, local 
traditions in managing chronic pain, and the willingness-to-pay of the Swiss premium 
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payer. There have been several instances of Swiss health politicians trying to reduce the 
total number of hospitals and rehabilitation clinics and direct self-referral to medical 
specialists. However, in most cases, Swiss voters made use of referendums (direct de-
mocracy in a federalist system), and reversed the decisions of the politicians. A relative-
ly flourishing Swiss economy might have facilitated these final judgements. Meanwhile, 
as an example, pain patients are burdened with an average duration of symptoms of six 
to eleven years before being admitted to the Zurzach Interdisciplinary Pain Program 
[34-36].  
 Each rehabilitation clinic in Switzerland has its own specific screening criteria for 
patients. The screening process for patients participating in the Zurzach Interdiscipli-
nary Pain Program consists of three steps. First, diagnostic screening is performed by 
the head of the program on the basis of the admission report. The diagnosis of nonspe-
cific back pain or general widespread pain syndromes including fibromyalgia must be 
confirmed (see also the inclusion criteria below). Second, the head of program contacts 
potential candidates by telephone to evaluate the inclusion and exclusion criteria listed 
below. Third, approximately 10% of the candidates interviewed by phone visit the clinic 
for a one-hour consultation to clarify any uncertainties concerning the first or second 
screening steps. Inclusion criteria are: 1) chronic back pain (i.e. lumbar, thoracic, cervi-
cal, or panvertebral pain syndrome) [13] or fibromyalgia according to the definition of 
the American College of Rheumatology [37], both of at least three months’ duration; 2) 
willingness to learn behavioral patterns and motivation to participate in exercise thera-
py programs; 3) ability to formulate realistic functional goals (e.g. increasing walking 
distance, ability to carry a shopping bag without apprehension); 4) sufficient cognitive 
abilities and German language skills to understand the content of the interventions; 
and 5) agreement to participate in all the therapies of the program (that means, no 
selection by the patient of preferred therapies). Exclusion criteria to participation in the 
Zurzach Interdisciplinary Pain Program are: 1) severe somatic illness requiring specific 
treatment such as cancer, inflammatory rheumatic disease, neurologic disease, pain 
after a recent operation; and 2) manifest psychiatric disorder such as dementia, psy-
chosis, suicidality. 
Content of the Zurzach Interdisciplinary Pain Program 
All studies in this thesis were performed with patients participating in the Zurzach In-
terdisciplinary Pain Program (ZISP). The Zurzach Interdisciplinary Pain Program was 
founded in March 1996. It emerged as a further development of “The meaning of so-
cial, interpersonal, and psychological factors for coping with chronic diseases and the 
development of disability”, being part of the National Research Program 26B supported 
by the Swiss National Science Foundation. Roberto Brioschi, clinical psychologist and 
research associate, developed a program for patients with musculoskeletal pain, mainly 
chronic back pain or fibromyalgia. He is still head of the program. In contrast to a psy-
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chosomatic clinic or a pain clinic, the Zurzach Interdisciplinary Pain Program limits itself 
to a small segment of pain patients. The program starts every month, lasts for four 
weeks, and is organized in the rehabilitation clinic RehaClinic, locations Bad Zurzach and 
Braunwald, Switzerland [38]. The program language is German. Since May 2000 addi-
tional groups for Italian-speaking patients have been organized. Two weekend holidays 
are permitted during their stay at the clinic.  
 The program is based on the biopsychosocial model [39], the concept of salutoge-
nesis [40], and the integration of various psychotherapeutic methods. It addresses the 
medical, personal, and social complexity of patients with chronic pain disorders. The 
interdisciplinary pain program aims to stop the process of pain chronification, to in-
crease resilience, and to improve quality of life [41, 42]. If a withdrawal reaction can be 
prevented by increasing the physical and mental activity level of the patient and by 
improving self-efficacy and competence to control pain (locus of control), i.e. active 
adaptive pain coping strategies, this will help to reduce perceived pain [34]. The pro-
gram is intensive (in total over one hundred hours of therapy). At the start of the pro-
gram the patients have to hand over their medication to the nursing staff. Over the 
course of treatment patients receive on average six daily sessions of the following 
treatments: physiotherapy, aerobic endurance training, qigong / tai chi exercises, indi-
vidual psychotherapy including cognitive behavioral therapy, participation in a pain 
coping group, relaxation therapy, humor therapy, horticultural therapy, information 
and education about the pathophysiology of pain mechanisms and management of 
chronic disabling pain, nursing care, and regular medical consultations including drug 
therapy.  
 Individual treatment strategies are identified and discussed during the interdiscipli-
nary meetings of the pain management team (two per week for six patients). Results of 
baseline assessment and follow-up are discussed with the patients. In the first and in 
the last week of the pain management program the patient participates in the planning 
and review of his or her individual treatment strategies. Standard self-report follow-up 
is done after three and six months. Outpatient rehabilitation after completing the inpa-
tient Zurzach Interdisciplinary Pain Program at RehaClinic is organized for selected pa-
tients and is performed by the therapists of the pain management team. Otherwise, 
further outpatient care by external therapists is discussed and organized with the pa-
tients.  
 The health care providers involved - all educated pain specialists - are: rheumatolo-
gists, clinical psychologists, physiotherapists, occupational therapists, nurses, a move-
ment analyst and clown Pello, a humor therapist. All health care providers of the pain 
management team have completed a standardized educational training in theoretical, 
conceptual, and therapeutic basics of interdisciplinary pain management. The head of 
the program, an experienced psychologist, provides clinical supervision, supervision of 
the health professionals in the pain management team, and additional case-specific 
instructions during the course of treatment. Several studies, published in peer-
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reviewed journals over the past few years, have reported the outcomes of different 
aspects of this pain management program [34-36]. 
Aim of the thesis 
The primary objective of this thesis is to examine the effectiveness of tailored pain 
management in patients with chronic musculoskeletal pain classified according the 
Multidimensional Pain Inventory Classification System in order to improve patient care. 
The secondary objective encompasses the exploration of differences in effects between 
individual Multidimensional Pain Inventory subgroups. Finally, the third objective, as a 
prerequisite to achieve the first two objectives, is testing clinimetric features of the 
measurement tools Coping Strategies Questionnaire and the Multidimensional Pain 
Inventory Classification System. 
Outline of the thesis 
Because many relevant systematic reviews, partly with meta-analyses, in the field of 
rehabilitation of chronic musculoskeletal pain conditions already exist (e.g. [10, 11, 14, 
41, 43-56] ), this thesis did not start with a review, but focussed on clinimetric and 
evaluation studies in patients participating in the Zurzach Interdisciplinary Pain Program 
(Figure 1).  
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Figure 1. Flow chart of the outline of the thesis 
 
Part 1: Clinimetric studies 
The research project started with a translation, cross-cultural adaptation, and valida-
tion of the internationally most widely used measure of pain coping strategies, the 
Coping Strategies Questionnaire (Chapter 2: Translation, cross-cultural adaptation, 
reliability, and validity of the German version of the Coping Strategies Questionnaire 
(CSQ-D)). As in the Zurzach Interdisciplinary Pain Program, one of the main goals of pain 
management is to support the patient in learning how to cope with his chronic, recur-
rent pain condition. Despite eventual failure to completely alleviate pain, patients 
should learn to set realistic, functional goals and “go on with their lives”. The success of 
these active, adapted pain coping strategies had to be evaluated with clinimetrically 
sound measurement tools. So far, like several other important questionnaires that have 
been developed in English-speaking countries, the CSQ was not available in German.  
Evaluation studies 
Cohort study 
Differences in outcome in  
Multidimensional Pain Inventory subgroups  
with chronic nonspecific back pain 
Cohort study
Differences in outcome in  
Multidimensional Pain Inventory subgroups  
with fibromyalgia 
Randomized controlled trial
A subgroup specific pain management program to reduce pain and disability 
in chronic back pain 
Validation study 
German Version of the  
Coping Strategies Questionnaire 
Correlation study, crosssectional
Pain-depression association in  
Multidimensional Pain Inventory subgroups 
Clinimetric studies 
Reliability study, crossvalidation 
Stability of the Multidimensional Pain  
Inventory Classification System 
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The Multidimensional Pain Inventory Classification System distinguishes three unique 
profiles or subgroups for patients on how they cope with chronic pain. Previous inter-
national studies mainly involving fibromyalgia patients showed poor test-retest reliabil-
ity scores for this classification tool. Previous international studies mainly involving 
fibromyalgia patients showed that retest resulted in 33-38% of patients being assigned 
to a different Multidimensional Pain Inventory subgroup classification. Therefore, the 
second study in this thesis was a cross validation study, examining the stability of the 
MPI Classification System mainly in chronic back pain patients (Chapter 3: Reliability of 
the Multidimensional Pain Inventory and stability of the MPI Classification System in 
chronic back pain). 
 In patients with chronic musculoskeletal pain, depression is the comorbidity with 
the highest prevalence. Depression and chronic pain have a high impact on health-
related quality of life and individual health care. Management of both disorders is often 
unsuccessful and the question arises as to whether pain and depression are not just 
highly associated, but causally related. If so, one disorder could be influenced by treat-
ment of the other. Several previous studies showed controversial results. In one of our 
studies we aimed to derive refined (i.e. by stratification into MPI subgroups, different 
methods, continuous scales, etc.) correlation and regression data from a patient sample 
to contribute to the debate of whether depression and pain are strongly enough relat-
ed to support the hypothesis of causality (Chapter 4: Refined insights into the pain-
depression association in chronic pain patients).  
Part 2: Evaluation studies 
MPI subgroups have been described in several studies with different patient groups and 
different settings. A subsequent study aimed to replicate and validate the empirically 
derived subgroup classification based on the Multidimensional Pain Inventory (MPI) in a 
sample of highly disabled fibromyalgia patients (Chapter 5: Does classification of per-
sons with fibromyalgia into Multidimensional Pain Inventory subgroups detect differ-
ences in outcome after a standard chronic pain management program?). Second, it 
examined how the identified subgroups differed in their response to our standard, 
interdisciplinary inpatient pain management program. If so, this retrospective MPI 
subgroup classification could provide information that might help to improve the ef-
fects of standard pain management programs: matching patients with the treatment 
strategies and therapeutic methods that they are most likely to respond to and where 
they show the greatest need of treatment and/or where they show the largest deficits. 
 The main aim of the next study was to examine a sample of highly disabled patients 
with chronic back pain to find out how the three subgroups based on the Multidimen-
sional Pain Inventory differed in their response to the standardized interventions of the 
Zurzach Interdisciplinary Pain Program (Chapter 6: Differences in pain, function and 
coping in Multidimensional Pain Inventory subgroups of chronic back pain: a one-
group pretest-posttest study). If this were the case, information would be provided 
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that might help to improve the clinical outcomes of standard pain management pro-
grams by a priori implementation of classification methods for matching interventions 
(i.e., tailored pain management) to subgroups of patients.  
 Finally, based on the information of the previous studies, subgroup-specific inter-
ventions in the fields of physiotherapy and psychotherapy were developed and subse-
quently tested by means of a randomized clinical trial (Chapter 7: Effectiveness of a 
subgroup-specific pain management program based on the MPI Classification System: 
A pragmatic randomized controlled trial in patients with chronic back pain). This study 
examined the effectiveness of tailored pain management on pain and disability in pa-
tients with chronic nonspecific back pain a priori classified according to the Multidi-
mensional Pain Inventory (MPI) Classification System, compared to general pain man-
agement. The secondary objective focussed on the exploration of differences in effects 
between individual MPI subgroups and the control group. 
 The last chapter (Chapter 8: General discussion) provides an overall discussion, 
including implications for clinical practice and recommendations for further research 
relevant to this PhD thesis project.  
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Abstract 
 Objectives. The aim of this study was to translate and cross-culturally adapt the 
American version of the Coping Strategies Questionnaire (CSQ) and to test the reliabil-
ity and validity of the German version (CSQ-D). 
 Methods. The CSQ was translated and cross-culturally adapted following interna-
tional guidelines. Reliability and validity were tested in 62 individuals with chronic mus-
culoskeletal pain syndromes. For the concurrent criterion-related validity, the CSQ-D 
scales were compared with the German Pain Coping Questionnaire (FESV-BW) and for 
the construct validity with the German Short Form 36 (SF-36).  
 Results. The translation process proceeded without major difficulties. In testing for 
reliability, the CSQ-D as a whole had a Cronbach’s alpha of 0.94 and an intraclass corre-
lation coefficient of 0.89 (95% CI: 0.86-0.98). The total CSQ-D score was correlated to 
the FESV-BW scales with scores of r = 0.32-0.55 and with the SF-36 Mental Component 
Summary with scores of r = 0.32-0.53. The CSQ-D is a precisely translated and highly 
reliable instrument in the assessment of chronic pain coping strategies. Its concurrent 
criterion-related validity and construct validity are low. The main reason for the low 
level of agreement between the CSQ-D and the FESV-BW was revealed by factor analy-
sis. 
 Conclusions. This paper presents the German Version of the CSQ, together with the 
results of clinimetric testing. The CSQ-D is a feasible and reliable outcome measure to 
be used in trials with German-speaking patients or large multicenter multinational trials 
to assess pain coping strategies in patients with chronic musculoskeletal pain. 
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Introduction 
Coping strategies in the context of chronic pain refer to the way individuals who expe-
rience pain develop ways to tolerate, minimize or reduce their pain. Interest in the 
concept of coping has been reinforced by a review of the literature on pain coping 
strategies and by meta-analytical research that supports interdisciplinary intervention 
in the form of cognitive-behavioral therapy as one of the few effective treatments for 
patients with chronic musculoskeletal pain [1-3]. 
 In the new European guidelines for the management of chronic nonspecific low 
back pain, the most promising approaches seem to be cognitive-behavioral interven-
tions encouraging activity and exercise [4]. The evaluation and training of cognitive and 
behavioral coping strategies is an interdisciplinary enterprise, in which patients, physio-
therapists, occupational therapists, psychologists, nurses and medical doctors are in-
volved. The Coping Strategies Questionnaire (CSQ) is internationally the most widely 
used measure of pain coping strategies [5]. The value of the CSQ is its ability to assess 
various cognitive and behavioral coping factors derived from a rationally constructed 
pool of strategies reported by patients experiencing pain and cross-validated by pain 
clinicians and pain psychologists [5-8]. It identifies both active and passive coping strat-
egies [7]. For example, the use of passive, maladaptive coping strategies such as “Pray-
ing or Hoping” and “Catastrophizing” is suggested as predictive of a poor 1-year re-
sponse to treatment [9-14]. The CSQ has received considerable research attention 
aimed at improving interpretability via factor-analytic studies of dimensions of coping, 
clinical studies comparing patient subgroups, and the evaluation of treatment out-
comes [5, 15-19]. 
 In the German-speaking countries, several pain coping strategy questionnaires exist 
in the German language (e.g. Fragebogen zur Erfassung Schmerzbezogener Selbstin-
struktionen (FSS)/Fragebogen zur Erfassung Schmerzbezogener Kontrollüberzeugungen 
(FSK), Kieler Schmerzinventar (KSI), and Fragebogen zur Erfassung der Schmerzverarbei-
tung (FESV) [20-23]. According to the recommendations of the Initiative on Methods, 
Measurement, and Pain Assessment (IMMPACT), the use of a standard set of validated 
outcome measures for chronic pain clinical trials would facilitate the process of devel-
oping research protocols, encourage development of multi-centre projects in which all 
participating institutions agree to include these measures, provide a basis for determin-
ing the treatment outcomes that constitute clinically important differences, permit 
pooling of data from different studies, and provide a basis for meaningful comparisons 
of treatments and the clinical importance of their outcomes, particularly through sys-
tematic reviews [24]. To be able to participate in large multicentre multinational trials, 
the adapted version of the CSQ must undergo the process of validation [25]. Several 
German translations of the CSQ exist, but none of them were done according to the 
C H A P T E R  2  
 30
international guidelines (Luka-Krausgrill, personal communication). The validation pro-
cess of a certain German version of the CSQ has been sustained in 1995 [26, 27]. 
Therefore, the aims of the study were: 1) to translate and develop a cross-cultural 
adaption of the original CSQ, and 2) to investigate the clinimetric properties (reliability 
and validity) of the German version of the CSQ in a Swiss-German population of pa-
tients with chronic musculoskeletal pain syndromes. The final version for use in clinical 
trials in German-speaking populations is presented. 
Methods 
The study was conducted at RehaClinic, a Swiss rehabilitation clinic in Bad Zurzach, 
which is attended by patients from all the German-speaking countries in Europe. All 
patients were participants in the in-house pain management programs with a cognitive-
behavioral approach, including physical exercise, and had no other diagnosis that could 
interfere with these rehabilitation activities. Twenty-two inpatients with chronic pain 
due to whiplash injury (n = 15), other back pain (n = 2), fibromyalgia (n = 4), or general-
ized widespread pain (n = 1) were assessed over a weekend for reliability data with an 
interval of 48 h between test and retest, i.e. without having undergone any therapy or 
intervention. Out of 208 names and addresses of former in-house chronic musculoskel-
etal pain patients who had consented to be addressed for studies of chronic musculo-
skeletal pain and who were registered in a database of the Research Department of 
RehaClinic, the 58 most recently treated patients were additionally enrolled for the 
validation study. After patient information by telephone, 4 patients refused participa-
tion. After written patient information was handed out, written informed consent was 
obtained from an additional 40 chronic pain patients (9 patients did not return the 
questionnaire, 1 had died, and 3 patients returned the questionnaire after the dead-
line), resulting in a sample of 62 patients for the validity testing [28].  
 The average age of the participants was 44 years (range 16-68 years), and 77% 
were female. Twenty-one had suffered a whiplash injury, 11 other chronic back pain, 17 
fibromyalgia, and 13 generalized widespread pain syndrome. 
Translation and cross-cultural adaptation 
Translation and cross-cultural adaptation was performed following the international 
guidelines for self-report measures published by the American Association of Orthope-
dic Surgeons Outcomes Committee [29]. This process consists of 6 steps, called stages, 
of which each is documented by a written report. 
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Stage I: Initial translation 
The primary translation of the CSQ was done independently by 1 bilingual researcher 
(FA) aware of the objective of the questionnaire and 1 other bilingual person (AK) with-
out any knowledge of the instrument or the construct of coping with chronic pain. 
Stage II: Synthesis of the translations 
The 2 translators and the recording observer (MLV) synthesized the results of the trans-
lations by consensus. 
Stage III: Back-translation 
The synthesis of the 2 translations was then independently translated back into English 
again by 2 different bilingual persons: 1 person with native-language American English 
(RH) and 1 professional translator with native-language British English (JB) who had no 
prior knowledge of the instrument. 
Stage IV: Expert committee review 
The expert committee, consisting of all translators, 1 neurologist (RM), 1 general practi-
tioner (FA), 2 psychologists (FG and MS), 2 physiotherapists (HS and MLV) and 1 re-
search assistant (SL), compared the original version with the various translations and 
back-translations and developed the prefinal version by consensus. The other role of 
the expert committee was to achieve semantic, idiomatic, experiential, and conceptual 
equivalence between the original CSQ and the CSQ-D. 
Stage V: Test of the prefinal version 
The pre-final version was tested for face and content validity purposes by physiothera-
pists and occupational therapists from Switzerland, Germany and Austria (with native-
language German). The questionnaire was also tested on 12-13-year-old children and 
evaluated to establish that this version could be understood by a person with limited 
educational status [30]. 
Stage VI: Submission of documentation to the developers 
All the reports and forms were submitted for appraisal of the adaptation process to 
Francis J. Keefe, co-developer of the original CSQ.  
Outcome measures 
Coping 
The CSQ is a widely used instrument to assess coping strategies used by individuals with 
chronic pain. It was developed in 1983 in the USA by Rosenstiel and Keefe [5]. It is a 48-
item self-report questionnaire that assesses 6 cognitive (Diverting Attention, Reinter-
preting Pain Sensations, Coping Self-Statements, Ignoring Pain Sensations, Praying or 
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Hoping, Catastrophizing) and 2 behavioral (Increasing Activity Level, Increasing Pain 
Behaviors) coping techniques. Each domain is comprised of 6 items, and participants 
rate the frequency of their use of specific coping strategies on a 7-point Likert scale 
from 0 (“Never do that”) to 6 (“Always do that”). The CSQ also includes 2 1-item scales 
that assess participants’ subjective ability to control or decrease their pain. These 2 
scales are not thought to measure coping strategies but rather their effectiveness. 
Using a similar 7-point Likert scale, participants rate from 0 to 6, with 0 signifying “No 
control/No ability to decrease pain”, and 6 signifying “Complete control/Complete 
ability to decrease pain”.  
 The CSQ has demonstrated satisfactory internal consistency and test-retest reliabil-
ity [5, 6]. Factor-analytic studies examining the relationships between the subscales 
have failed to find a reliable factor structure underscoring the difficulties in conceptual-
izing important dimensions of coping [5, 15-19]. Therefore, given the extensive use of 
the CSQ, as well as the concerns and apparent variability of its factor structure in dif-
ferent populations and lack of longitudinal data for measuring responsiveness, we de-
cided to translate, cross-culturally adapt, and test the reliability and validity of the orig-
inal “full-version” (48+2 items) CSQ.  
 Pain-related coping strategies were also assessed by the German Pain Coping Ques-
tionnaire “Fragebogen zur Erfassung der Schmerzverarbeitung-Schmerzbewältigung” 
(FESV-BW), comprising 6 subscales [22]. It is divided into 3 subscales with cognitive 
coping strategies Action-Oriented Coping (German: Handlungsplanungskompetenzen), 
Cognitive Restructuring (German: Kognitive Umstrukturierung) and Self-Efficacy (Ger-
man: Kompetenzerleben), and 3 subscales with behavioral coping strategies Mental 
Distraction (German: Mentale Ablenkung), Counter-Activities (German: Gegen-
steuerende Aktivitäten), and Relaxation (German: Ruhe- und Entspannungstechniken). 
Each scale consists of 4 items. Scale values range from 4 to 24. Cronbach’s alpha coeffi-
cients of the scales vary between α = 0.68 and α = 0.78, and the test-retest reliability 
scores of the scales vary between r = 0.71 and r = 0.89 [31]. This German instrument 
showed low and moderate correlations with stress coping questionnaires (r = 0.35-
0.60) but has not been validated against other German pain coping strategies question-
naires. 
Health Related Quality of Life (HRQL) 
The Medical Outcomes Study Short Form 36 (SF-36) is a widely accepted self-
administered generic instrument that assesses biopsychosocial health related to quality 
of life [32]. The 36 questions of the SF-36 comprise 8 scales, each containing between 2 
and 10 items, plus a single item to assess health transition. The scales cover the dimen-
sions of Physical Functioning (unweighted mean of 10 items), Role Physical (4 items), 
Bodily Pain (2 items), General Health (5 items), Vitality (4 items), Social Functioning (2 
items), Role Emotional (3 items), and Mental Health (5 items). It yields a total score 
ranging from 0 (maximal symptoms/maximal limitations/poor health) to 100 (no symp-
G E R M A N  V E R S I O N  O F  C O P I N G  S T R A T E G I E S  Q U E S T I O N N A I R E  
 33 
toms/no limitations/excellent health). The SF-36 allows the construction of 2 summary 
scales, the Physical Component Summary (PCS) and the Mental Component Summary 
(MCS). We used the validated German version of the SF-36 [33]. 
Statistical analysis 
All instruments’ scales were transformed into a scale from 0 (maximal symp-
toms/maximal limitations/poor health/no control or coping ability) to 100 (no symp-
toms/no limitations/excellent health/maximal control or coping ability) according to 
the original scaling of the widespread SF-36. For the CSQ-D, 0 means “never do that” 
and 100 means “always do that”, except for Praying and Hoping and Catastrophizing, 
for which 0 means “always do that” and 100 means “never do that”, because these 2 
scales reflect the maladaptive passive coping strategies [7]. The purpose was to ease 
comparison of the scores across different instruments in the listing of the descriptive 
data. 
 The test-retest reliability of the CSQ-D was determined by intraclass correlation 
coefficients (ICCs). The ICC measures the agreement of the 2 (test and retest) responses 
pairwise for each item and each patient for the whole sample and ranges from 0 (no 
agreement) to 1 (perfect agreement). It is calculated using variance estimates obtained 
through the analysis of variance. Therefore, it reflects both degree of correspondence 
and agreement among ratings [34]. Although the ICC is primarily designed for use with 
interval/ratio data, the ICC can be applied without distortion to data on the ordinal 
scale when intervals between such measurements are assumed to be equivalent [35]. 
 The internal consistency for the CSQ-D was assessed with Cronbach’s alpha, a sta-
tistic used to calculate the strength of the association between the individual questions 
within the scale (carried out separately for the total score and for the cognitive coping 
strategies and behavioral coping strategies subscales) [36]. The alpha coefficient exam-
ines inter-item correlations within a subscale and therefore relates to its homogeneity. 
The concurrent criterion-related validity of the CSQ-D, assessed with non-parametric 
 Spearman rank correlation coefficients, was determined by analyzing the relation-
ship between its scores and the scores from the subscales of the FESV-BW. As both 
questionnaires consist of both cognitive and behavioral scales for pain coping strate-
gies, we decided to use the FESV-BW as the “gold standard” in testing the validity of the 
CSQ-D. The 2 other existing German pain coping strategy questionnaires, the FSS/FSK 
and the KSI, were rejected because the FSS/FSK showed lower reliability scores and the 
KSI was too extensive (120 items) [6, 23]. There is no universally accepted measure for 
pain coping (a so-called “gold standard”) but there is a broad consensus of using in-
struments with the same construct to assess validity. 
 Confirmatory factor analysis of the subscales of the CSQ-D and the FESV-BW was 
used to determine whether the FESV-BW could actually be regarded as the “gold 
standard” for measuring cognitive and behavioral pain coping strategies [37]. This 
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strategy of including subscales into the factor analysis was also applied to the original 
CSQ [6]. A priori, we hypothesized that the cognitive CSQ scales would load together 
with the cognitive FEVS-BW scales on one factor, and the behavioral CSQ scales togeth-
er with the behavioral FESV-BW scales on another factor. This would be a precondition 
for the use of the FESV-BW as a so-called “gold standard” measuring the same con-
struct. 
 The construct validity of the CSQ-D, also assessed with nonparametric Spearman 
rank correlation coefficients, was investigated by examining the relationship between 
the CSQ-D scores and those from the MCS and PCS scales of the SF-36.  
 A priori, a high correlation was expected between the CSQ-D and the FESV-BW, a 
moderate correlation between the CSQ-D and the MCS subscale of the SF-36 (conver-
gent validity), and a low correlation between the CSQ-D and the PCS subscale of the SF-
36 (discriminant validity). 
 As a further construct validity analysis, the overall rating of item 49, “Based on all 
the things you do to cope, on an average day, how much control do you feel you have 
over it?”, was Spearman rank correlated to the eight CSQ scales. This procedure corre-
sponds to the “known groups method”, expecting that the patients with high scores in 
item 49 would also show high scores in the other 8 scales [34]. 
 Data were analyzed with SPSS 11.5 for Windows (SPSS, Chicago, IL). 
Ethical approval 
The study was approved by the local research ethics committee (Health Department in 
Aarau, Switzerland) and was carried out at the Research Department of RehaClinic in 
Zurzach, Switzerland. All participants gave written informed consent. 
Results 
Development of the CSQ-D 
The translation and back-translation of the CSQ proceeded without major difficulties. 
The expert committee discussed seven items (nos. 10, 18, 30, 36, 47, 49, and 50), but 
consensus for the prefinal version was easily obtained (e.g. in item 47, “projects” was 
translated into “andere Alltagstätigkeiten” because the word-by-word translation into 
“Projekte” would represent a more technical term used in science or technology). The 
German translation of the 1-item scales about control (item 49) and the ability to de-
crease pain (item 50) were differently formulated to improve ease of understanding 
without losing their original meaning. 
 After testing the prefinal version on 3 12-13-year-old children, 29 physiotherapists 
and 9 occupational therapists from Switzerland, Germany, and Austria (with native 
G E R M A N  V E R S I O N  O F  C O P I N G  S T R A T E G I E S  Q U E S T I O N N A I R E  
 35 
language German), and appraisal of the adaptation process by Francis J. Keefe, no revi-
sions had to be made for the final version. The final German version of the CSQ is en-
closed in Appendix A. 
Descriptive data 
Table 1 shows the descriptive data of the validation setting (n = 62). All CSQ-D scores 
were well distributed over almost the full range of the scaling, showing means around 
the middle of the scales from 0 to 100. For the CSQ-D, only in the subscale Reinterpret-
ing Pain Sensations was a floor effect over 20% measured. All other CSQ-D subscales 
and the total scales showed very low or no floor and ceiling effects. 
 
Table 1. Descriptive data of the validation setting (n = 62) 
Instr. Scale Minimum Floor Maximum Ceiling Mean s 
SF-36 Physical Functioning 0 - 95.0 - 51.7 21.6 
 Role Physical 0.0 74% 100.0 5% 14.1 28.1 
 Bodily Pain 0.0 15% 51.0 - 21.3 13.7 
 General Health 20.0 - 92.0 - 46.0 17.3 
 Vitality 0.0 5% 75.0 - 24.9 17.0 
 Social Functioning 0.0 7% 100.0 5% 43.4 25.8 
 Role Emotional 0.0 52% 100.0 26% 38.2 43.5 
 Mental Health 4.0 - 96.0 - 47.7 19.9 
 Physical Component Summary 17.6 - 50.6 - 31.9 7.1 
 Mental Component Summary 15.2 - 61.8 - 36.3 11.3 
CSQ-D Diverting Attention 13.9 - 80.6 - 47.5 16.0 
 Reinterpreting Pain Sensations 0.0 21% 75.0 - 24.7 21.9 
 Coping Self-Statements 19.4 - 97.2 - 55.3 13.8 
 Ignoring Pain Sensations 6.7 - 94.4 - 46.7 16.2 
 Praying or Hoping 8.3 - 94.4 - 58.4 20.6 
 Catastrophizing 5.6 - 100.0 2% 54.6 20.8 
 Increasing Activity Level 22.2 - 86.1 - 53.9 15.0 
 Increasing Pain Behaviors 27.8 - 83.3 - 56.2 12.0 
 Control over Pain 0.0 2% 66.7 - 45.2 16.1 
 Ability to Decrease Pain 16.7 - 83.3 - 40.3 13.7 
 CSQ-D total 30.3 - 68.7 - 49.4 8.4 
FESV-BW Action-Oriented Coping  10.0 - 95.0 - 53.9 20.4 
 Cognitive Restructuring  0.0 2% 90.0 - 48.4 21.3 
 Self-Efficacy  0.0 2% 95.0 - 49.4 22.1 
 Mental Distraction  0.0 2% 90.0 - 48.4 22.1 
 Counter-Activities  0.0 2% 85.0 - 41.9 20.4 
 Relaxation  0.0 3% 100.0 2% 43.7 22.7 
Abbreviations: Instr., instrument; SF-36, Short Form 36, German version; CSQ-D, Coping Strategies Question-
naire, German version; FESV-BW, Fragebogen zur Erfassung der Schmerzverarbeitung-Bewältigung (German 
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Pain Coping Questionnaire); s, standard deviation.  
NOTE. Scaling: 0=worst; 100=best. 
Reliability 
The single ICCs (n = 22) for the individual CSQ-D scales are listed in Table 2 together 
with the corresponding Cronbach’s alpha. Instead of listing all the single item ICCs, their 
ranges are indicated per scale to reduce the size of the table. All scale ICCs ranged from 
0.82 to 0.93 except the Ability to Decrease Pain scale (ICC=0.55). At the item level, the 
lowest ICC’s (ICC = 0.55) could be measured for item 33 (“When I feel pain, I take a 
shower or a bath”) and item 26 (“No matter how bad it gets, I know I can handle it”). 
The highest ICCs at item level were measured for items 34, 7, 19, 41, 48 (ICC = 0.89) and 
item 39 (“When I feel pain, I try to be around other people”) (ICC = 0.90). 
 
Table 2. Results of the reliability testing of the CSQ-D scales with a 48-hour interval (n = 22) 
Scale CA ICC 95%-CI Range of item ICC’s No. of items 
Diverting Attention 0.93 0.88 0.72-0.95 0.72-0.87 6 
Reinterpreting Pain Sensations 0.95 0.90 0.78-0.96 0.71-0.89 6 
Coping Self-Statements 0.93 0.87 0.71-0.94 0.61-0.82 6 
Ignoring Pain Sensations 0.96 0.93 0.83-0.97 0.73-0.87 6 
Praying or Hoping 0.96 0.92 0.82-0.97 0.78-0.89 6 
Catastrophizing 0.97 0.93 0.85-0.97 0.63-0.88 6 
Increasing Activity Level 0.95 0.91 0.80-0.96 0.78-0.90 6 
Increasing Pain Behaviors 0.92 0.85 0.67-0.94 0.55-0.89 6 
Ability to Decrease Pain - 0.55 0.18-0.78 - 1 
Control over Pain - 0.82 0.62-0.92 - 1 
CSQ-D total 0.94 0.89 0.76-0.95 0.55-0.90 50 
Abbreviations: CA, Cronbach’s alpha coefficient; ICC, intraclass correlation coefficient; 95% CI, 95% confi-
dence interval. 
Concurrent criterion-related validity  
Concurrent validity was measured by comparing the total CSQ-D score with the scores 
of the scales of the FESV-BW (Table 3). The total CSQ-D score was correlated to the 
FESV-BW scales with scores between r = 0.32 (Self-Efficacy) and r = 0.55 (Counter-
Activities). At the scale level of the CSQ-D, moderate correlations were found between 
Ignoring Pain and Cognitive Restructuring (r = 0.60), Catastrophizing and Mental Dis-
traction (r = 0.52), Activity Level and Relaxation (r = 0.51) and Activity Level and Cogni-
tive Restructuring (r = 0.57). All other scales showed very low correlations to each oth-
er, with scores between -0.22 and 0.46. 
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Construct validity 
Construct validity was measured by comparing the responses of the scales of the CSQ-D 
with the responses of the scales of the SF-36 (Table 4). The total CSQ-D correlated to 
the MCS subscale of the SF-36 with a score of r = 0.53 and to the SF-36 mental health 
scales with scores between r = 0.32 and r = 0.53. The total CSQ-D correlated to the PCS 
subscale of the SF-36 with a score of r = 0.15 and correlated to the SF-36 physical health 
scales with scores between r = 0.22 and r = 0.35.  
 
Table 4. Spearman rank correlation coefficients of the scales of the CSQ-D with the scales of the SF-36 (n = 
62) 
SF-36 
CSQ-D 
Physical 
Functioning 
Role 
Physical 
Bodily 
Pain 
General 
Health Vitality 
Social 
Functioning 
Role 
Emotional 
Mental 
Health 
 
  PCS 
 
MCS
Diverting Attention 0.12 0.17 0.05 0.11 0.22 0.27 0.11 0.31 0.05 0.27
Reinterpreting Pain 0.02 0.15 0.08 -0.10 0.12 0.01 0.10 0.09 0.01 0.09
Self-Statements 0.19 0.16 0.30 0.13 0.34 0.40 -0.02 0.29 0.20 0.23
Ignoring Pain 0.07 0.19 0.06 0.06 0.36 0.26 0.14 0.31 0.00 0.32
Praying or Hoping 0.15 0.22 0.25 0.06 0.19 0.07 0.26 0.12 0.13 0.17
Catastrophizing 0.28 0.31 0.21 0.49 0.46 0.45 0.30 0.58 0.19 0.53
Activity Level 0.31 0.28 0.24 0.20 0.50 0.38 0.21 0.38 0.22 0.38
Pain Behaviors -0.17 -0.20 -0.21 -0.18 -0.17 -0.06 0.05 -0.02 -0.31 0.04
Decrease Pain 0.31 0.15 0.18 0.17 0.29 0.26 0.23 0.30 0.16 0.29
Control over Pain 0.06 0.01 -0.05 0.17 0.21 0.12 0.10 0.18 -0.02 0.19
CSQ-D total 0.27 0.35 0.27 0.22 0.53 0.44 0.32 0.53 0.15 0.53
Abbreviations: CSQ-D, German version of the Coping Strategies Questionnaire; SF-36, Short Form 36, German 
version. 
 
The CSQ-D scales’ correlations to the global effectiveness rating item 49 (Control over 
Pain) was poor to moderate (reflecting the known groups method): r = –0.13 (Praying 
and Hoping); r = 0.13 (Increasing Pain Behaviors); r=0.28 (Reinterpreting Pain Sensa-
tions); r = 0.32 (Ignoring Pain Sensations); r = 0.34 (Increasing Activity Level); r = 0.39 
(Catastrophizing); r = 0.40 (Coping Self-Statements); and r = 0.43 (Diverting Attention). 
Confirmatory factor analysis 
Factor analysis revealed that 5 out of 10 CSQ-D scales, together with the CSQ-D total 
score, loaded on 1 factor (together with Counter-Activities of the FESV-BW) which was 
the strongest and explained most of the variance (31%). The other 5 scales loaded on 
further factors, independent of the FESV-BW and the SF-36 (Table 5). 
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Table 5. Results of the varimax-rotated confirmatory factor analysis of the scales of the CSQ-D, SF-36 and the 
FESV-BW (n=62) 
  Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Factor 6 
  Explained variance
Instr. Scale 31.0% 15.0% 8.2% 6.2% 5.9% 5.1% 
CSQ-D Ignoring Pain Sensations 0.86 -0.05 0.19 0.02 0.06 0.08 
CSQ-D Total 0.83 0.13 0.25 0.21 0.15 0.18 
CSQ-D Reinterpreting Pain Sensations 0.76 0.05 -0.16 0.03 0.15 -0.05 
CSQ-D Diverting Attention 0.68 0.02 0.20 0.21 -0.01 0.24 
CSQ-D Increasing Activity Level 0.66 0.14 0.18 0.51 0.08 0.07 
CSQ-D Coping Self-Statements 0.64 0.24 0.26 -0.04 -0.16 0.04 
FESV-BW Counter-Activities 0.61 0.06 -0.08 0.29 -0.03 0.00 
SF-36 Physical Component Summary 0.02 0.90 -0.01 0.10 -0.12 0.01 
SF-36 Bodily Pain 0.12 0.83 0.24 0.03 -0.06 -0.07 
SF-36 Physical Functioning -0.01 0.81 0.19 0.15 0.36 0.10 
SF-36 Social Functioning 0.16 0.32 0.84 0.09 0.01 0.06 
SF-36 Mental Health 0.16 0.12 0.74 0.08 0.42 0.06 
SF-36 Mental Component Summary 0.18 0.00 0.72 0.08 0.60 0.08 
SF-36 Vitality 0.27 0.41 0.50 0.21 0.20 0.16 
FESV-BW Mental Distraction 0.20 0.06 -0.02 0.85 0.02 -0.12 
FESV-BW Action-Oriented Coping 0.07 0.19 0.23 0.76 0.03 0.16 
SF-36 Role Emotional 0.08 0.06 0.25 0.03 0.89 0.05 
CSQ-D Ability to Decrease Pain 0.08 -0.08 0.11 0.00 -0.01 0.94 
CSQ-D Control over Pain 0.26 0.25 0.00 0.03 0.20 0.69 
Abbreviations: Instr., instrument; CSQ-D, German version of the Coping Strategies Questionnaire; SF-36, Short 
Form 36, German version; FESV-BW, Fragebogen zur Erfassung der Schmerzverarbeitung-Bewältigung (Ger-
man Pain Coping Questionnaire). 
Discussion 
In this study, we were able to develop a precise translation and cross-cultural adapta-
tion of the original CSQ. Testing it on 62 patients with chronic musculoskeletal pain 
demonstrated that the German version of the CSQ is highly reliable in a set of patient 
data which were well distributed over the possible scale range. It can be recommended 
for use in trials with German-speaking patients or large multicenter multinational trials 
to assess chronic pain coping strategies. Its concurrent criterion-related validity and 
construct validity are acceptable in some scales, but factor analysis showed that the 
German Pain Coping Questionnaire (FESV-BW) was inappropriate to serve as the so-
called “gold standard” for the validation analysis. For that reason, the CSQ-D may not 
automatically replace other measures of chronic pain coping strategies, such as the 
FESV-BW, which only exists in German. Rigorously interpreted, this is the main reason 
why the validation of the CSQ-D failed. The Catastrophizing subscale was one of the few 
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subscales for which there was moderate evidence of construct validity. Catastrophizing, 
however, shows a much stronger correlation with pain-related anxiety and more closely 
reflects appraisal processes than a coping strategy per se [38]. In addition, the global 
effectiveness rating by item 49 (Control over Pain) showed low to only moderate corre-
lations to all 8 scales. 
  Most of the CSQ-D scales showed almost equal agreement between the test and 
retest ratings compared to the original CSQ and slightly higher agreement in compari-
son to the Swedish CSQ (Table 6) [5, 6, 39]. The ICCs and Pearson product-moment 
correlation coefficients for the Control over Pain were better in all 3 versions (original 
American: r = 0.81; Swedish version, 5-week interval: ICC = 0.63; CSQ-D: ICC = 0.82) 
than those for the Ability to Decrease Pain (original American: r = 0.75; Swedish ver-
sion, 5-week interval: ICC = 0.29; CSQ-D: ICC = 0.55). Within pain management settings, 
emphasis is placed on maintaining function and coping with pain rather than on reduc-
ing pain, which, in many cases, may be unrealistic [15]. For this reason, because pa-
tients may not be able to decrease their pain but may increase their functional level 
and cope better, the better reliability score for the Control over Pain has more clinical 
relevance than the Ability to Decrease Pain. 
 
Table 6. Comparison of reliability data 
 CA coefficients
of the subscales 
ICCs** or Pearson product-moment 
correlation coefficients* of test-retest 
data of the subscales 
Original CSQ [5] 0.71-0.85 (n = 61) 0.68-0.93 (n = 120) *
Swedish Version of CSQ [39] 0.69-0.84 (n = 282) 0.42-0.82 (n = 22) **
German Version of CSQ 0.71-0.97 (n = 62) 0.55-0.93 (n = 22) **
Abbreviations: CSQ, Coping Strategies Questionnaire; CA, Cronbach’s alpha coefficient; ICC, intraclass correla-
tion coefficient. 
 
This means that the CSQ-D is at least as appropriate as the original and the Swedish 
version in these measurement properties. This is a precondition to pooling results from 
different rehabilitation clinics (e.g. for reviews) and different patient samples (e.g. fi-
bromyalgia and chronic low back pain) across different cultures and languages. This 
increases knowledge of the outcomes or rehabilitation programmes and of “who bene-
fits from what” [40]. 
 To our knowledge, there are no validity studies that compare the original CSQ with 
the SF-36. Snow-Turek et al. found correlation coefficients (unspecified) of r = 0.56-0.71 
for the CSQ and the Vanderbilt Pain Management Inventory, differentiating active and 
passive coping domains [7]. In a report by Tan et al. [8], only Catastrophizing showed a 
moderate correlation with depression (r = 0.58). All other correlations between the 
scales of the CSQ and pain, disability and depression were equal to or lower than r = 
0.32. An attempt to validate a questionnaire on pain sensations and coping (Pain Beliefs 
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and Perceptions Inventory) with the CSQ failed, probably owing to different constructs 
[41].  
 All these validation studies demonstrate the difficulties in conceptualizing im-
portant dimensions of coping [7, 8, 31, 41]. This supports the difficulties we experi-
enced in finding the optimal German pain coping instrument to validate the CSQ-D.  
 A limitation of the study was that the patient sample was somewhat heterogene-
ous, consisting of various diagnoses leading to chronic pain syndromes. This is a possi-
ble source of variance that may complicate the analysis, but the reliability and the valid-
ity analyses compared scores for the same patient, which is not affected by the hetero-
geneity of the sample. 
 The CSQ-D proved to be qualified for further clinimetric testing, especially for valid-
ity. For any longitudinal use of the CSQ-D, it will be necessary to determine the sensitiv-
ity to change (responsiveness) and the smallest detectable difference, a further im-
portant quality aspect of an instrument in the clinical and research assessment [34]. 
Furthermore, decisions on possible item and/or scale reduction to obtain a shorter 
version should be taken on the basis of longitudinal validation studies and further fac-
tor analysis. However, testing of the original CSQ revealed that factor solutions are 
highly dependent of the patient setting under investigation. 
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Conclusions 
This paper presents the German Version of the CSQ, together with the results of clini-
metric testing. The CSQ-D is a feasible and reliable outcome measure to be used in 
trials with German-speaking patients or large multicenter multinational trials to assess 
pain coping strategies in patients with chronic musculoskeletal pain. 
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Appendix A. German version of the CSQ 
Fragebogen zur Schmerzbewältigung: CSQ-D 
Anweisung:  
Personen mit Schmerzen haben eine Vielzahl von Methoden entwickelt, mit ihren 
Schmerzen fertig zu werden oder mit ihnen umzugehen. Es folgt eine Liste mit Beispie-
len der Schmerzbewältigung von befragten Patienten. Bitte beurteilen Sie. was Sie 
machen wenn Sie Schmerzen haben. Bei jedem Beispiel umkreisen Sie die für Sie zutref-
fende Zahl. Dazu benutzen Sie bitte die Skala 0-6.  
Eine 0 bedeutet: ich mache das nie. wenn ich Schmerzen empfinde. 
Eine 3 bedeutet: ich mache das manchmal, wenn ich Schmerzen empfinde. 
Eine 6 bedeutet: ich mache das immer, wenn ich Schmerzen empfinde.  
Beachten Sie. dass Sie irgendeine für Sie zutreffende Zahl in der Skala umkreisen kön-
nen. 
Wenn ich Schmerzen habe: 
1. Ich versuche, Abstand von den Schmerzen zu gewinnen, fast so, als ob die Schmer-
zen im Körper einer anderen Person wären. 
2. Ich gehe aus dem Haus und unternehme etwas, wie z.B. ins Kino oder einkaufen 
gehen. 
3. Ich versuche, an etwas Angenehmes zu denken. 
4. Ich stelle ihn mir nicht als Schmerz vor, sondern eher als dumpfes oder warmes 
Gefühl. 
5. Es ist schrecklich und ich habe das Gefühl, es wird nie besser. 
6. Ich sage mir, dass ich tapfer sein muss, obwohl ich Schmerzen habe. 
7. Ich lese. 
8. Ich sage mir, dass ich den Schmerz bezwingen kann. 
9. Ich nehme meine Medikamente ein. 
10. Ich zähle in Gedanken oder denke an ein Lied. 
11. Ich stelle mir den Schmerz als anderes Gefühl vor, z.B. als Taubheit. 
12. Es ist schrecklich und ich habe das Gefühl, dass der Schmerz mich überwältigt. 
13. Ich mache Gedankenspiele, damit ich nicht an den Schmerz denke. 
14. Ich habe das Gefühl, dass mein Leben nicht mehr lebenswert ist.  
15. Ich weiss, eines Tages wird mir jemand helfen, und der Schmerz wird für eine Weile 
weggehen. 
16. Ich spaziere viel. 
17. Ich bete zu Gott, dass der Schmerz nicht lange anhält. 
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18. Ich versuche mir vorzustellen, dass der Schmerz nicht zu meinem Körper gehört, 
sondern eher ausserhalb von mir ist. 
19. Ich entspanne mich. 
20. Ich denke nicht an den Schmerz. 
21. Ich versuche, an die kommenden Jahre zu denken und wie alles sein wird, wenn ich 
den Schmerz losgeworden bin. 
22. Ich sage mir, dass es nicht weh tut. 
23. Ich sage mir, ich darf nicht zulassen, dass mir der Schmerz, bei dem, was ich zu tun 
habe, im Wege steht. 
24. Ich beachte den Schmerz nicht. 
25. Ich habe Vertrauen in die Ärzte, dass meine Schmerzen eines Tages geheilt werden. 
26. Egal wie schlimm die Schmerzen werden, ich weiss, wie ich damit umgehe. 
27. Ich tue so, als ob der Schmerz nicht da wäre. 
28. Ich mache mir Sorgen, ob der Schmerz jemals aufhören wird.  
29. Ich lege mich hin. 
30. Ich denke an schöne Erlebnisse zurück.  
31. Ich denke an Leute, mit denen ich gerne etwas unternehme. 
32. Ich bete, damit der Schmerz aufhört. 
33. Ich dusche oder nehme ein Bad. 
34. Ich stelle mir vor, dass der Schmerz ausserhalb meines Körpers ist. 
35. Ich mache weiter, als ob nichts geschehen wäre. 
36. Ich sehe den Schmerz als Herausforderung und lasse nicht zu, dass er mich stört. 
37. Obwohl es weh tut, mache ich einfach weiter. 
38. Ich habe das Gefühl, dass ich den Schmerz nicht mehr aushalten kann. 
39. Ich versuche unter die Leute zu gehen.  
40. Ich ignoriere den Schmerz. 
41. Ich verlasse mich auf meinen Glauben an Gott. 
42. Ich habe das Gefühl, dass ich kann nicht mehr kann. 
43. Ich denke an Dinge, die ich gerne mache. 
44. Ich mache alles, um mich vom Schmerz abzulenken. 
45. Ich mache etwas Erfreuliches, wie z.B. fernsehen oder Musik hören. 
46. Ich stelle mir vor, dass der Schmerz kein Teil von mir ist. 
47. Ich mache etwas Aktives, wie z.B. Haushaltarbeiten oder andere Alltagstätigkeiten. 
48. Ich benutze ein Heizkissen. 
Aufgrund all Ihrer Methoden, mit dem Schmerz umzugehen oder damit fertig zu 
werden: 
49. Wie viel Kontrolle haben Sie an einem durchschnittlichen Tag über Ihre Schmerzen?  
Keine Kontrolle 
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Durchschnittliche Kontrolle 
Vollständige Kontrolle 
50. Wie stark können Sie den Schmerz an einem durchschnittlichen Tag reduzieren?  
Gar nicht 
Mittel 
Vollständig 
Zuordnung der Items zu den Subskalen: 
Aufmerksamkeitsablenkung 3,10,13,30,31,43
Umdeuten 1,4,11,18,34,46
Selbstinstruktionen 6,8,23,26,36,37
Ignorieren 20,22,24,27,35,40
Beten oder hoffen 15,17,21,25,32,41
Katastrophisieren 5,12,14,28,38,42
Aktivitätssteigerung 2,7,39,44,45,47
Schmerzverhalten 9,16,19,29,33,48
Schmerzkontrolle 49
Schmerzreduktion 50
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CHAPTER 3 
Reliability of the Multidimensional Pain 
Inventory and stability of the MPI 
Classification System in chronic back pain 
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Abstract 
 Objectives. This cross validation study examined the reliability of the Multidimen-
sional Pain Inventory (MPI) and the stability of the Multidimensional Pain Inventory 
Classification System of the empirically derived subgroup classification obtained by 
cluster analysis in chronic musculoskeletal pain. Reliability of the German Multidimen-
sional Pain Inventory was only examined once in the past in a small sample. Previous 
international studies mainly involving fibromyalgia patients showed that retest resulted 
in 33-38% of patients being assigned to a different Multidimensional Pain Inventory 
subgroup classification. 
 Methods. Participants were 204 persons with chronic musculoskeletal pain (82% 
chronic non-specific back pain). Subgroup classification was conducted by cluster analy-
sis at 4 weeks before entry (= test) and at entry into the pain management program (= 
retest) using Multidimensional Pain Inventory scale scores. No therapeutic interven-
tions in this period were conducted. Reliability was quantified by intraclass correlation 
coefficients (ICC) and stability by kappa coefficients (κ). 
 Results. Reliability of the Multidimensional Pain Inventory scales was least with ICC 
= 0.57 for the scale life control and further ranged from ICC = 0.72 (negative mood) to 
0.87 (solicitous responses) in the other scales. At retest, 82% of the patients in the 
Multidimensional Pain Inventory cluster interpersonally distressed (κ = 0.69), 80% of 
the adaptive copers (κ = 0.58), and 75% of the dysfunctional patients (κ = 0.70) did not 
change classification. In total, 22% of the patients changed Multidimensional Pain In-
ventory cluster group, mainly into the adaptive copers subgroup.  
 Conclusions. Test-retest reliability of the German Multidimensional Pain Inventory 
was moderate to good and comparable to other language versions. Multidimensional 
Pain Inventory subgroup classification is substantially stable in chronic back pain pa-
tients when compared to other diagnostic groups and other examiner-based subgroup 
classification systems. The MPI Classification System can be recommended for reliable 
and stable specification of subgroups in observational and interventional studies in 
patients with chronic musculoskeletal pain.  
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Background 
The search for homogeneous subgroups of patients with nonspecific low back pain who 
respond best to subgroup-specific pain management interventions has been on the 
international research agenda for over 15 years [1]. The process of developing treat-
ment-based subgroups can be divided into 3 stages: 1) hypothesis generation; proposal 
of potential effect modifiers; 2) hypothesis testing; testing of the potential effect modi-
fiers; 3) replication; assessing generalizability [2]. Several physiotherapy-based classifi-
cation systems for low back pain have been developed [3, 4]. So far, most subgrouping 
approaches have been based on unproven theories, are poorly validated or remain, as 
yet, unreplicated in other studies [5]. Besides biological factors of low back pain and 
spinal movement or mechanical loading strategies, especially in chronic pain syndromes 
psychosocial factors are also likely to modify treatment response. As such, investigation 
of effect modifiers from the full biopsychosocial spectrum seems the most likely way to 
identify clinically important subgroups [6]. 
 The Multidimensional Pain Inventory is a self-report instrument assessing not only 
pain intensity and pain interference, but also the way people cope with pain, it 
measures support as well as potential reinforcement of pain behaviors by the patient’s 
significant other, and peoples’ general activity level. The Multidimensional Pain Inven-
tory has been translated into several languages and validated in various settings for 
several diagnostic pain groups [7, 8]. The reliability of the German version of the Multi-
dimensional Pain Inventory has been tested in a relatively small sample by only one 
research group for over 20 years [9]. An approach based on cluster analysis of the mean 
scores of the scales of the Multidimensional Pain Inventory yielded three unique pro-
files or subgroups for patients with chronic pain [10]. So far, two research groups as-
sessed test-retest stability of the MPI Classification System [11-13]. In their samples of 
patients with low back pain and fibromyalgia up to one third of the patients changed 
Multidimensional Pain Inventory classification at retest. The authors concluded that for 
a sizeable number of chronic pain patients, Multidimensional Pain Inventory subgroup 
classifications may not be stable and need to be reconsidered [11, 13]. 
 The main aim of the present study was to re-examine the test-retest stability of the 
MPI Taxonomy Classification in patients with persistent musculoskeletal pain. The sec-
ondary objective focussed on the elaboration of additional evidence concerning inter-
nal consistency of items within scales and test-retest reliability at scale level of the 
German version of the Multidimensional Pain Inventory. 
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Methods 
Setting and participants 
The study was conducted at the rehabilitation clinic “RehaClinic” (locations Bad Zurzach 
and Braunwald, Switzerland), which is attended by severely disabled patients suffering 
from persistent musculoskeletal pain. The patients were assessed prior to participating 
in the “Zurzach Interdisciplinary Pain Program” - ZISP. The program is a 4-week in-
house, standardized, interdisciplinary pain management program. All subjects were 
consecutively admitted and included in the study and 1) suffered either from chronic 
non-specific back pain (i.e. lumbar, thoracic, or pan-vertebral pain syndrome without 
serious spinal pathology or nerve root pain) or suffered from fibromyalgia according to 
the original American College of Rheumatology criteria, 2) had pain for at least 6 
months and 3) were disabled by their pain enough to warrant admission to an intensive 
inpatient pain management program [14, 15]. Further inclusion criteria were 4) ability 
to complete self-assessment questionnaires, 5) understand the German language, 6) no 
psycho-intellectual inabilities, and 7) provision of written, signed informed consent. 
Exclusion criteria were 1) severe somatic illness requiring specific treatment such as 
cancer, inflammatory rheumatic disease, neurological disease, and pain after a recent 
operation, 2) manifest psychiatric disorder such as dementia, psychosis, suicidality, and 
3) failed inclusion criteria. 
 The study design is a cohort study with 4 weeks follow-up. The study protocol was 
approved by the Local Ethic Commission (Health Department in Aarau, Switzerland, no. 
EK AG 2008/026). All participants gave written informed consent according to the Dec-
laration of Helsinki. 
Outcome measures 
The West Haven-Yale Multidimensional Pain Inventory (MPI) measures multiple aspects 
of the individual pain experience and comprises three sections with a total of 13 factors 
analytically derived from scales based on items ranging from 0 to 6 (seven points) [16]. 
The factor structure has been replicated in several international samples. Kerns and 
colleagues reported excellent validity, internal consistency, and reliability of this in-
strument [16]. Results of a study by Junghaenel and Broderick revealed that Multidi-
mensional Pain Inventory ratings obtained from the partner or health care provider 
corresponded with the self-report patient profiles [12]. The Initiative on Methods, 
Measurement, and Pain Assessment in Clinical Trials (IMMPACT) recommended the 
Multidimensional Pain Inventory as a valuable component of a comprehensive assess-
ment tool [17]. The German version of the Multidimensional Pain Inventory is a self-
report 51-item inventory with the same eleven scales as the original US version: pain 
severity, interference due to pain, life control, affective distress (synonymously de-
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scribed as negative mood), support, punishing responses, solicitous responses, distract-
ing responses, social and recreational activities, household chores, and activities away 
from home [18]. The last three subscales can be summarized into one subscale of gen-
eral activities. Cronbach’s alpha reliability coefficients vary between α = 0.63-0.93, and 
test-retest reliability scores ranged from rp = 0.46-0.93 [9]. Comparing 5 assessment 
instruments for chronic pain, the Multidimensional Pain Inventory was most responsive 
in all comparable domains [19]. 
 An approach based on cluster analysis of the mean scores of the scales of the Mul-
tidimensional Pain Inventory yielded three unique profiles or subgroups for patients 
with chronic pain. The Multidimensional Pain Inventory differentiates between three 
subgroups labelled as adaptive copers, dysfunctional, and interpersonally distressed 
[10]. The interpersonally distressed cluster is mainly characterized by lower levels of 
perceived solicitous and distraction responses from the patients’ partners or spouses 
and higher levels of punishing responses compared to the adaptive copers and dysfunc-
tional clusters. The adaptive copers cluster, compared with the other two subgroups, is 
characterized by less pain severity, less interference with everyday life due to pain and 
less affective distress, more perception of life control and higher activity level. The 
persons of the dysfunctional cluster report high pain severity, high interference and 
activity distress, low life control, and low activity level. 
Statistical analysis 
The Multidimensional Pain Inventory was assessed 4 weeks before entry to the clinic 
and at entry to the clinic (pre-treatment). No therapeutic interventions took place in 
this period. This time interval is 1) sufficiently short that we can assume that the under-
lying process of chronic musculoskeletal pain is unlikely to have changed, and 2) suffi-
ciently long that we can assume that the patients did not memorize their item respons-
es of the first occasion.  
 The internal consistency of the Multidimensional Pain Inventory was assessed by 
using Cronbach’s alpha, a statistic used to calculate the strength of the association 
between the individual items within the scale. The alpha coefficient examines inter-
item correlations and therefore relates to its homogeneity. Because a Cronbach’s alpha 
≥ 0.90 might suggest a high level of item redundancy, ideally Cronbach’s alpha should 
be above 0.70, but probably not higher than 0.90 [20]. 
 Test-retest reliability of the Multidimensional Pain Inventory scales was determined 
by intraclass correlation coefficients (ICC). The intraclass correlation coefficient 
measures the consistency and degree of correspondence of the test and retest re-
sponses pairwise for each item and each patient for the whole sample and ranges from 
0.00 (no consistency) to 1.00 (perfect consistency). Although the intraclass correlation 
coefficient is primarily designed for use with interval or ratio data, the intraclass corre-
lation coefficient can be applied without distortion of the data on the ordinal scale of 
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the Multidimensional Pain Inventory when intervals between such measurements are 
assumed to be equivalent [21]. For comparability with other studies test-retest reliabil-
ity of the Multidimensional Pain Inventory scales was also determined by Pearson cor-
relation coefficients: 0.00 means no correlation and 1.00 means perfect correlation. 
 According to Turk and colleagues, the empirically derived subgroups were defined 
by confirmatory cluster analysis using a predefined three cluster solution [10]. The 
Multidimensional Pain Inventory score patterns of this study were depicted as graphs 
of the mean Multidimensional Pain Inventory baseline scale scores and compared to 
the patterns described by Turk and colleagues and our previous studies on this topic 
using the rank orders of the three subgroups within one Multidimensional Pain Inven-
tory subscale [22, 23].  
 The test-retest stability of the Multidimensional Pain Inventory clusters was deter-
mined by percent of agreement and kappa coefficients. The kappa statistic is a chance-
corrected measure of percent agreement for ordinal or nominal scales [24]. It is a use-
ful method for summarizing observer consistency (intra- or intertester reliability) and 
provides valuable information on the stability of classification procedures used in mus-
culoskeletal practice, for example. The following standards for strength of agreement 
for the Kappa coefficient have been proposed: <0 = poor, 0.00-0.20 = slight, 0.21-0.40 = 
fair, 0.41-0.60 = moderate, 0.61-0.80 = substantial and 0.81-1.00 = almost perfect [25].  
 All analyses were performed using the statistical software package SPSS 20.0 for 
Windows® (SPSS Inc., Chicago, IL, USA). 
Results 
Participants at baseline 
Table 1 describes the demographic and medical data of the total sample of patients 
with mainly chronic non-specific back pain on entry into the pain management program 
(n = 204). The subjects were characterized by relatively young age (on average 46.8 
years), high level of incapacity for work (50.5%), and a long history of pain (on average 
10.4 years). High scores for pain intensity, interference with pain, and negative mood, 
and low scores for life control and general activity level complete the profile of these 
patients in this sample (Table 2). 
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Table 1. Demographic characteristics of the sample (n = 204) 
Dimension  
Diagnosis chronic back pain (%) 82
Diagnosis fibromyalgia (%) 15
Diagnosis, other (%) 3
Average age, min-max (years) 46.8   (16.7-72.8)
Average beginning of symptoms, min-max (years) 10.4  (0.25-64.5)
Sex: female (%) 71
Education: none (%) 1
Education: Grade 10-12 (%) 31
Education: High school graduate (%) 55
Education: College graduate (%) 9
Education: University graduate (%) 4
Employment status: inability for work (%) 50
Employment status: full-time (%) 29
Smoking: yes (%) 43
Marital status: single (%) 23
Marital status: married (%) 66
Marital status: other (%) 11
 
Table 2. Test-retest reliability of mean MPI scale scores and internal consistency of the items at scale level for 
all subjects (n = 204)  
MPI subscales T0 (m±s) T1 (m±s) ICC (95% CI) CA (95% CI) 
Pain severity (100 = most) 76.1±16.5 73.9±16.0 0.77 (0.70 to 0.82) 0.81 (0.77 to 0.86) 
Interference (100 = worst) 74.7±15.9 72.5±16.1 0.82 (0.77 to 0.86) 0.83 (0.76 to 0.86) 
Life control (100 = best) 49.4±22.1 50.2±21.4 0.57 (0.47 to 0.66) 0.76 (0.69 to 0.81) 
Negative mood (100 = worst) 61.0±19.6 58.4±22.1 0.72 (0.65 to 0.78) 0.60 (0.49 to 0.69) 
Support (100 = most) 69.4±24.8 69.0±26.2 0.85 (0.80 to 0.88) 0.82 (0.77 to 0.86) 
Negative responses (100 = most) 25.6±26.1 24.3±24.4 0.75 (0.69 to 0.81) 0.86 (0.82 to 0.89) 
Solicitous responses (100 = best) 58.3±25.0 58.6±25.0 0.87 (0.83 to 0.90) 0.81 (0.76 to 0.85) 
Distracting responses (100 = best) 53.6±25.3 55.3±24.8 0.77 (0.71 to 0.82) 0.69 (0.61 to 0.76) 
General activity (100 = most) 34.5±13.7 35.1±13.4 0.86 (0.82 to 0.90) 0.82 (0.78 to 0.86) 
Abbreviations: MPI, Multidimensional Pain Inventory; CA, Cronbach’s alpha; 95% CI, 95% confidence interval; 
T0, 4 weeks before entry to pain management program; T1, at entry to pain management program; m, mean; 
s, standard deviation; ICC, intraclass correlation coefficient. 
Internal consistency and test-retest reliability of the MPI scales 
Cronbach’s alpha was measured for 7 out of 9 Multidimensional Pain Inventory scales 
with scores between 0.76 and 0.86 and so reflects a good association between the 
individual items within their scales. The internal consistency of the items within the 
scales negative mood and distracting responses was smaller (0.60, and 0.69, respective-
ly). Test-retest reliability, measured at an average 4-week time interval, for the mean 
C H A P T E R  3  
 56
Multidimensional Pain Inventory scale scores was very good with scores between ICC = 
0.72 and 0.87. Only the score for the MPI scale life control (ICC = 0.57) was less favour-
able (Table 2). 
Classification and test-retest stability of patients in the MPI subgroups 
All 204 patients could be allocated by cluster analysis into one of the three predefined 
chronic pain subgroups at both time points. The Multidimensional Pain Inventory 
scores differed significantly between the three clusters: the patients in the dysfunction-
al cluster showed highest scores for pain severity, interference due to pain, and nega-
tive mood and lowest scores for general activities. In accordance with the predefined 
profile of the empirically derived MPI Classification System, the cluster interpersonally 
distressed showed lowest scores for support, solicitous and distracting responses by 
their partner or spouses, and the highest score for negative/ punishing responses by 
their partner or spouses. Compared to the other two subgroups, the adaptive copers 
showed best scores for life control, negative mood, and general activities (Table 3). 
 At retest after 4 weeks, 82% of the patients in the Multidimensional Pain Inventory 
cluster interpersonally distressed (κ = 0.69), 80% of the adaptive copers (κ = 0.58), and 
75% of the dysfunctional patients (κ = 0.70) did not change classification profile (Figure 
1). Over the whole sample, 159 patients (78%) had a stable MPI subgroup classification. 
But, 22% of the patients (n = 45) did change Multidimensional Pain Inventory cluster 
group at retest. Most of the retest classification changes occurred in the subgroup 
adaptive copers: 18 dysfunctional patients (17%) and 7 interpersonally distressed pa-
tients (14%) were classified as adaptive copers at retest. Least retest classification 
changes took place in the dysfunctional subgroup (4% of interpersonally distressed 
patients and 6% of the adaptive copers). 
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Table 3. Mean scores and standard deviations of the scales of the MPI clusters at 4 weeks before and at entry 
to a pain program 
 
MPI scales 
MPI clusters at T0 (m±s) MPI clusters at T1 (m±s) 
ID n = 49 AC n = 51 DYS n = 104 ID n = 55 AC n = 66 DYS n = 83 
Pain severity (100 = most) 75.9±15.1 63.0±17.0 82.6±12.7 76.4±12.1 59.5±15.2 83.6±9.4 
Interference (100 = worst) 77.2±13.0 58.9±16.4 81.3±10.9 76.6±11.7 57.5±15.2 81.7±9.7 
Life control (100 = best) 42.2±17.6 65.2±18.2 45.1±22.2 42.7±19.2 63.7±17.0 44.4±20.9 
Negative mood (100 = worst) 66.3±13.6 39.8±17.3 68.9±15.0 67.3±14.9 38.0±17.3 68.8±18.0 
Support (100 = most) 44.0±23.5 61.9±19.7 85.0±13.7 41.6±24.0 66.9±18.5 88.7±12.0 
Negative, punishing responses (100 = most) 34.4±29.1 11.0±13.8 28.6±26.5 33.0±29.2 13.9±15.3 26.9±24.1 
Solicitous responses (100 = best) 33.3±17.1 47.5±20.0 75.5±15.2 34.5±16.7 53.0±19.0 79.0±15.5 
Distracting responses (100 = best) 30.5±18.7 43.0±21.2 69.7±17.6 33.7±20.5 50.5±19.4 73.5±16.9 
General activity (100 = most) 34.1±12.0 38.1±12.1 33.0±14.9 37.5±11.6 38.2±12.5 30.9±14.3 
Abbreviations: MPI, Multidimensional Pain Inventory; ID, MPI cluster interpersonally distressed; AC, MPI 
cluster adaptive copers; DYS, MPI cluster dysfunctional; T0, 4 weeks before entry to pain management pro-
gram; T1, at entry to pain management program; m, mean; s, standard deviation. 
 
Figure 1. MPI subgroup classification changes 
Abbreviations: T0, 4 weeks before entry to pain management program; T1, at entry to pain management
program; MPI, Multidimensional Pain Inventory; ID, MPI cluster interpersonally distressed; AC, MPI cluster 
adaptive copers; DYS, MPI cluster dysfunctional; κ, Cohen’s Kappa coefficient. 
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Discussion 
In this study, we were able to provide additional evidence about the clinimetrical prop-
erties of the Multidimensional Pain Inventory. Testing it in 204 patients with chronic 
musculoskeletal pain – mainly chronic nonspecific back pain – demonstrated that test-
retest reliability at scale level of the German version of the Multidimensional Pain In-
ventory was moderate to good and comparable to other language versions. The Multi-
dimensional Pain Inventory Classification System – classifying patients into predefined 
subgroups labelled as adaptive copers, dysfunctional, and interpersonally distressed – is 
substantially stable. 
Reliability of scales compared to other versions 
In a sample of 185 patients (60% chronic low back pain) Flor and colleagues measured 
an internal consistency score for the scale general activities of α = 0.63 [9]. In our sam-
ple we found for the same scale the superior score of α = 0.82. Test-retest reliability at 
an average 4-week time interval of the mean Multidimensional Pain Inventory scores at 
scale level yielded correlation coefficients between rp = 0.73 and 0.87, making it on 
average better than the original German version and comparable with the original US 
version and several other language versions (Table 4). For this benchmark, the test-
retest correlation coefficient for life control in our sample (rp = 0.57) was lower. 
 
Table 4. Comparison of different versions of the MPI concerning test-retest reliability of scales  
Pearson correlation coefficients (rp) 
 
 
MPI subscales 
Original German 
version  
[9]  
(n = 25) 
Current 
study  
 
(n = 204) 
Original US 
version  
16]  
(n = 60) 
US cross-
validation 
[11] 
(n = 199) 
Swedish 
version  
[28] 
(n = 54) 
Dutch 
version 
[29]  
 (n = 59) 
Pain severity 0.59 0.77 0.82 0.74 0.75 0.74 
Interference 0.78 0.82 0.86 0.87 0.85 0.89 
Life control 0.72 0.57 0.68 0.62 0.81 0.74 
Negative mood 0.68 0.73 0.69 0.53 0.74 0.73 
Support 0.46 0.85 0.80 0.84 0.88 0.88 
Negative responses 0.70 0.75 0.84 0.79 0.75 0.81 
Solicitous responses 0.72 0.87 0.89 0.83 0.73 0.78 
Distracting responses 0.89  0.77 0.62 0.80 0.76 0.65 
General activity 0.73 0.86 0.89 0.85 0.80 0.78 
Abbreviations: MPI, Multidimensional Pain Inventory; US, United States of America. 
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Interpretation of MPI classification changes 
Most of the retest classification changes occurred in the subgroup adaptive copers: 
17% of the dysfunctional patients and 14% of the interpersonally distressed patients 
were at retest classified in the less disabled subgroup of adaptive copers (Figure 1). This 
change in the subjective pain experience of the patients in this sample occurred within 
a 4-week period, although no therapeutic interventions took place. We hypothesize 
that anticipation of participation in a pain management program might have a positive 
effect on the mental health of the patients (improvement of locus of control, reduction 
of anxiety and depression), and so explains why a substantial number of dysfunctional 
and interpersonally distressed patients change at retest into the more favorable adap-
tive copers cluster. 
Stability of MPI Classification System compared to other research samples 
This study partly challenges the results of three other research groups assessing the 
test-retest stability of the MPI Classification System [11-13]. In the two samples of fi-
bromyalgia up to one third of the patients changed Multidimensional Pain Inventory 
classification at retest (Table 5). These authors concluded that for a sizeable number of 
chronic pain patients, Multidimensional Pain Inventory classifications may not be stable 
and need to be reconsidered [11-13]. Our data on test-retest stability in patients with 
predominantly chronic back pain suggest that the MPI Classification System is according 
the definition of the kappa values of 0.58-0.70 substantially stable: only 22% of patients 
with predominantly chronic back pain who completed the Multidimensional Pain Inven-
tory and who had been classified into one of the empirically derived subgroups altered 
their responses sufficiently to be classified into a different pain coping style after a four 
week time interval without therapeutic interventions. Our results are in line with the 
score changes of 28% of the predominantly low back pain patients in the study by 
Junghaenel & Broderick [12]. Further studies are needed to replicate these results in 
other musculoskeletal pain disorders. So far, the German version of the Multidimen-
sional Pain Inventory can be recommended for reliable and stable classification of sub-
groups of patients with chronic back pain in observational studies and randomized 
controlled trials.  
 
Table 5. Comparison of this sample with prior research samples investigating MPI subgroup stability 
Authors Number of 
patients 
Main diagnosis Average time 
between test-retest 
Percentage of unstable 
patients at retest 
Current study  n = 204 Chronic back pain (82%) 28 days 22%
Junghaenel & Broderick [12]  n = 99 Low back pain (84%) 14 days 28%
McKillop & Nielsen [13] n = 376 Fibromyalgia (100%) 56 days 33%
Broderick et al.[11] n = 199 Fibromyalgia (100%) 27 days 35%
Abbreviation: MPI, Multidimensional Pain Inventory. 
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Comparison of MPI Classification System with other back pain classification systems 
The Treatment Based Classification developed by Delitto and colleagues and the 
O’Sullivan Classification System are validated physiotherapy movement-based classifi-
cation approaches to low back pain [26, 27]. In these classifications, analysis of mainly 
mechanical spinal loading strategies and modified spinal movement strategies deter-
mines subgrouping. In accordance with the MPI Classification System, both classifica-
tions also assess certain psychosocial aspects (fear-avoidance behavior, and/ or mala-
daptive pain behavior). Comparison of percent agreement scores (75-82%) and kappa 
coefficients (0.58-0.70) for test-retest stability of the MPI Classification System reveals 
scores that are at least as good as the corresponding scores of the widely accepted 
Treatment Based Classification and the O’Sullivan Classification System (31-97% agree-
ment, κ = 0.11-0.80) (Table 6). 
 
Table 6. Chance-corrected measures of agreement of different back pain classification systems comprising 
psychosocial aspects  
Classification system No. of clusters Percent agreement Kappa coefficient (κ) 
MPI Classification System 3  75-82% 0.58-0.70 (current study) 
Treatment Based Classification  3  65%
76% 
31-55% 
79-81% 
58-90% 
0.49-0.56 [30] 
0.60 [31]  
0.14-0.45 [32] 
0.14 [33] 
0.11-0.77 [34] 
O’Sullivan Classification System 5 70-97%
73-92% 
0.61 (0.47-0.80) [35] 
0.65 (0.57-0.74) [36] 
Abbreviation: MPI, Multidimensional Pain Inventory. 
Strengths and limitations of this study 
The present study has several strengths: a large sample size, no missing data, and the 
use of a valid assessment tool implemented worldwide. On the other hand, a limitation 
of the study was that the patient sample was somewhat heterogeneous with 82% 
chronic nonspecific back pain, 15% fibromyalgia and 3% other medical diagnoses. This is 
a possible source of variance that may complicate the analysis, but the reliability and 
stability analyses compared scores for the same patient, a procedure which is not af-
fected by the heterogeneity of the sample. 
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Conclusions 
The reliability of the German Multidimensional Pain Inventory was moderate to good 
and comparable to other language versions. Multidimensional Pain Inventory subgroup 
classification is substantially stable in chronic back pain patients when compared to 
other diagnostic groups and other examiner-based subgroup classification systems. The 
MPI Classification System can be recommended for reliable and stable specification of 
subgroups in observational and interventional studies. 
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CHAPTER 4 
Refined insights into the pain-depression 
association in chronic pain patients 
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Abstract 
 Objectives. The relationship between chronic pain and depression is controversial 
and the data on association show strong variation. This study aimed to provide refined 
correlation and regression data on the basis of categorical and continuous measures. 
 Methods. Cross-sectional assessment was based on standardized instruments that 
measure on a quasi-continuous scale, the Short From-36 (SF-36), the Hospital Anxiety 
and Depression Scale (HADS) and the Multidimensional Pain Inventory (MPI). Correla-
tions between depression and pain were determined by the instruments’ scales, with 
and without correction for confounders, and within chronic pain subgroups using mul-
tivariate regression analysis. 
 Results. In 273 chronic pain patients participating in an inpatient pain rehabilitation 
program, the Multidimensional Pain Inventory pain severity scale and the Hospital 
Anxiety and Depression Scale depression scale showed maximum overall correlations of 
0.27 to 0.29 (bivariate) and 0.30 (partial). The odds ratios for depression varied be-
tween 1.72 and 2.10 for different pain levels. Distinguishing three subtypes of pain 
patients, the pain-depression correlation was moderate in the “interpersonally dis-
tressed” subgroup (up to 0.57) (characterized by relatively low support, high punishing, 
low solicitous, and low distracting responses), weak in the “dysfunctional” subgroup (up 
to 0.26), and absent in the “adaptive copers / minimizers” subgroup (up to –0.09). 
 Conclusions. The strengths of the pain-depression association and the “dose-
response” relationship were both weak – weaker than to be expected if the hypothesis 
of a causal relationship were true. In the “interpersonally distressed” subgroup, the 
moderate association may have an impact on pain management, that is, pain could be 
treated by treatment of depression and vice versa. 
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Introduction 
Depression and (chronic) pain are highly prevalent disorders that make an enormous 
impact and high demands on individual health care and public health management and 
lead to high rates of chronic courses [1-3]. Management of both disorders is often un-
successful and the question arises as to whether 1 disorder could be influenced by 
treatment of the other [4, 5]. On the basis of our intuition, our clinical experience, and 
the findings and hypotheses of many study reports, depression and chronic pain are 
likely to be causally related and vice versa. This means that reduction of pain would 
imply reduction of depression and reduction of depression would lead to less pain. 
Comprehensive literature overviews on these issues and on the impact of antidepres-
sants on pain can be found in several reviews [6-9]. Some studies favored the pathway 
of pain leading to depression – through the loss of functional and psychosocial activities 
and learned helplessness – rather than depression leading to pain [6, 10-12]. Other 
reports showed that pain decreased when depression was successfully treated (re-
viewed in Ref. [12]). 
 On the one hand, there are several plausible explanatory hypotheses for the pain-
depression association that are outlined, for example, in Ref. [13], serotonin and nora-
drenalin play a role in both depression and pain sensations and may influence each 
other. This is supported by the observation that tricyclic antidepressants and dual (ser-
otonin and noradrenalin) reuptake inhibitors relieve pain. Additionally, exercise, psy-
chological, and behavioral treatments both address pain and depression simultaneously 
[14]. In contrast, it was not possible to prove the other pathway that analgesics can 
reduce depression; in contrary, there are findings which indicate that the (common) 
use of non-steroidal antirheumatic drugs may increase the risk of depression [13]. 
 On the other hand, the majority of experimental studies failed to prove a positive 
correlation between pain and depression: experimentally induced pain revealed in-
creased pain thresholds, that is, diminished perception of pain in depressed subjects 
[15]. Moreover, there are many other explanatory models that hypothesized different 
pathophysiologic, genetic, psychosocial, psychological, therapeutic, cognitive, and role 
behavioral pathways [16-18]. Some of them, however, contradicted each other [15-18]. 
 A literature search in MedLine (1966 till the end of September 2007) with the key-
words depression, pain, and association or correlation yielded over 1200 articles. Re-
ports of a large number of studies state a positive association of depression with chron-
ic pain in population surveys (e.g. Refs. [3, 14, 19-28], in primary care (e.g. Ref. [29]), 
and in elderly people with a high prevalence of musculoskeletal disorders (e.g. Refs. [1, 
21, 30-32]). Most of these studies were cross-sectional surveys with huge sample sizes 
up to 42,697 [23] and some were longitudinal [25, 26, 28, 31]. The variation of the as-
sociation in these studies has a wide range showing odds ratios (ORs) from 1.14 to 7.31 
[1, 3, 13, 14, 19-27, 29-32]. 
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However, there are also studies which resulted in weak or no associations between 
depression and chronic pain, especially when calculating correlation data in primary 
care (e.g. Ref. [28]: correlation 0.27, corrected for the confounders age, sex, social 
class, employment status, and disability: -0.04) and in clinic patient samples (e.g. Ref 
[33]: correlation 0.22, [34]: correlation 0.01 for young and 0.51 for elderly patients); see 
also Ref. [11]. Without adjustment for confounders, chronic pain predicted future de-
pression, but with adjustment (by age, sex, anxiety, and various general health scores) 
it did not [35]. Lifetime depression diagnosis was elevated in fibromyalgia when self-
assessed, but was not confirmed when the patients were clinically interviewed and 
received DSM-IV diagnoses [20]. In summary, the strength of the pain-depression asso-
ciation is, therefore, not clear.  
 Most of the reviewed studies only used (percentage) prevalences and ORs to quan-
tify the pain-depression association. This implies thresholds of the symp-
toms/syndromes to define presence or absence of the disorder. Depending on these 
thresholds and the disease definitions, prevalences of subjects with the diagnosis of 
pain and depression show a large variability resulting in widely varying association re-
sults when comparing different studies (e.g. see Refs [8, 20]).  
 In contrast to a dichotomous diagnostic decision, (quasi-)continuous quantification 
capturing the degree, the severity, and the burden of the depression and pain syn-
dromes on a finely graded scale, for example, from 0 = no pain/depression to 100 = 
maximal pain/depression with all possible values in between, will produce a much more 
refined assessment as it corresponds to clinical reality. With this approach, the associa-
tion could be examined by correlation and regression analysis in a much more sophisti-
cated way taking into account the whole range of symptoms. Although pain is usually 
interval (e.g. on a numeric rating scale: 0 = no pain to 10 = worst pain) and depression 
ordinal scaled (presence of symptoms: always, …, sometimes, … , never), the 2 scales 
can be correlated to each other assuming that the interval scale also represents a ordi-
nal grading (rather than vice versa).  
 This study aims to derive refined (i.e. by different methods, continuous scales, 
stratification into subgroups, etc.) correlation and regression data from a patient sam-
ple to contribute to the debate of whether depression and pain are strongly enough 
related to support the hypothesis of causality. The influence of confounders on the 
association and the hypothesis as to whether correlations are different within partial 
samples/subgroups was examined. 
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Methods 
Setting and participants 
The “Zurzach chronic pain study” was conducted to examine health and quality of life in 
a specific and comprehensive way before and after a specifically structured in-patient 
interdisciplinary pain management program [36]. Patients with chronic pain, that is, 
pain of at least 6 months duration, subsequently admitted to the rehabilitation clinic 
“RehaClinic”, Bad Zurzach, Switzerland, were included. To qualify for inclusion, they had 
to have back pain, fibromyalgia, or chronic widespread pain, that is, soft-tissue pain 
syndromes in at least 3 body quadrants without meeting the diagnostic criteria for 
fibromyalgia (for the definition of fibromyalgia see Ref. [37]). The study’s protocol was 
approved by the local ethics committee and written informed consent was obtained 
from all participants. 
Outcome measures 
Data were obtained by a set of self-assessment instruments, including the Short Form 
36 (SF-36), the Multidimensional Pain Inventory (MPI), and the Hospital Anxiety and 
Depression Scale (HADS), and by reviewing the medical records. The SF-36 is the most 
frequently applied generic, holistic health status and quality of life instrument world-
wide. It comprehensively measures self-rated biopsychosocial health and abilities on 
the basis of 36 items resulting in the following 8 scales: physical functioning, role physi-
cal, bodily pain, general health, vitality, social function, role emotional, and mental 
health [38]. It has been cross-culturally adapted into German and extensively tested in 
numerous settings [39]. The MPI was specially developed for the research of chronic 
pain and assesses pain and its biopsychosocial consequences on the basis of 51 items 
resulting in the following 12 scales: pain severity, interference with pain, negative 
mood, support, life control, self-efficacy/locus of control (control item), negative re-
sponses, solicitous responses, distracting responses (by the partner or spouse for each 
response scale), social and away from home activities, household chores, and outdoor 
work (the latter 3 activity scales are often summarized into 1 activity scale) [40]. As the 
German version has been tested and validated, it has been extensively used in various 
studies [41]. The HADS was originally developed for the specific and continuous as-
sessment of affective health of hospital medical (nonpsychiatric) outpatients and con-
sists of 14 items that make up the 2 scales, anxiety and depression [42]. After standard-
ized cross-cultural adaptation, the German version was extensively tested and validated 
in various settings [43]. 
 The MPI pain severity, the HADS depression, and HADS anxiety scales were trans-
formed into a scale from 0 = no pain/depression/anxiety to 100 = maximal 
pain/depression/anxiety to ease comparison. The SF-36 bodily pain scale was scored 
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from 0 = maximal pain to 100 = no pain and the SF-36 physical functioning from 0 = 
worst/no function to 100 = best/full function as originally described. All other scores 
were scaled from 0 to 100 according to the instructions in the manuals (see legend of 
Table 1). 
 In addition, pain was assessed by the numerical rating scale scaling pain into inte-
ger numbers from 0 = no pain to 10 = maximal pain (11 levels) [44]. 
 
Table 1. Descriptive data of the sample and the subgroups 
Mean±s Whole sample Dysfunctional Interpersonally 
distressed 
Adaptive copers/ 
minimizers 
n (% female) 273 (79.9%) 107 (77.6%) 61 (85.2%) 100 (79.0%) 
Age 46.3±10.5 44.4±10.2 48.0±11.3 47.2±10.3 
MPI pain severity 77.0±15.0 83.3±12.4 71.5±16.5 73.8±14.2 
MPI interference with pain 71.7±16.7 82.8±9.6 66.4±18.3 63.0±15.0 
MPI negative mood 57.6±22.1 70.6±15.5 61.1±22.1 41.4±17.7 
MPI support 68.3±29.6 86.3±15.7 25.0±20.3 75.4±17.2 
MPI life control 47.8±20.2 39.2±17.5 41.3±17.8 61.0±16.7 
MPI punishing responses 22.5±23.6 24.4±23.2 30.8±29.5 16.6±17.9 
MPI solicitous responses 55.8±28.6 74.8±17.0 20.5±17.2 59.9±20.5 
MPI distracting responses 52.1±28.1 69.7±19.0 21.9±21.1 54.4±21.9 
MPI general activity 39.9±13.4 36.2±13.5 40.2±14.5 43.7±11.7 
HADS depression 44.5±20.8 52.7±17.8 50.0±21.5 32.0±17.1 
HADS anxiety 50.1±20.9 59.7±17.7 53.1±20.4 38.2±18.6 
SF-36 physical functioning 39.5±21.0 32.4±18.8 44.1±21.5 44.3±21.1 
SF-36 mental health 45.7±19.6 36.9±15.0 41.2±18.8 57.8±18.6 
Abbreviations: s, standard deviation; MPI, Multidimensional Pain Inventory; HADS, Hospital Anxiety and 
Depression Scale; SF-36, Short Form 36.  
NOTE. Scaling: 0=best, 100=worst for MPI pain severity, MPI interference with pain, MPI negative mood, 
HADS depression, HADS anxiety; 0=no response, 100= most responses for MPI responses; 0=worst, 100=best 
for MPI activity, SF-36 physical functioning, SF-36 mental health. 
Statistical analysis 
The baseline data before treatment in the rehabilitation program were analyzed for this 
study. The instruments’ scores for pain and depression are shown descriptively and 
were tested for normal distribution using the Komolgorov-Smirnov test, and transfor-
mations were performed by various arithmetic functions to improve “normality” and 
correlation. The following transformations were tested: 1/x, x2, x3, √x, 1.5√x, 3√x, ln(x), 
exp(x), sin (x), tan(x), arctan(x), where x = pain or depression. A scatter plot for depres-
sion and pain was compiled and the bivariate linear regression function was deter-
mined.  
 Bivariate parametric Pearson and non-parametric (i.e. distribution independent) 
Spearman rank-correlation coefficients were then calculated for pain and depression 
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and these were compared to each other [45]. Dichotomized data analysis was per-
formed to compare our data with values obtained from published reports. The ORs 
were determined using the MPI pain severity scale with thresholds of ≥ 25, ≥ 50, ≥ 75 
(to stratify arbitrarily chosen thresholds), and 100 score points (100 = maximal pain) 
and the HADS depression scale with the (empirically determined) threshold score of 
42.9 (100 = maximal depression) corresponding to a cut-off score of 9 (21 = maximal 
depression), which showed the highest sensitivity and specificity in differentiating be-
tween depression or no depression [43].  
 Stepwise linear regression modelling was used to predict pain levels (dependent 
variable) on the basis of depression and possible confounders (independent variables) 
and to determine the partial Pearson correlation coefficients for depression and pain 
after controlling for the confounders [46]. According to previous studies, confounders 
were sex, age, living with a partner, education level, working capacity, over-
weight/obesity as assessed by the body mass index, no sports, smoking, number of 
comorbidities, history of arthritis, neurologic, and gastrointestinal diseases [19, 25].  
 Some previously conducted studies have dealt with the confounding role of anxiety 
and physical function [12, 24]. Obviously, anxiety is part of the depressive syndrome 
and depressed persons – with or without pain – are physically less active. Thus, in a 
separate regression model, anxiety and physical functioning were included as con-
founders resulting in a predictive model for depression controlling for anxiety (assessed 
by the HADS anxiety) and physical function (assessed by the SF-36 physical functioning), 
that is, depression dominated by reduced mood, fatigue, and reduced concentration 
ability. 
 As primary outcomes, pain was analyzed by the MPI pain severity and depression 
by the HADS. The MPI pain severity scale is often used in comparable literature and has 
shown the best construct validity properties for the sensation of pain in comparison to 
the other scales of the MPI as these are confounded by psychosocial symptoms and 
problems [47]. The HADS depression scale revealed to be highly sensitive and specific in 
many settings and showed high concurrent validity when compared to other well-
established instruments, as for example the Beck Depression Scale and the Symptom 
Checklist 90 Scale [48]. 
 To keep our results comparable with literature, sensation of pain (MPI pain severi-
ty) was chosen as main outcome and not physical or psychosocial consequences of pain 
(i.e. by MPI interference). In a second step, all instrument scales for depression and 
pain were tested by the model and compared to each other. “Depression” is used to 
abbreviate depressive syndrome in the following. 
 As a last step, we tried to characterize persons with a high correlation between 
depression and pain. First, patients with a high pain-depression correlation were identi-
fied by the regression function using the (arbitrarily determined) +/-10 point intercept 
range and were then compared to those with a low correlation by analysis of variance 
and logistic regression [49]. Second, comparison was made between the subgroups of 
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correlations empirically determined by cluster analysis of the MPI scales according to 
the subgroup definition of Turk et al.[50, 51], a concept which was originally developed 
for back pain and fibromyalgia and which has been applied in several trials (e.g. Refs. 
[52-55]). 
 All analyses were performed using the statistical software package SPSS 15.0 for 
Windows® (SPSS Inc., Chicago, IL). 
Results 
Patients and descriptive data 
Among all 323 patients admitted to the clinic for the first time, 273 were included, 
corresponding to a refusal rate of 15.5%. The reasons for the 50 refusal were, that is, 
inability to fill out the questionnaires (n = 43, 86%), dementia (n = 1), psychosis (n = 2), 
noncompliance (n = 1), and other reasons (n = 3). Descriptive data are shown in Tables 
1 and 2. There were only a few missing data in the assessed parameters: 12 (4.4%) in 
education, 10 (3.7%) in smoking, and 13 (4.8%) in sports leading to a total number of 
258 patients with complete data for the regression analysis (5.5% drop-outs). Age was 
normally distributed (Komolgorov-Smirnov test: p > 0.20). 
 
Table 2. Descriptive data of the confounding variables (whole sample only, n = 273) 
Variable  n      % 
Diagnosis Back pain
Fibromyalgia 
Widespread pain 
116
118 
39 
42.5 
43.2 
14.3 
Education Basic school (8-9 years)
Vocational training 
College/High school/University 
79
133 
49 
28.9 
48.7 
17.9 
Working capacity No 135 49.5 
Living With partner/spouse 210 76.9 
Smoking Yes 108 39.6 
Sport No 127 46.5 
Comorbidities (n) One or more 216 81.1 
Arthritis Present 38 13.9 
Neurological disease Present 24 8.8 
Gastrointestinal disease Present 16 5.9 
Body mass index Mean (standard deviation) 25.7 5.0 
Comorbidities: heart and circulatory, obesity, diabetes mellitus, pulmonary, gastrointestinal, cancer, endo-
crinologic, neurologic, psychiatric (excluded are anxiety and depression), substance abuse, and arthritis. 
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The MPI pain severity and HADS depression scales ranged widely, leading to well-fitted 
data for the regression analysis. However, these scales were not normally distributed 
(Komolgorov-Smirnov test: p ≤ 0.01), although not far from normal distribution, show-
ing relatively low skewness and kurtosis values (data not shown in further detail, see 
Table 2 and also the scatter plot in Fig. 1). The best transformations were pain2 and 
1.5√depression in the sense that they led to distributions which were closest to normal 
distribution. There were very low floor and ceiling effects on the HADS depression scale 
(1 patient scored 0 = no depression, 2 patients scored 100 = maximal depression) and 
no floor but some ceiling effects on the MPI pain severity scale (n = 27, 9.9% scored 100 
= maximal pain). The other parameters measuring pain or depression, the SF-36 bodily 
pain (floor: 23.4% scored 0 = maximal pain), the pain numeric rating scale (ceiling: 
10.6% scored 10 = maximal pain), the MPI negative mood (ceiling: 1.8% scored 100 = 
maximal depression), and the SF-36 mental health (floor: 0.4% scored 0 = worst mental 
health) (Table 2) also showed distributions not far from the normal distribution (data 
not shown in detail). 
Correlation and regression data, dichotomized data 
The bivariate relationship between depression (HADS depression) and pain (MPI pain 
severity) is shown in the scatter plot of Figure 1. The linear equation was pain = 0.21 x 
depression + 67.63, with a bivariate Spearman correlation of 0.27, a bivariate Pearson 
of 0.28, and a multivariate, partial Pearson correlation of 0.30 (all p < 0.001 when test-
ed to correlation 0.00).  
 
Figure 1. Scatterplot of HADS depression against MPI pain severity (n = 273) 
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All these correlation results for the 9 possible combinations of pain and depression 
assessments and the goodness to fit of the regression models (explained variance r2) 
are depicted in Table 3. Although all models resulted in a highly significant better esti-
mate of pain than the constant model (pain = constant) (p < 0.001, F13,245-Test), the 
potential to explain the variance of the pain scales was limited in all models and ranged 
from 13.7% to 20.6%. Further consideration of duration of pain showed that this poten-
tial confounder had almost no predictive power (increase of explained variance of 
+0.01% and partial correlation of –0.04 to the MPI pain severity), and was therefore 
excluded from regression in the following considerations. 
 
Table 3. Correlation and regression results of the different instrument scales of all subjects (n=258) 
  Correlations Regression 
Pain Depression Bivariate
Spearman 
Bivariate 
Pearson 
Partial 
Pearson 
Explained 
variance (r2) (%) 
MPI pain severity HADS depression 0.27 0.28 0.30 20.6 
MPI pain severity MPI negative mood 0.25 0.24 0.24 17.6 
MPI pain severity SF-36 mental health 0.25 0.26 0.24 17.5 
SF-36 bodily pain HADS depression 0.23 0.26 0.22 16.7 
SF-36 bodily pain MPI negative mood 0.16 0.19 0.19 13.7 
SF-36 bodily pain SF-36 mental health 0.22 0.21 0.17 15.0 
Pain NRS HADS depression 0.22 0.24 0.26 18.8 
Pain NRS MPI negative mood 0.13 0.11 0.11 14.3 
Pain NRS SF-36 mental health 0.13 0.13 0.12 14.4 
Abbreviations: MPI, Multidimensional Pain Inventory; HADS, Hospital Anxiety and Depression Scale; SF-36, 
Short Form 36; NRS, Numeric Rating Scale (0-10). 
 
The best model was that of MPI pain severity and HADS depression with 20.6% ex-
plained variance as expected a priori by the appropriateness of the content validity of 
these 2 scales. The model with the closest to normal distribution of variables, that is, 
with MPI pain severity2 as dependent and 1.5√HADS depression as independent varia-
bles, attained an explained variance of 20.0%, a bivariate Pearson correlation of 0.27, 
and a partial correlation of 0.29, and thus, did not fit better than the model with the 
untransformed, linear variables. 
 Dichotomized data analysis revealed an indeterminable OR for the MPI pain severi-
ty threshold score ≥ 25 as there were no patients with scores < 25. For pain ≥ 50 (mod-
erate pain) the OR for presence/absence of depression was 2.10 [95% confidence inter-
val (CI): 0.60, 7.36], for pain ≥ 75 (severe pain), the OR was 1.72 (95% CI: 1.06, 2.79), 
and for maximal pain of 100, the OR was 1.81 (95% CI: 0.78, 4.19). 
R E F I N E D  I N S I G H T S  I N T O  T H E  P A I N - D E P R E S S I O N  A S S O C I A T I O N  
 75 
Correlations and properties within subsamples 
First, the total patient sample (n = 273, complete data for n = 258) was split into 2 
groups: those with a high correlation, defined by the linear regression equation, whose 
scores were in the intercept interval of ± 10 score points: MPI pain = 0.21 x HADS de-
pression + 57.63 and: MPI pain = 0.21 x HADS depression + 77.63, and all others with 
low correlations. The group of “high correlators” consisted of 117 subjects and showed 
the following correlations: bivariate Spearman 0.58, bivariate Pearson 0.62, and partial 
Pearson 0.60. The group of “low correlators” consisted of 141 subjects and showed the 
following correlations: bivariate Spearman 0.27, bivariate Pearson 0.23, and partial 
Pearson 0.24. The 2 groups did not differ in any of the confounding variables, the HADS 
depression, nor in any of the MPI scales (results of 1-way analysis of variance and lo-
gistic regression, not shown in detail), that is, did not show specific characteristics. 
 Second, all patients were allocated to one of the three characterizing chronic pain 
subgroups obtained by cluster analysis of all MPI scales according to the concept of 
Turk et al.[50, 51]. To assess whether a 3-cluster solution was appropriate according to 
mathematical criteria, hierarchical cluster analysis according to the Ward method was 
performed [49]. The resulting diagram with the number of clusters and the course of 
the sum of residual squares did not favour a 3-cluster solution (data not shown in de-
tail). However, factor analysis revealed that a 3-factor solution fitted best with 69.6% 
explained variance. This was consistently true within all 3 diagnostic groups, that is, 
back pain, fibromyalgia, and widespread pain. Thus, the proposed “best feasible”, that 
is, clinically characterized, empirically determined solution according to the subgroups 
defined by Turk et al. was chosen [49-51].  
 The properties of the groups according to the concept of Turk and Rudy [50] and 
the correlation results within these groups are shown in Table 4. Pain and depression 
were best, that is, moderately, correlated (up to 0.57) in the interpersonally distressed 
subgroup, weakly correlated (up to 0.26) in the dysfunctional subgroup, and absent in 
the adaptive copers/minimizers subgroup. 
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Table 4. Correlation and regression results of the MPI pain severity and the HADS depression within the MPI 
cluster groups according to the concept of Turk et al. (n = 251 classified) 
Group Properties n Correlations Regression 
 MPI scales Bivariate 
Spearman 
Bivariate
Pearson 
Partial
Pearson 
Explained  
variance (r2) (%) 
Dysfunctional ↑ Pain severity 
↑ Interference with pain 
↑ Negative mood 
↓ Life control 
↓ Activity 
100
  
0.26
 
0.24
 
0.21
 
27.4 
 
Interpersonally  
distressed 
↓ Support (social) 
↑ Punishing responses 
↓ Solicitous responses 
↓ Distracting responses 
 56
   
0.53
 
0.52
 
0.57
 
46.3 
 
Adaptive  
copers/minimizers
↓ Pain severity 
↓ Interference with pain 
↓ Negative mood 
↑ Life control 
↑ Activity 
 95
 
-0.08
 
-0.05
 
0.01
 
21.9 
 
Abbreviations: ↑ indicates higher level compared with the other 2 clusters; ↓, lower level compared with the 
other 2 clusters; n, number of patients with complete data for all co-factors; HADS, Hospital Anxiety and 
Depression Scale; MPI, Multidimensional Pain Inventory. 
Alternative models including anxiety and function as additional confounders 
The results of the model predicting MPI pain severity based on all previously included 
confounders (see legend of Table 3), the HADS depression, the HADS anxiety, and the 
SF-36 physical functioning are listed in Table 5 for the whole sample and within the MPI 
subgroups. Function attained the highest correlations (up to –0.61 bivariate and -0.53 
partial) and improved the predictive power of the regression models to 30.8% to 61.3% 
(explained variance, as compared to the models without anxiety and function). The 
inclusion of anxiety and function reduced the correlations of depression to pain to 0.12 
overall (before: 0.30, Table 3) and to 0.42 (before: 0.57, Table 4) in the interpersonally 
distressed subgroup. The pattern of the correlations between the MPI subgroups re-
mained consistent. After controlling for confounders, depression, and function, anxiety 
no longer showed any association with pain (correlations –0.06 to 0.01). 
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Table 5. Alternative model to predict pain by depression, anxiety, and physical function 
  Correlations Regression 
  
MPI pain severity by 
Bivariate 
Spearman 
Bivariate
Pearson 
Partial 
Pearson 
Explained variance 
(r2) (%) 
Overall  
(n = 258) 
HADS depression 0.27 0.28 0.12 34.8 
HADS anxiety 0.20 0.19 0.01
SF-36 physical functioning -0.50 -0.53 -0.42
Dysfunctional  HADS depression 0.26 0.26 0.11 35.2 
(n = 100) HADS anxiety 0.13 0.12 -0.04
 SF-36 physical functioning -0.41 -0.46 -0.32
Interpersonally  HADS depression 0.53 0.49 0.42 61.3 
distressed  
(n = 95) 
HADS anxiety 0.28 0.24 -0.02
 SF-36 physical functioning -0.59 -0.61 -0.53
Adaptive  
copers/  
HADS depression -0.08 -0.09 -0.02 30.8 
minimizers  
(n = 56) 
HADS anxiety -0.08 -0.14 -0.06
 SF-36 physical functioning -0.37 -0.42 -0.30
Abbreviations: MPI, Multidimensional Pain Inventory; HADS, Hospital Anxiety and Depression Scale; SF-36, 
Short Form 36; n, number of patients with complete data for all co-factors. 
Discussion 
The overall cross-sectional association between chronic pain and depression with max-
imum correlations of 0.30 was weak – a correlation of 1.00 represents perfect associa-
tion, 0.00 implies no association. A value of 0.30 means that only 9.0% (= 0.302) of the 
variance of pain can be explained by depression [56]. In addition, the model including 
all possible a priori confounders explained a maximum of only 20.6% of the variance of 
pain, which shows that all these variables were poor predictors of the level of chronic 
pain. Inclusion of anxiety and function as co-factors improved the predictive power of 
the models, but reduced the correlations between pain and depression. Only the mem-
bers of the interpersonally distressed subgroup subjectively perceiving low (social) 
support and high negative responses by their partners or spouses were characterized 
by moderate pain-depression association in our data which means that subjects with 
relatively low depression showed relatively low levels of pain and vice versa. A total of 
32.5% (= correlation 0.572) of the variance of pain in this subgroup was explained by 
depression. 
 The low correlations observed are in accordance with those of several other studies 
that show weak correlations ranging from 0.22 to 0.27 [28, 33]. In the United States 
general population survey to validate the SF-36, the correlations between the SF-36 
bodily pain items with the SF-36 mental health scale, and the correlation of SF-36 men-
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tal health items with the SF-36 bodily pain scale ranged from 0.27 to 0.33 (n = 3445) 
[38]. In 404 elderly primary care patients, the SF-36 bodily pain association with the 
Hamilton depression score attained a standardized regression coefficient of β = 0.23 
and was almost identical to our data showing a β = 0.29 (regression data not shown in 
detail) [57]. Our ORs of around 2.0 showed that depression in patients with higher lev-
els of pain was twice as frequent as in patients with no or lower pain (on different pain 
thresholds) and were thus consistent with the data from the published literature (see 
Introduction). However, dichotomized data analysis is dependent on thresholds for the 
classification of the cases and can even lead to statistically significant OR data (OR = 
1.72 for MPI pain ≥ 75) although continuous data do not show strong associations. 
 Therefore, the pain-depression association was present, but its strength was weak. 
A strong association (correlation) is more likely to have a causal component than a 
moderate association [58]. However, a weak association does not rule out causality but 
is likely to be explained by undetected biases [51]. Second, the biological gradient be-
tween depression and pain was also weak: the outcome should increase monotonically 
with increasing dose of exposure [58, 59]. On the one hand, the slope of the linear pain-
depression curve was very low (1 unit depression leads to 0.21 unit pain, Fig. 1), on the 
other hand, the ORs determined for different pain thresholds did not show a gradient 
at all because depression was not more frequent in patients with increasingly severe 
pain. The strength of the association and the biological gradient are the 2 most im-
portant of 9 necessary conditions for causality as expressed by the well-known Brad-
ford Hill epidemiological criteria, however, their value to predict causality has been the 
subject of an ongoing philosophical debate for decades [58, 59]. In other words, if there 
was a (strong) causal relationship between pain and depression, a high correlation and 
a high biological gradient would have to be empirically observed, even in cross-
sectional examinations. It may prove extremely difficult to resolve the issue of the pain-
depression interaction by (currently known) epidemiological methods alone because 
there may be other, currently unknown, confounders [59].  
 Coping with pain and especially catastrophizing may play an important confounding 
role as was also shown by the MPI subgroup analysis in this and in other studies [16, 34, 
60]. Patients with high correlations of pain and depression could not be specifically 
characterized a priori, that is, by strata of pain level, but there were large correlation 
differences between the groups characterized psychobehaviorally according to the 
concept of Turk et al. [50, 51]. According to the MPI subgroup results, it can be hypoth-
esized that treatment of depression in the interpersonally distressed subgroup may 
have an impact on pain reduction (and vice versa) but little in the dysfunctional and no 
impact in the adaptive copers/minimizers subgroup. 
 Pain management programs may have a certain number of treatment modalities 
that are the same for all patients, but they should also include (additional) subgroup-
specific interventions [55]. In the treatment study of Turk et al, the dysfunctional pa-
tients improved in pain, disability, and depression, but the interpersonally distressed 
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subjects did not improve in any of these 3 health dimensions [53]. They should proba-
bly receive treatment that addresses their pain problem and also their specific psycho-
social needs, for example, family therapy, focussing on interpersonal and marital prob-
lems as stated previously and to be examined in future [60, 61]. In our study, the dys-
functional subgroup with the highest scores for pain and depression did not show the 
highest correlation between pain and depression possibly owing to a relatively high 
ceiling effect in pain (15.9% rated maximal pain in the MPI pain severity in contrast to 
6.6% of the interpersonally distressed and 6.0% in the adaptive copers/minimizers – 
data not shown in the results). 
 The alternative regression model including anxiety (HADS) and function (SF-36) 
showed that decrease of function was moderately correlated to increase of depression, 
and anxiety was not correlated with pain when controlling for depression and function. 
This means that depressive syndrome characterized mainly by reduced mood level and 
reduced concentration ability (and not by anxiety and function) had a much lower cor-
relation with pain than depressive syndrome additionally characterized by anxiety and 
reduced activity. The inclusion of function increased the predictive value of the models 
by an approximate factor of 1.5, that is, by 50%. 
 the use of valid and reliable assessment tools, and controlling for possible con-
founders. However, the following limitations have to be stated: the sample consisted of 
severely affected chronic pain patients, which may limit the generalizability of the re-
sults. The cross-sectional assessment principally did not capture time-dependent ef-
fects on course, for example, when pain increased by increased depression (only) after 
a certain time (and vice versa). However, this quantification would be difficult by 2 
reasons: to determine the integral of the symptoms over time would require multiple 
assessment time points with narrow intervals, and latency and symptom threshold to 
induce pain (or depression) may have wide inter-individual variation. 
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Conclusions 
The strengths of the pain-depression association and the “dose-response” relationship 
were both weak – weaker than to be expected if the hypothesis of a causal relationship 
were true. In the interpersonally distressed subgroup, the moderate association may 
have an impact on pain management, that is, pain could be treated by treatment of 
depression and vice versa. 
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CHAPTER 5 
Does classification of persons with 
fibromyalgia into Multidimensional Pain 
Inventory subgroups detect differences in 
outcome after a standard chronic pain 
management program? 
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Abstract 
 Objectives. The present study aimed to replicate and validate the empirically de-
rived subgroup classification based on the Multidimensional Pain Inventory (MPI) in a 
sample of highly disabled fibromyalgia patients. Second, it examined how the identified 
subgroups differed in their response to an intensive, interdisciplinary inpatient pain 
management program.  
 Methods. Participants were 118 persons with fibromyalgia who experienced persis-
tent pain and were disabled. Subgroup classification was conducted by cluster analysis 
using MPI subscale scores at entry to the program. At program entry and discharge, 
participants completed the MPI, Medical Outcomes Study Short Form-36, Hospital 
Anxiety and Depression Scale, and the Coping Strategies Questionnaire.  
 Results. Cluster analysis identified three subgroups in this highly disabled sample 
that were similar to those described by other studies using less disabled samples of 
fibromyalgia. The dysfunctional subgroup (DYS; 36% of the sample) showed the highest 
level of depression, the interpersonally distressed subgroup (ID; 24%) showed a modest 
level of depression and the adaptive copers subgroup (AC; 38%) showed the lowest 
depression scores in the MPI (negative mood), Medical Outcomes Study Short Form-36 
(mental health), Hospital Anxiety and Depression Scale (depression), and Coping Strate-
gies Questionnaire (catastrophizing). Significant differences in treatment outcome were 
observed among the three subgroups in terms of reduction of pain severity (as as-
sessed using the MPI). The effect sizes were 1.42 for DYS, 1.32 for AC, and 0.62 for ID (p 
= 0.004 for pair wise comparison of ID-AC and p = 0.018 for ID-DYS).  
 Conclusions. These findings underscore the importance of assessing individuals’ 
differences in how they adjust to fibromyalgia. 
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Introduction 
People with fibromyalgia, classified according the American College of Rheumatology 
1990 criteria [1], are viewed as a homogeneous group. However, both health care pro-
fessionals and researchers often state that fibromyalgia patients with widespread pain 
for at least six months in combination with tenderness at 11 or more of the 18 specific 
tender point sites are extremely heterogeneous with regard to their biopsychosocial 
impairments and responsiveness to interventions. Classification of people with fibrom-
yalgia into homogeneous subgroups may be an important objective in order to tailor 
interventions and to control for subgroup differences when evaluating treatment out-
come. The process of subclassification is a clinical reality, but is often undertaken on an 
individual level and in an unstructured way [2]. Recent research shows that persons 
with fibromyalgia have profiles showing difficulties in both the physical, and functional 
and psycho-social realms [3, 4]. Several research groups identified subgroups of people 
with fibromyalgia on the basis of fear of pain, readiness to adopt a self-management 
approach to chronic pain, or psychosocial and behavioral responses to pain [5-7].  
 The Multidimensional Pain Inventory (MPI), which measures a number of psycho-
social and behavioral variables, has been used to identify subgroups of people with 
chronic musculoskeletal pain in different settings and with different biomedical diagno-
sis [8, 9]. Persons with temporomandibular disorders [7], whiplash-associated disorders 
[10], and back pain [6, 11-13] have been classified into empirically derived subgroups 
based on analyses of the scales of the MPI. In the studies cited above, the MPI differen-
tiated between three distinct subgroups labelled as adaptive copers (AC), dysfunctional 
(DYS), and interpersonally distressed (ID) [9, 14]. The ID cluster is mainly characterized 
by lower levels of perceived solicitous and distraction responses from the patients’ 
partners or spouses and higher levels of punishing responses compared with the AC 
and DYS clusters. The AC cluster, compared with the other two subgroups, is character-
ized by less pain severity, less interference with everyday life due to pain and less affec-
tive distress, as well as more perception of life control and higher activity level. The 
persons of the DYS cluster report high pain severity, high interference and activity dis-
tress, low life control and low activity level. 
 Several studies have attempted to identify MPI subgroups in persons with fibrom-
yalgia [7, 15, 16]. These studies have found the same three subgroups identified in 
other populations. At least one study has found that subgroup membership is related to 
the outcome of an outpatient multidisciplinary pain management program. Although 
the results of these studies are interesting, they were obtained from samples of fi-
bromyalgia patients who were outpatients and much less disabled than those typically 
seen in inpatient pain management programs.  
 The aims of the present study were to investigate whether it was possible to repli-
cate and describe the three MPI cluster solution and profiles found in less disabled 
American sample of outpatients with fibromyalgia in a more disabled German-speaking 
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sample of patients with fibromyalgia treated in an intensive inpatient pain manage-
ment program; validate the three-cluster solution by comparing the three clusters with 
measures of pain, psycho-social function, physical and mental health, anxiety and de-
pression, and chronic pain coping strategies; and examine the effects of cluster mem-
bership on the outcome of a standardized four-week interdisciplinary in-patient pain 
management program.  
 The first hypothesis was that moderate validity would be found between the MPI 
subgroups and the corresponding subscales of the Medical Outcome Study Short Form-
36 (SF-36) – especially worst physical functioning and mental health in the DYS sub-
group; the Hospital Anxiety and Depression Scale (HADS) – especially most anxiety and 
depression in the DYS subgroup; and the Coping Strategies Questionnaire (CSQ) – espe-
cially most catastrophizing in the DYS subgroup. Second, we hypothesized that, with 
pair wise comparisons between subgroups, the most significant differences in effect 
sizes after the standard pain management program would be seen between the AC and 
DYS subgroups (with highest effect sizes for DYS).  
Methods 
Setting and participants 
The present study was conducted at the rehabilitation clinic “RehaClinic” (Bad Zurzach, 
Switzerland), which is attended by disabled patients having persistent pain and come 
from all German-speaking countries in Europe. This report is an extension of the recent-
ly published cohort study [17]. 
 All subjects included in the study suffered from fibromyalgia according to the 
American College of Rheumatology criteria [1], had pain for at least six months and 
were disabled by their pain enough to warrant admission to an intensive inpatient pain 
management program. Further inclusion criteria included the ability to complete self-
assessment questionnaires, which especially requires sufficient German language skills, 
and psycho-intellectual abilities; and written, signed informed consent. The patients 
with fibromyalgia were participants in the “Zurzach Interdisciplinary Pain (German: 
Schmerz) Program”. The program is a four-week, in-house, standardized, interdiscipli-
nary pain management program. This program has three main components: medical 
care (including adapted drug therapy), exercise therapy and psychotherapy (mainly 
cognitive and operant behavioral therapy) - a total over 100 h of therapy. The program 
is intensive. Over the course of treatment patients received, on average, six daily ses-
sions of the following treatments: physiotherapy, aerobic endurance training, qigong 
and tai chi exercises, individual psychotherapy including cognitive behavioral therapy, 
participation in a pain coping group, relaxation therapy, humor therapy, information 
and education about pathophysiology of pain mechanisms and management of chronic 
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disabling pain, nursery care, and regular medical consultations including drug therapy. 
Individual treatment strategies were identified and discussed during the interdiscipli-
nary meetings of the pain management team (2 h per week for six patients). Detailed 
information on inclusion and exclusion criteria, as well as interdisciplinary treatment 
goals, are published elsewhere [17]. 
 The present study’s protocol was approved by the Independent Local Ethic Com-
mission (Health Department in Aarau, Switzerland, no. EK AG 2008/026). 
Outcome measures 
Sociodemographic data and comorbidities 
Sociodemographic data were collected using a standardized questionnaire from a pre-
vious study [18]. Additional information about physical and mental comorbidities and 
medication were obtained from the medical records. 
Psycho-social and behavioral aspects of chronic pain 
The West Haven-Yale Multidimensional Pain Inventory (MPI) assesses pain and its con-
sequences in terms of symptoms, disability, activity, behavior, mood and social rela-
tionships [8]. The German version of the Multidimensional Pain Inventory (MPI-D) is a 
self-reported 51-item inventory with 11 subscales: “pain severity”, “interference with 
pain”, “life control”, “affective distress” (synonymously described as “negative mood”), 
“support”, “punishing responses”, “solicitous responses”, “distracting responses”, “so-
cial and recreational activities”, “household chores”, and “activities away from home” 
[19]. The last three subscales can be summarized into one subscale – “general activi-
ties”. The range of each subscale is 0 to 6 (seven points). The internal consistency coef-
ficient of MPI-D subscales has been reported to range from 0.63 to 0.94, and the test-
retest intra-class correlation coefficient ranges from 0.46 to 0.93 [20]. 
 For external validation of the cluster solution and calculation of effect sizes (entry = 
baseline in pain program – discharge after 4 weeks), the instruments listed below were 
used. 
Health related quality of life  
The Medical Outcome Study Short Form-36 (SF-36) is a self-administered generic in-
strument that assesses health-related quality of life [21]. It consists of four physical 
scales (“physical functioning”, “role physical”, “bodily pain” and “”general health”) and 
four mental scales (“vitality”, “social functioning”, “role emotional” and “mental 
health”). “The SF-36 has been implemented in numerous studies in over 40 languages 
worldwide and its clinimetric quality has been proven in various settings. The reliability 
of SF-36 scale scores, estimated using internal consistency methods for 3455 patients, 
vary with a range of coefficients from 0.65 to 0.94. Test-retest reliability scale scores, 
measured over a two-week interval, vary from 0.60 to 0.81 [22]. The validated German 
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version of the SF-36 was used to enquire about symptoms and functioning during the 
preceding four weeks [23].  
Anxiety and depression 
The Hospital Anxiety and Depression Scale (HADS) is a short, self-rating measure of 
anxiety and depression (seven items each), these being two of the most important 
affective health dimensions for people with chronic musculoskeletal pain [24]. The 
questionnaire was developed for the evaluation of persons in a nonpsychiatric setting, 
has a long history of application in chronic pain management and has been well tested 
in large populations and patient surveys [25]. The validated German version (HADS-D) 
was used. The internal consistency coefficients of the HADS-D subscales are 0.80 (anxie-
ty subscale) and 0.81 (depression subscale). The split-half coefficient is 0.81 for both 
scales [26]. 
Coping  
The Coping Strategies Questionnaire (CSQ) is an internationally used self-report instru-
ment to assess active and passive coping strategies: it is used by individuals with chron-
ic pain [27, 28]. This widely used measure is a 48-item questionnaire that assesses six 
cognitive (“diverting attention”, “reinterpreting pain sensations”, “coping self-
statements”, “ignoring pain sensations”, “praying or hoping”, and “catastrophizing”) 
and two behavioral coping strategies (“increasing activity level” and “increasing pain 
behaviors”). Each domain comprises six items, and participants rate the frequency of 
their use of specific coping strategies on a seven-point Likert scale from 0 (i.e. “never 
do that”) to 6 (i.e. “always do that”). The CSQ also includes two one-item scales that 
assess participants’ subjective ability to control or decrease their pain. These two scales 
measure the perceived effectiveness of participants' coping strategies. Using a similar 
seven-point Likert scale, participants rate their ability from 0 to 6, with 0 signifying “no 
control/no ability to decrease pain”, and 6 signifying “complete control/complete abil-
ity to decrease pain”. The validated German version of the CSQ (CSQ-D) was used, 
which is a translation and cross-cultural adaptation of the original questionnaire. The 
internal consistency coefficient of the CSQ-D subscales has been reported to range 
from 0.71 to 0.97, and the test-retest intraclass correlation coefficient ranges from 0.55 
to 0.93 [29]. 
Statistical analysis 
The outcome measures were administered on entry to the clinic (baseline, pre-
treatment) and at discharge from the rehabilitation clinic after four weeks (post-
treatment). Other than as an outcome measure, the baseline scores of the scales of the 
MPI were used for subgroup classification. 
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The scores of the SF-36, HADS, CSQ, MPI “life control”, MPI “support”, MPI “solicitous 
responses”, MPI “distracting responses” and MPI “general activities” were scaled from 
0 (maximal pain/maximal disability/maximal symptoms/worst coping) to 100 (no 
pain/full function/no symptoms/best coping) based on a procedure originally described 
in the SF-36 manual. This scaling was performed to ease comparison of the clusters on 
these external validation measures. According to the subgroup classification of Turk 
and Rudy, the MPI “pain severity”, MPI “interference with pain”, MPI “affective dis-
tress” and MPI “punishing responses” were scaled from 0 (best) to 100 (worst). Descrip-
tive statistics were determined according to the “missing rules” of the instruments’ 
scores; i.e. at least 50% valid items per scale for the SF-36, two of three valid items for 
the MPI and the CSQ, and at least six of seven valid items for the HADS.  
 According to Turk and Rudy [9], the empirically derived subgroups were defined by 
confirmatory cluster analysis using a predefined three-cluster solution. Cluster analysis 
is an exploratory method by which multiple sources of information are analyzed simul-
taneously to group individuals into clusters. Individuals within a cluster are similar to 
each other on the variables included in the statistical analysis and differ significantly 
from those in the other cluster groups. The MPI score patterns were depicted as graphs 
of the mean MPI baseline scores and compared to the patterns described by Turk et al. 
using the rank orders of the three subgroups within one MPI scale. To assess whether a 
three-cluster solution was appropriate according to mathematical criteria, hierarchical 
cluster analysis according to the Ward method was performed [30]. The resulting dia-
gram with the number of clusters and the course of the sum of residual squares did not 
favour a three-cluster solution (data not shown in detail). However, factor analysis 
revealed that a factor solution fitted best with three factors explaining 67.4% of the 
variance. Thus, the proposed “best feasible” (i.e. clinically characterized) empirically 
determined solution according to the subgroups defined by Turk et al. was chosen. 
 To test validity, the SF-36, HADS and CSQ scores had to show the same or similar 
patterns (across the three subgroups) within the sub scores with a similar construct; 
e.g. the pattern of the MPI “pain severity” was compared with the SF-36 “bodily pain”, 
and the MPI “negative mood” was compared with SF-36 “mental health”, HADS “de-
pression”, and CSQ “catastrophizing” [31]. Pairwise analyses between the three MPI 
subgroups were tested using the Mann-Whitney-U-test for significance (type-one error 
0.05).  
 Effect sizes (ES) were determined by the score difference between entry (baseline) 
and discharge, divided by the group standard deviation at entry for the whole sample 
and the three subgroups [32]. Positive ES indicate improvement of the pain condition, 
while negative ES indicate worsening after completion of the pain management pro-
gram. An ES of 0.80 or greater is considered as large, 0.50 to 0.79 as moderate, 0.20 to 
0.49 as small and 0.00 to 0.19 as very small [32]. Pairwise analyses between the three 
MPI subgroups were tested using the Mann-Whitney-U-test for significance (type one 
error 0.05). The minimal clinically important difference (MCID), which is principally a 
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method to assess the smallest effect that patients perceive to be beneficial, was added 
to get an impression of the clinical relevance of the effects at discharge[33]. If the MCID 
is less than the lower limit of the 95% confidence interval (95% CI), results are likely to 
be statistically significant and clinically important [34]. If the MCID is greater than the 
upper limit of the 95% CI, results are likely to be clinically unimportant. If the MCID lies 
within the limits of the 95% CI, it is unclear whether the effect is clinically important. 
 All analyses were performed using the statistical software package SPSS 16.0 for Win-
dows (SPSS Inc, USA). 
Results 
Participants at baseline 
Table 1 describes the demographic and medical data of the total sample of patients 
with fibromyalgia on entry into the pain management program (n = 118). The present 
sample is an extension of the recently published cohort study of 65 persons with fi-
bromyalgia [17]. The subjects were characterized by a relatively young age, a long his-
tory of pain, high levels of pain, high physical disability, high prevalence and high levels 
of depression and anxiety, and low psychosocial functioning, as characterized by far 
lower scores than expected by general population norms for SF-36 and HADS. 
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Table 1. Demographic and medical data for the total sample of persons 
with fibromyalgia at entry to the pain program (n = 118)  
Age, mean ± s (range), years 45.5±9.84 (19.7-67.2)
Female sex 95.8
Marital status 
    Single 
    Married 
    Other 
16.7 
68.4 
14.9 
Education 
    Grade 10 –12 
    High school graduate 
    College graduate 
    University 
31.6 
50.0 
12.3 
6.1 
Employment status
    Full time 
    Part time 
    Unemployed 
    Retired 
12.3 
43.0 
42.1 
0.6 
Use of medication
    No medication 
    NSAR or acetaminophen 
    Opioids or opiates 
    Antidepressants 
3.4 
49.3 
17.0 
20.4 
Depression 
    No depression 
    Depression 
28.0 
72.0 
Pain duration 
    7 – 12 months 
    13 - 24 months 
    25 – 36 months 
    37 – 48 months 
    49 – 60 months 
    > 5 years 
  3.5 
  9.6 
  7.0 
  7.0 
27.8 
44.1 
Abbreviations: s, standard deviation; NSAR, nonsteroidal antirheumatic 
NOTE. Data presented as percentages unless otherwise indicated.  
Classification of persons with fibromyalgia by the MPI into subgroups 
Table 2 and Figure 1 show the mean baseline scores of the MPI. A total of 116 of 118 
patients with fibromyalgia could be allocated to one of the three chronic pain sub-
groups obtained by cluster analysis of all MPI scales, according to the concept of Turk et 
al.[7, 9]. Twenty-four percent (n = 28) were classified as “interpersonally Distressed” 
(ID), 38% (n = 45) were classified as “Adaptive Copers” (AC) and 36% (n = 43) were clas-
sified as “Dysfunctional” (DYS). The two remaining persons with fibromyalgia were 
classified as “anomalous” (did not fit into any of the 3 profiles). With the exception of 
pain duration – persons with fibromyalgia in the DYS cluster had shorter pain duration 
than people in the AC and ID clusters - no significant differences in demographic and 
C H A P T E R  5  
 94
medical baseline data were found between the three clusters (data not shown in de-
tail).  
 
 
Figure 1. Mean baseline scores for patient profiles on the German version of the Multidimensional Pain
Inventory 
 
Table 2. Mean Multidimensional Pain Inventory subscale baseline scores and pairwise analyses for signifi-
cance of the three cluster groups 
MPI subscales ID (n = 28) AC (n = 45) DYS (n = 43) ID-AC ID-DYS AC-DYS 
Pain severity (6=worst, most) 4.3±1.0 4.6±0.8 5.3±0.6 0.090 <0.001* <0.001* 
Interference with pain (6=worst, most) 4.0±1.6 4.2±0.9 5.1±0.5 ns <0.001* <0.001* 
Life control (6=best, most) 2.5±1.1 3.3±1.2 2.3±1.1 0.010* 0.193 <0.001* 
Affective distress (6=worst, most) 3.6±1.2 2.9±1.0 4.5±0.8 0.011* 0.001* <0.001* 
Support (6=best, most) 1.6±1.2 4.7±1.1 5.2±1.0 <0.001* <0.001* 0.026* 
Punishing responses (6=worst, most) 1.7±1.8 0.8±0.9 2.0±1.5 0.086 ns <0.001* 
Solicitous responses (6=best, most) 1.1±1.0 3.7±1.2 4.3±1.1 <0.001* <0.001* 0.018* 
Distracting responses (6=best, most) 1.1±1.2 3.6±1.4 3.9±1.2 <0.001* <0.001* ns 
General activities (6=best, most) 2.4±0.9 2.7±0.7 2.1±0.8 ns ns 0.001* 
Abbreviations: MPI, Multidimensional Pain Inventory; ID, MPI cluster interpersonally distressed; AC, MPI 
cluster adaptive copers; DYS, MPI cluster dysfunctional; *Significance level p ≤ 0.0050; ns, not significant 
(p>0.050) 
NOTE. Data presented as mean ± standard deviation unless other indicated. 
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Validation of the subgroup classification 
Table 3 shows the mean baseline scores and standard deviations of the scales of the SF-
36, HADS, and CSQ for the three MPI cluster groups. Comparing the results of Table 2 
and Table 3, the scores of the subgroups of the SF-36, HADS and CSQ showed almost 
the same pattern as the MPI. On the MPI “pain severity”, the rank order of the three 
cluster subgroups in terms of reported pain was DYS (most pain), AC, and ID (least 
pain). This same order was found on the SF-36 “bodily pain”; DYS showed most pain 
(bodily pain 10.7; p = 0.005, comparing ID with DYS; p = 0.014 comparing AC with DYS). 
The MPI “general activities” was compared to SF-36 “physical functioning”; DYS showed 
the lowest activity level (“physical functioning” 26.1; p = 0.001, comparing ID with DYS 
and AC with DYS). The same was consistently true when comparing MPI “interference 
with pain” with SF-36 “physical functioning”. The mean baseline score of MPI “life con-
trol” was compared to the score of CSQ “ability to control pain”; AC had best control 
(48.2; p = 0.016 comparing ID with AC). The MPI “affective distress” was compared to 
the SF-36 “mental health”, HADS “Depression” and “Anxiety”, and CSQ “Catastrophiz-
ing”; DYS showed most and AC the least affective symptoms in all scales (significant 
differences in various pairwise subgroup comparisons). It was not possible to replicate 
the specific MPI characteristics of the ID subgroup (punishing responses and lack of 
support by partner or spouse) because the scores of the subscales of the SF-36, HADS 
and CSQ are not able to measure social support. Overall, the differences of scores be-
tween the three clusters were in agreement with theoretical expectations and implied 
support for moderate validity. 
Differential treatment responses within the MPI subgroups 
Table 4 shows significant differences between the scores of the ES of pairwise compari-
sons between the three MPI subgroups that were found for four MPI scales (pain sever-
ity, interference with pain, affective distress and support), two SF-36 scales (physical 
functioning and social functioning) and three CSQ scales (increasing activity level, ability 
to control pain and ability to decrease pain). For example, significant differences in 
treatment outcome were observed among the three subgroups in terms of pain severi-
ty, as assessed using the MPI. The ES were 1.42 for DYS, 1.32 for AC, and 0.62 for ID (p = 
0.004 for pair wise comparison of ID-AC and p = 0.018 for ID-DYS). Also, significant dif-
ferences in treatment outcome could be measured in terms of physical functioning, as 
assessed using the SF-36. The ES were 0.82 for DYS, 0.69 for AC, and 0.22 for ID (p = 
0.028 for pair wise comparison of ID-AC and p = 0.090 for ID-DYS).  
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Table 3. Mean baseline scores and pair wise analyses for significance of the scales of the SF-36, HADS, and 
CSQ for the three MPI cluster groups  
 p
Subscales ID (n = 28) AC (n = 45) DYS (n = 43) ID-AC ID-DYS AC-DYS 
SF-36 (100 = best)
    Physical functioning 
    Bodily pain 
    General health 
    Vitality 
    Social functioning 
    Role emotional 
    Mental health 
43.6±22.2 
19.9±14.0 
37.3±13.0 
19.8±16.4 
36.4±19.9 
17.8±26.4 
42.3±17.5 
40.1±13.4 
18.0±14.5 
42.2±14.3 
26.7±15.6 
44.4±24.1 
38.5±43.8 
52.1±16.3 
26.1±15.8 
10.7±10.7 
34.5±12.1 
16.1±14.3 
35.7±26.1 
16.3±32.0 
32.3±15.2 
ns 
ns 
ns 
0.092 
ns 
0.083 
0.074 
0.001 
0.005 
ns 
ns 
ns 
ns 
0.006 
 
 0.001 
 0.01 
 0.015 
<0.001 
 0.086 
 0.009 
<0.001 
HADS (100 = no anxiety or depression) 
    Anxiety  
    Depression 
47.6±20.2 
51.4±20.5 
55.0±20.1 
63.5±17.1 
37.9±18.6 
45.9±18.4 
ns 
0.009 
0.053 
ns 
 
<0.001 
<0.001 
CSQ (100 = best) 
    Diverting attention 
    Praying or hoping 
    Catastrophizing 
    Increasing activity level 
    Pain behaviors 
    Ability to control pain 
    Ability to decrease pain 
42.4±18.0 
58.8±22.9 
44.6±15.5 
52.5±15.3 
56.6±12.4 
34.5±23.1 
25.6±17.9 
54.4±18.7 
50.7±25.2 
52.2±19.1 
58.4±15.4 
60.2±14.1 
48.2±22.5 
45.2±20.6 
54.5±16.7 
41.5±21.6 
33.9±16.3 
58.0±15.8 
66.0±13.3 
41.7±23.4 
36.5±19.9 
0.007 
ns 
ns 
0.090 
ns 
0.016 
0.001 
0.005 
0.002 
0.003 
ns 
0.007 
ns 
0.030 
 
ns 
ns 
<0.001 
ns 
 0.070 
ns 
 0.051 
Abbreviations: MPI, Multidimensional Pain Inventory; SF-36, Medical Outcome Studies – Short Form 36; 
HADS, Hospital Anxiety and Depression Scale; CSQ, Coping Strategies Questionnaire; ID, MPI cluster interper-
sonally distressed; AC, MPI cluster adaptive copers; DYS, MPI cluster dysfunctional; p, significance level p ≤ 
0.0050; ns, not significant (p > 0.050) 
NOTE. Data presented as mean ± standard deviation. 
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Comparing the three MPI subgroups, the DYS cluster showed the highest effects in MPI 
“pain severity” (ES = 1.42) and “interference with pain” (ES = 1.55), SF-36 “physical 
functioning” (ES = 0.82), but also the least improvement in SF-36 “social functioning” 
(ES = 0.40), worsening in CSQ “increasing activity level” (ES = -0.17), and the least im-
provement in CSQ “ability to control pain” (ES = 0.19) and “ability to decrease pain” (ES 
= 0.41). The AC cluster showed most improvement in MPI “support” (ES = 0.39) and 
CSQ “increasing activity level” (ES = 0.27). 
Discussion 
Summary of main findings 
The findings of the present study showed that the MPI subgroups previously identified 
in less disabled samples of fibromyalgia patients are also evident in a highly disabled 
fibromyalgia sample. The three subgroups identified (DYS, ID and AC) showed signifi-
cant differences in pain severity outcomes following a standard inpatient pain man-
agement program. The results of the present study suggest that, by attending to fi-
bromyalgia patients' subgroup status, one may be able to individualize some of the 
patient management efforts. 
Comparison with other studies 
Our results after completing the four-week pain management program challenge the 
conclusions of the study of Turk et al. An analysis of 48 American patients with fibrom-
yalgia, who completed a six-half day outpatient pain management program consisting 
of medical, physical, occupational, and psychological therapies spaced over a period of 
four weeks, revealed that persons in the DYS subgroup seemed to benefit most from 
the pain program. After completing this less intensive pain program, these persons 
showed significant improvement in pain severity, self-reported disability and psycho-
logical distress. In contrast, the persons in the AC subgroup showed significant im-
provement in pain severity but their self-reported psychological distress and disability 
did not change (Table 5). Therefore, Turk et al.[15] raised the question of whether 
these persons with fibromyalgia actually require all the components of the outpatient 
pain management program. In another study by King et al. [35, 36], the subjects were 
randomly assigned into one of three interventions (exercise only, education only, or a 
combination of exercise and education, one to three times per week) or a control 
group. This study (n = 128) stated that no MPI subgroup responded more than another 
subgroup on any of the instruments involved. With the exceptions of pain severity and 
depression in the DYS subgroup, our patients showed larger ES in all subgroups when 
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compared to the study of Turk et al. mentioned previously (Table 5). Especially in the ID 
subgroup (physical functioning) and the AC subgroup (physical functioning and depres-
sion), in which Turk et al. found no effect (ES = -0.03 to 0.01), our patients showed at 
least small (ES = 0.22) to moderate (ES = 0.50 and 0.69) ES. One explanation may be the 
different interventions and differences in treatment intensity. Our standard four-week 
inpatient pain management program involved a broad array of chronic pain manage-
ment strategies (active individual physiotherapy, aerobic endurance training, individual 
psychology, participation in a pain coping group, relaxation therapy, humor therapy, 
occupational therapy, qigong and tai chi, information about neurophysiology of pain 
and the possible contribution of psycho-social aspects in chronic pain, nursery care, and 
medical consultations including drug therapy) and was more intense; therapies were 
administered up to six h per day and six days per week [17]. Another explanation may 
be that, although the patients in the AC subgroup at entry to the pain program scored 
better than the other two subgroups, their burden of disease was nevertheless sub-
stantial compared with available normative data collected from healthier outpatient 
samples. 
 
Table 5. Comparison of differences in effect sizes (entry-discharge) between the American four-week outpa-
tient pain management program ([15] ; six half-days) and the present Swiss four-week inpatient pain man-
agement program (Verra et al; 29 days, up to 6 h of therapy per day) 
 Dysfunctional ES Interpersonally distressed ES Adaptive copers ES 
 Turk et al.  
(n=16) 
Verra et al. 
(n=43) 
Turk et al. 
(n=17) 
Verra et al. 
(n=28) 
Turk et al.  
(n=15) 
Verra et al.  
(n=45) 
MPI Pain severity 1.85 1.42 0.21 0.62 1.00 1.32 
MPI Interference with pain 1.00 1.55 0.20 0.47 0.54 0.87 
Physical functioning 0.63 (ODI) 0.82 (SF-36) 0.01 (ODI) 0.22 (SF-36) 0.01 (ODI) 0.69 (SF-36) 
Depression 0.80 (CES-D) 0.54 (HADS) 0.44 (CES-D) 0.50 (HADS) -0.03 (CES-D) 0.50 (HADS) 
Abbreviations: CES-D, Center for Epidemiological Studies Depression Scale; HADS, Hospital Anxiety and de-
pression Scale; MPI, Multidimensional Pain Inventory; ODI, Oswestry Disability Index; SF-36, Medical Out-
comes Studies Short Form-36, physical functioning scale. NOTE. Data from reference 15 and the present 
study.  
Validation of the subgroup pattern 
In support of the first hypothesis, the score differences at entry between the sub-
groups, as described by the MPI, were consistent with comparable constructs meas-
ured using the SF-36, HADS, and CSQ. The persons in the AC cluster showed better 
general and mental health, less fear and depression, less catastrophizing, and better 
self-efficacy (ability to control and decrease their pain) than persons in the DYS cluster. 
The persons in the DYS cluster reported higher levels of pain, anxiety, depression, and 
use of maladaptive coping strategies (praying and hoping, and catastrophizing), and the 
lowest levels of physical function, social function, and mental health compared with the 
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AC cluster (Table 3). The ID pattern of the MPI could not be replicated by the other 
instruments due to lack of scales with comparable construct. 
Differences in effect between MPI subgroups  
Our second hypothesis was that, with pairwise comparisons between subgroups at 
discharge, we expected to find the highest ES for DYS and most significant differences 
in effects between the AC and DYS subgroups. This hypothesis could be partly con-
firmed by our results - the hypothesis was true for pain (MPI and SF-36), interference 
with pain (MPI), activities and function (MPI and SF-36), and affective health (MPI, SF-
36, HADS, and CSQ “catastrophizing”). However, some of these effect differences were 
small and did not reach significance. No other scales showed significant differences. 
Clinical implications for pain management program  
This study showed, for most scales, positive small (ES = 0.20 to 0.49) to large (ES > 0.80) 
ES for the total population of 116 persons with fibromyalgia, as well as for the corre-
sponding clusters. Nevertheless, there were significant differences in outcome between 
MPI subgroups in 17 out of 87 pair wise comparisons (last three columns of Table 4). 
This retrospective MPI subgroup classification (a posteriori) provides information that 
may help to improve the effects of standard pain management programs. It suggests 
matching persons with the treatment strategies and therapeutic methods they are 
most likely to respond to and where they show the greatest need of treatment and/or 
where they show the largest deficits [17]. The development and implementation (a 
priori) of classification methods for matching interventions of pain management pro-
grams to subgroups of patients may improve clinical outcomes. Several recent studies 
in the field of (sub-) acute “nonspecific” low back pain and acute neck pain have pro-
vided preliminary evidence that using specific inclusion criteria to identify more ho-
mogenous subgroups of subjects, and attempting to match treatment to the subgroup, 
has the potential to enhance treatment effects [37-42]. 
Future research directions  
A focus of research may be the further analysis of the AC subgroup. Although these 
people score better than the other two subgroups with self-report measures on pain, 
self-perceived disability, mental health and their ability to cope with chronic pain, the 
impact of musculoskeletal pain on their consumption of pain medication and therapeu-
tic interventions, physical performance, not returning to work, etc, is comparable with 
the ID and DYS subgroups. Aspects of overuse behavior have been hypothesized and 
are subject of further research [43-48]. 
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Limitations of the present study 
The sample consisted of selected persons who had suffered from severe and disabling 
chronic pain disorders for a long time and who fulfilled certain criteria (e.g. motivation 
and ability to understand German). Therefore, they may differ in important ways from 
people with fibromyalgia in general, thus limiting the generalizability of the results. 
Because the design of the study did not include a control group, the changes after the 
pain program cannot be solely attributed to the interventions. The number of persons 
in each subgroup was relatively small (n = 28, n = 45 and n = 43), but larger than a com-
parable study. Another limitation is the short-term measurement of effects (between 
entry and discharge from the rehabilitation clinic after four weeks). Future studies 
should use standardized outcome measurements, not only at the end of the experi-
mental program, but at follow-up times that are long enough for the person with fi-
bromyalgia to modify behavior patterns and master effective strategies [49]. When 
using a post- or pre-test difference to define improvement after an intervention, the 
possibility of regression towards the mean cannot be excluded. We aimed to minimize 
this effect by using only reliable measurement instruments that have been used previ-
ously with persons with fibromyalgia [35]. Also, all outcome variables were obtained 
from self-reported questionnaires; e.g. MPI “general activities” screening for perceived 
disability and not observing physical performance. Finally, one study was able to 
demonstrate that, in two samples of persons with fibromyalgia, MPI classifications may 
not be stable, trait-like characterizations. As such, caution must be applied when 
treatment is tailored to MPI clusters [50]. However, new evidence from the data of 976 
pain patients provides evidence for the stability and replicability of three new clusters 
based on the MPI system [51]. 
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Conclusion 
The findings of this study underscore the importance of assessing patients’ differences 
in how they adjust to fibromyalgia. 
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CHAPTER 6 
Differences in pain, function and coping  
in Multidimensional Pain Inventory 
subgroups of chronic back pain:  
A one-group pretest-posttest study 
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Abstract 
 Objectives. Patients with non-specific back pain are not a homogeneous group but 
heterogeneous with regard to their bio-psycho-social impairments. This study exam-
ined a sample of 173 highly disabled patients with chronic back pain to find out how the 
three subgroups based on the Multidimensional Pain Inventory (MPI) differed in their 
response to an inpatient pain management program.  
 Methods. Subgroup classification was conducted by cluster analysis using MPI 
subscale scores at entry into the program. At program entry and at discharge after four 
weeks, participants completed the MPI, the MOS Short Form-36 (SF-36), the Hospital 
Anxiety and Depression Scale (HADS), and the Coping Strategies Questionnaire (CSQ). 
Pairwise analyses of the score changes of the mentioned outcomes of the three MPI 
subgroups were performed using the Mann-Whitney-U-test for significance.  
 Results. Cluster analysis identified three MPI subgroups in this highly disabled sam-
ple: a dysfunctional, interpersonally distressed and an adaptive copers subgroup. The 
dysfunctional subgroup (29% of the sample) showed the highest level of depression in 
SF-36 mental health (33.4 ± 13.9), the interpersonally distressed subgroup (35% of the 
sample) a modest level of depression (46.8 ± 20.4), and the adaptive copers subgroup 
(32% of the sample) the lowest level of depression (57.8 ± 19.1). Significant differences 
in pain reduction and improvement of mental health and coping were observed across 
the three MPI subgroups, i.e. the effect sizes for MPI pain reduction were: 0.84 (0.44 - 
1.24) for the dysfunctional subgroup, 1.22 (0.86 - 1.58) for the adaptive copers sub-
group, and 0.53 (0.24 - 0.81) for the interpersonally distressed subgroup (p = 0.006 for 
pairwise comparison). Significant score changes between subgroups concerning activi-
ties and physical functioning could not be identified.  
 Conclusions. MPI subgroup classification showed significant differences in score 
changes for pain, mental health and coping. These findings underscore the importance 
of assessing individual differences to understand how patients adjust to chronic back 
pain.  
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Introduction 
For more than twenty years, a simple diagnostic triage for back pain has been widely 
accepted and advocated as part of various clinical guidelines to distinguish between 
possible serious spinal pathology, nerve root pain or simple nonspecific back pain [1, 2]. 
By far the largest proportion of the three categories is the nonspecific back pain catego-
ry. Patients with nonspecific back pain, according to this diagnostic model, are viewed 
as a homogeneous group [1]. Various recent randomized controlled trials that have 
studied the effect of physiotherapy on nonspecific back pain, for example, found only 
small improvements in pain and disability [3, 4].  
 However, both health care professionals and researchers often state that patients 
with nonspecific back pain are heterogeneous with regard to their biopsychosocial 
impairments and responsiveness to interventions. Classification of people with chronic 
“nonspecific” back pain into homogeneous subgroups might be an important objective 
in order to tailor interventions and to control for subgroup differences when evaluating 
treatment outcome. Consequently, to achieve better clinical outcomes, scientifically 
confirmed criteria for building subgroups that relate to both diagnoses, pain coping 
strategies and prognosis of chronic pain patients are required. Thus, it would be possi-
ble to fit the treatment modalities to the patient, define the main therapeutic focus and 
optimally allocate human and financial resources [5-7].  
 Some randomized trials have demonstrated that effect sizes increase when classifi-
cation and matching are taken into account [8, 9]. However, there are several problems 
with a subgrouping approach and it is important that the subgrouping paradigm is 
closely examined [10, 11]. Several studies have proposed methods for subgrouping 
patients with back pain as a means of determining the treatment most likely to benefit 
patients with particular characteristics, to aid in prognosis or to identify pathology. 
However, overall consensus has not yet been achieved [12-16]. In their systematic re-
view Billis et al. identified classification systems of low back pain from nine countries 
[17]. Most studies were classified according to pathoanatomical and/or clinical fea-
tures, whereas fewer studies utilized a psychosocial and even less, a biopsychosocial 
approach. According to the International Classification of Functioning, disability and 
health (ICF) and the Initiative on Methods, Measurement, and Pain Assessment in Clini-
cal Trials (IMMPACT recommendations), chronic nonspecific back pain disorders should 
be evaluated within a biopsychosocial framework [18, 19].  
 The Multidimensional Pain Inventory - which measures pain, a number of psycho-
social and behavioral variables, and activities - has been used to classify patients with 
chronic back pain into empirically derived subgroups according to their pattern of 
symptoms [6, 20-22]. In the studies cited above, the Multidimensional Pain Inventory 
differentiated between three subgroups labelled as adaptive copers, dysfunctional, and 
interpersonally distressed [20]. The interpersonally distressed cluster is mainly charac-
terized by lower levels of perceived solicitous and distraction responses from the pa-
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tients’ partners or spouses and higher levels of punishing responses compared to the 
adaptive copers and dysfunctional clusters. The adaptive copers cluster, compared with 
the other two subgroups, is characterized by less pain severity, less interference with 
everyday life due to pain and less affective distress, more perception of life control and 
higher activity level. The persons of the dysfunctional cluster report high pain severity, 
high interference and activity distress, low life control and low activity level. 
 The main aim of this study was to examine the score changes on outcomes for pain, 
physical and mental function, and coping across the Multidimensional Pain Inventory 
subgroups after a standardized four-week interdisciplinary in-patient pain management 
program. Based on our previous study on patients with fibromyalgia, we hypothesized 
that the cluster dysfunctional would report, on average, higher improvements than the 
adaptive copers and the interpersonally distressed in pain, physical function, mental 
health, and coping [23]. Secondary aims were to investigate whether it was possible to 
describe the three Multidimensional Pain Inventory cluster solution in line with Turk 
and Rudy and validate the three-cluster solution by comparing the three clusters with 
measures of pain, psychosocial function, physical and mental health, and pain coping 
strategies. The hypothesis was that the symptom patterns on the Multidimensional 
Pain Inventory of the subgroups were similar to those of the corresponding subscales of 
the Medical Outcome Study Short Form-36, the Hospital Anxiety and Depression Scale, 
and the Coping Strategies Questionnaire. For example, the dysfunctional were expected 
to report more pain, worse physical function, and worse mental health than the other 
two subgroups in the corresponding Short Form-36 subscales. 
Methods 
Setting and participants 
The study was conducted at the rehabilitation clinic “RehaClinic” (locations Bad Zurzach 
and Braunwald, Switzerland), which is attended by severely disabled patients suffering 
from persistent musculoskeletal pain. All subjects were consecutively admitted and 
included in the study and 1) suffered from chronic non-specific back pain (i.e. lumbar, 
thoracic, or pan vertebral pain syndrome without serious spinal pathology or nerve root 
pain) and had had pain for at least six months. Further inclusion criteria were 2) ability 
to complete self-assessment questionnaires, understand the German language, no 
psycho-intellectual inabilities; and 3) provision of written, signed informed consent. 
Exclusion criteria were 1) severe somatic illness requiring specific treatment such as 
cancer, inflammatory rheumatic disease, neurological disease, and pain after a recent 
operation 2) manifest psychiatric disorder such as dementia, psychosis, suicidality, and 
3) failed inclusion criteria.  
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The patients with chronic nonspecific back pain were participants in the “Zurzach Inter-
disciplinary Pain (German: Schmerz) Program” - ZISP. The program is a four-week in-
house, standardized, interdisciplinary pain management program. This program has 
three main components: 1) medical care including adapted drug therapy, 2) exercise 
therapy and 3) psychotherapy, mainly cognitive and operant behavioral therapy (in 
total over 100 h of therapy). The program is intensive. Over the course of treatment 
patients received on average six daily sessions of the following treatments: physiother-
apy, aerobic endurance training, qigong / tai chi exercises, individual psychotherapy 
including cognitive behavioral therapy, participation in a pain coping group, relaxation 
therapy, humor therapy, information and education about the pathophysiology of pain 
mechanisms and management of chronic disabling pain, nursing care, and regular med-
ical consultations including drug therapy. The involved health care providers are: rheu-
matologists, clinical psychologists, physiotherapists, occupational therapists, nurses, a 
movement analyst and a humor therapist. Individual treatment strategies were identi-
fied and discussed during the interdisciplinary meetings of the pain management team 
(2 h per week for six patients). Detailed information on inclusion / exclusion criteria and 
interdisciplinary treatment goals are published elsewhere [24].  
 The study protocol was approved by the Local Ethic Commission (Health Depart-
ment in Aarau, Switzerland, no. EK AG 2008/026). All participants gave written in-
formed consent according to the Declaration of Helsinki. 
Outcome measures 
Sociodemographic data were collected using a standardized questionnaire from a pre-
vious study [25]. The West Haven-Yale Multidimensional Pain Inventory assesses pain 
and its consequences in terms of symptoms, disability, activity, behavior, mood, and 
social relationships [26]. The German version of the Multidimensional Pain Inventory is 
a self-reported 51-item inventory with eleven subscales: pain severity, interference due 
to pain, life control, affective distress (synonymously described as negative mood), 
support, punishing responses, solicitous responses, distracting responses, social and 
recreational activities, household chores, and activities away from home [27]. The last 
three subscales can be summarized into one subscale of general activities. The Multi-
dimensional Pain Inventory has been validated in various settings [26-28]. The Multidi-
mensional Pain Inventory has been used to identify subgroups of people with chronic 
musculoskeletal pain in different settings and with different biomedical diagnoses [28]. 
Two studies examined the cluster stability of the empirically derived subgroup classifi-
cation based on the Multidimensional Pain Inventory and found that retest resulted in 
65 to 70% of patients being assigned to the same cluster [29, 30]. 
 For external validation and calculation of effect sizes, the scales of the instruments 
listed below were used. The Medical Outcome Study Short Form-36 is a self-
administered generic instrument that assesses health-related quality of life [31]. Two 
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physical scales (physical functioning and bodily pain) and two mental scales (vitality and 
mental health) were examined. We used the validated German version of the Short 
Form-36 to enquire about symptoms and functioning during the preceding four weeks 
[32]. The Short Form-36 is used and has been validated in a large number of studies all 
over the world. The Hospital Anxiety and Depression Scale is a short self-rating of anxie-
ty and depression (seven items each), these being two of the most important affective 
health dimensions for people with chronic musculoskeletal pain [33]. It has especially 
been developed and validated in non-psychiatric settings [33, 34]. We used the validat-
ed German version of the Hospital Anxiety and Depression Scale [34]. The Coping Strat-
egies Questionnaire is a self-report instrument designed to assess the active and pas-
sive coping strategies of individuals with chronic pain [35]. For this study we used scales 
that measure cognitive (catastrophizing) and behavioral coping strategies (increasing 
activity level). We also used the two one-item scales that assess participants’ subjective 
ability to control or decrease their pain. These two scales measure the perceived effec-
tiveness of participants' coping strategies. We used the validated German version of the 
Coping Strategies Questionnaire which is a translation and cross-cultural adaptation of 
the original questionnaire [36]. Validation studies were performed in chronic musculo-
skeletal pain, including low back pain, and osteoarthritis [35, 36]. 
Statistical analysis 
The outcome measures were assessed on entry to the clinic (pre-treatment baseline) 
and at discharge after four weeks (post-treatment). The baseline scores of the scales of 
the Multidimensional Pain Inventory were used for subgroup classification. Differences 
between the baseline scores of the Short Form-36-/ Hospital Anxiety and Depression 
Scale-/ Coping Strategies Questionnaire-subscales of the three Multidimensional Pain 
Inventory subgroups – as a clue for construct validity – were tested. 
 The scores of the subscales of the Short Form-36, the Hospital Anxiety and Depres-
sion Scale, the Coping Strategies Questionnaire, the Multidimensional Pain Inventory 
life control/ support/ solicitous responses/ general activities were scaled from 0 = max-
imal pain/ maximal disability/ maximal symptoms/ worst coping to 100 = no pain/ full 
function/ no symptoms/ best coping, based on a procedure originally described in the 
Medical Outcomes Study Short Form-36 manual. This scaling was done to facilitate 
comparison of the clusters on these external validation measures. According to the 
subgroup classification of Turk and colleagues, the Multidimensional Pain Inventory 
pain severity/ interference with pain/ affective distress/ punishing responses were 
scaled from 0 = best to 100 = worst [20].  
 According to Turk et al., the empirically derived subgroups were defined by con-
firmatory cluster analysis using a predefined three cluster solution [20]. The Multidi-
mensional Pain Inventory score patterns were depicted as graphs of the mean Multidi-
mensional Pain Inventory baseline scores and compared to the patterns described by 
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Turk and colleagues using the rank orders of the three subgroups within one Multidi-
mensional Pain Inventory subscale. To assess whether a three-cluster solution was 
appropriate according to mathematical criteria, hierarchical cluster analysis according 
to the Ward method was performed [37]. Thus, the proposed “best feasible”, that is, 
clinically characterized, empirically determined solution according to the three Multi-
dimensional Pain Inventory subgroups originally defined by Turk and colleagues was 
chosen.  
 Effect sizes of the subscales of all four questionnaires were determined by the 
score difference between entry (baseline) and discharge from the pain management 
program after four weeks divided by the group standard deviation at entry [38]. Posi-
tive effect sizes indicate improvement of the pain condition, while negative effect sizes 
indicate worsening. An effect size ≥ 0.80 is considered as large, 0.50-0.79 as moderate, 
0.20-0.49 as small, and 0.00-0.19 as very small. 
 Pairwise analyses of the outcomes (entry to discharge) of the three Multidimen-
sional Pain Inventory subgroups were tested using the Mann-Whitney-U-test for signifi-
cance. In multiple pairwise testing of nonindependent subscale scores (e.g. within the 
patient rating of pain), the significance level must be reduced by the number of tested 
subscale scores (k), that is, p = 0.050/(k![k-2]! x 2!), which is well known as the Bonfer-
roni correction [39]. Thus, the significance level for the Type 1 error was p = 0.050/6 = 
0.008 for the comparisons of the k = 4 scores, p = 0.050/3 = 0.017 for the comparisons 
of the k = 3, and p = 0.050 for those of two subscale scores. 
 All analyses were performed using the statistical software package SPSS 17.0 for 
Windows® (SPSS Inc., Chicago, IL, USA). 
Results 
Participants at baseline 
Table 1 describes the demographic and medical data of the total sample of patients 
with chronic back pain on entry into the pain management program (n =173). The sub-
jects were characterized by a relatively young age, high prevalence and high level of 
depression, high level of unemployment, and a long history of pain.  
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Table 1. Demographic and medical data for the total sample at 
entry to the pain management program (n = 173) 
Age (years) 
    Mean±s 
    Range 
46.9±12.8 
21.3-79.6 
Sex (%) 
    Female 77.8 
Marital status (%)
    Single 
    Married 
    Other 
20.1 
72.0 
7.9 
Education (%) 
    Grade 10 –12 
    High school graduate 
    College graduate 
    University graduate 
30.9 
50.9 
14.5 
3.7 
Employment status 
    Full time 
    Part time 
    Unemployed 
    Retired 
9.6 
40.1 
41.9 
3.6 
Mental health (%)
    Depression* 54.5 
Pain duration (%)
    7 – 12 months 
    13 - 24 months 
    25 – 36 months 
    37 – 48 months 
    49 – 60 months 
    > 5 years 
  6.2 
  12.7 
  14.8 
  4.9 
22.8 
38.6 
Abbreviation: s, standard deviation 
NOTE. *HADS depression cut-off score: ≤ 9 out of 21 points.  
Classification of persons with chronic back pain into the Multidimensional Pain 
Inventory subgroups  
Table 2 shows the mean baseline scores of the Multidimensional Pain Inventory. One 
hundred and sixty-seven out of one hundred and seventy-three patients with chronic 
back pain could be allocated to one of the three chronic pain subgroups. Thirty-five 
percent (n = 61) were classified as “Interpersonally Distressed”, 32% (n = 56) were clas-
sified as “Adaptive Copers”, and 29% (n = 50) were classified as “Dysfunctional”. The six 
remaining persons with chronic back pain (4%) were classified as “Anomalous” (did not 
fit into any of the three profiles). The Multidimensional Pain Inventory baseline scores 
differed between the three clusters: the patients in the dysfunctional cluster showed 
highest scores for pain severity, interference due to pain, and affective distress and 
lowest scores for life control and general activities. The cluster interpersonally dis-
tressed showed lowest scores for solicitous and distracting responses by their partner 
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or spouses, and the highest score for negative or punishing responses by their partner 
or spouses. Compared to the other two subgroups, the adaptive copers showed best 
scores for life control, affective distress, and general activities.  
 
Table 2. Multidimensional Pain Inventory subscale baseline scores (m±s) 
MPI subscales Interpersonally
distressed  
n = 61 
Adaptive copers 
 
n = 56 
Dysfunctional 
 
n = 50 
Pain severity (6=worst, most) 4.2±1.0 4.6±0.8 5.1±0.7 
Interference with pain (6=worst, most) 3.9±0.9 4.0±0.9 5.1±0.6 
Life control (6=best, most) 2.9±1.1 3.8±0.8 1.9±1.0 
Affective distress (6=worst, most) 3.3±1.3 2.4±1.1 4.6±1.0 
Support (6=best, most) 2.5±1.5 5.4±0.7 5.2±0.9 
Punishing responses (6=worst, most) 1.8±1.6 0.9±1.0 1.4±1.5 
Solicitous responses (6=best, most) 2.0±1.0 4.7±1.0 4.4±1.1 
Distracting Responses (6=best, most) 2.3±1.7 4.1±1.2 4.2±1.4 
General activities (6=best, most) 2.5±0.8 2.5±0.8 1.9±0.9 
Abbreviations: MPI, Multidimensional Pain Inventory; m, mean subscale score; s, standard deviation. 
Validation of the subgroup classification 
Comparing the results of Table 2 and Table 3, the scores of the subgroups of the Short 
Form-36, Hospital Anxiety and Depression Scale, and Coping Strategies Questionnaire 
showed almost the same pattern as the Multidimensional Pain Inventory. On the Mul-
tidimensional Pain Inventory pain severity, the rank order of the three cluster sub-
groups in terms of reported pain was dysfunctional (most pain), adaptive copers, and 
interpersonally distressed (least pain). This same order was found on the Short Form-36 
bodily pain: the cluster dysfunctional showed most pain, 14.0±12.8. The Multidimen-
sional Pain Inventory general activities scale was compared to Short Form-36 physical 
functioning: the dysfunctional patients showed the lowest activity level (Short Form-36 
physical functioning: 34.7±19.6). The mean baseline score of Multidimensional Pain 
Inventory life control was compared to the score of Coping Strategies Questionnaire 
ability to control pain: the adaptive copers had best control, 48.5±22.1. Multidimen-
sional Pain Inventory affective distress was compared to Short Form-36 mental health, 
Hospital Anxiety and Depression Scale depression and anxiety, and Coping Strategies 
Questionnaire catastrophizing: the cluster dysfunctional showed most and the adaptive 
copers least affective symptoms on all scales (significant differences in all subgroup 
comparisons). It was not possible to replicate the specific Multidimensional Pain Inven-
tory characteristics of the interpersonally distressed subgroup (punishing responses 
and lack of support and distraction of pain by partner or spouse) because the scores of 
the subscales of the Short Form-36, Hospital Anxiety and Depression Scale and Coping 
Strategies Questionnaire do not assess social support.  
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Table 3 Baseline scores for the three Multidimensional Pain Inventory cluster groups (m±s)  
 
Subscales 
Interpersonally distressed
n = 61 
Adaptive copers
n = 56 
Dysfunctional 
n = 50 
SF-36 (100 = best)
    Physical functioning 
    Bodily pain 
    Vitality 
    Mental health 
46.0±20.7 
23.5±12.7 
28.2±16.6 
46.8±20.4 
43.1±22.2 
19.5±11.1 
35.7±14.6 
57.8±19.1 
 
34.7±19.6 
14.0±12.8 
18.2±15.3 
33.4±13.9 
HADS (100 = no anxiety or depression) 
    Anxiety  
    Depression 
52.5±22.1 
57.5±20.1 
60.5±18.5 
65.1±18.4 
 
37.5±15.4 
39.9±18.3 
CSQ (100 = best) 
    Catastrophizing 
    Increasing activity level 
    Ability to control pain 
    Ability to decrease pain 
50.2±17.9 
55.6±15.0 
48.0±24.4 
38.7±20.4 
51.2±15.4 
63.8±13.4 
48.5±22.1 
36.9±19.3 
 
35.1±17.2 
51.5±16.9 
33.3±22.8 
32.3±23.4 
Abbreviations: m, mean subscale score; s, standard deviation; SF-36, Medical Outcome Study Short-Form 36; 
HADS, Hospital Anxiety and Depression Scale; CSQ, Coping Strategies Questionnaire. 
 
Differential score changes within the Multidimensional Pain Inventory subgroups 
Table 4 shows entry-to-discharge scores of the three Multidimensional Pain Inventory 
subgroups. According our main hypothesis, significant differences in pairwise compari-
son of score changes were found. Comparing the dysfunctional and adaptive copers 
subgroups, the dysfunctional subgroup showed significantly higher score changes on 
Multidimensional Pain Inventory life control, Multidimensional Pain Inventory affective 
distress, and Short Form-36 mental health. The adaptive copers subgroup showed most 
and significantly higher improvements in Multidimensional Pain Inventory pain severity, 
Short Form-36 bodily pain, and Coping Strategies Questionnaire ability to decrease pain 
when compared to the other two subgroups. After Bonferroni correction, the score 
change of the adaptive copers remained statistically significantly higher than that of the 
interpersonally distressed in the domain of the four coping dimensions (p = 0.003 < 
0.008). In the domain of the four mental (affective) health scales, the score change of 
the dysfunctional cluster remained statistically significantly higher than those of the 
interpersonally distressed and the adaptive copers (p = 0.001 < 0.008). 
 In all three Multidimensional Pain Inventory subgroups the pain management pro-
gram led to small improvements in physical function and general activities but did not 
reach significance between subgroups. 
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Discussion 
According to the main aim of the study, our hypothesis was that the three Multidimen-
sional Pain Inventory subgroups showed significant differences in the change of pain, 
physical and mental function and coping after the pain management program. This was 
partly confirmed by our results: The hypothesis was true for the two scales measuring 
pain reduction - Multidimensional Pain Inventory pain severity and Short Form-36 bodi-
ly pain showed highest effects in the adaptive copers subgroup - , three mental health 
dimensions - Multidimensional Pain Inventory life control, Multidimensional Pain Inven-
tory affective distress, and Short Form-36 mental health showed highest effects in the 
dysfunctional subgroup -, and the two pain coping dimensions – Coping Strategies 
Questionnaire ability to control pain and Coping Strategies Questionnaire ability to 
decrease pain scored in favor of the adaptive coper and dysfunctional subgroups. In our 
previous study with one hundred and eighteen persons with fibromyalgia, significant 
differences in treatment outcome across the three Multidimensional Pain Inventory 
subgroups were mainly observed in favour of the dysfunctional subgroup [23]. Signifi-
cant subgroup differences in score changes concerning physical functioning and general 
activities could not be identified.  
 Talo et al. first showed that different Multidimensional Pain Inventory subgroups 
might have different treatment outcomes [40]. Patients with poor functional profiles 
(the subgroups of dysfunctional and interpersonally distressed) may gain a lot from 
rehabilitation. Three other studies with chronic back pain patients treated in rehabilita-
tion programs did not find inter-group differences [6, 7, 41]. It was hypothesised that 
the treatments may not have been relevant to the dysfunctional patients and may not 
have been sufficiently potent for the interpersonally distressed and adaptive copers 
patients [28]. In their Multidimensional Pain Inventory subgroup analysis, Vollenbroek-
Hutten et al. were able to demonstrate more improvement in the dysfunctional and 
interpersonally distressed patients, and no differences in the adaptive copers patients 
[42]. They postulated that the adaptive copers patient group was probably “too good” 
for an extensive, multidisciplinary, physically oriented rehabilitation program or usual 
care outside the rehabilitation centre. However, the Multidimensional Pain Inventory 
subgroups were too small to perform a statistical analysis (dysfunctional, n= 9; inter-
personally distressed, n = 9; adaptive copers, n = 11). In contrast, the results of the 
present study showed significant improvements in the different domains of pain reduc-
tion, improvement of mental health and pain coping for all three Multidimensional Pain 
Inventory subgroups, including the adaptive copers patients.  
 In support of the other hypothesis (secondary aims), the score differences at entry 
between the subgroups as described by the Multidimensional Pain Inventory were 
consistent with comparable constructs measured on the Short Form-36, Hospital Anxie-
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ty and Depression Scale, and Coping Strategies Questionnaire. The persons in the adap-
tive copers subgroup showed better general and mental health, less anxiety and de-
pression, less catastrophizing, and better self-efficacy (ability to control and decrease 
their pain) than persons in the dysfunctional subgroup. The persons in the dysfunction-
al cluster reported higher levels of pain, anxiety, depression, and use of maladaptive 
coping strategies, and lowest levels of physical function, social function, and mental 
health as compared to the adaptive copers subgroup. The interpersonally distressed 
pattern of the Multidimensional Pain Inventory could not be replicated by the other 
instruments due to lack of scales with comparable constructs. Overall, the differences 
of scores between the three clusters implied support for moderate convergent validity. 
 This retrospective Multidimensional Pain Inventory subgroup classification (a pos-
teriori) provides information that may help to improve the effects of standard pain 
management programs. It suggests matching persons with the treatment strategies and 
therapeutic methods they are most likely to respond to and where they show the 
greatest need of treatment and/or where they show the largest deficits (i.e. tailored 
pain management). Several recent studies in the field of (sub-) acute nonspecific low 
back pain and acute neck pain have provided preliminary evidence that using specific 
inclusion criteria to identify more homogenous subgroups of subjects and attempting 
to match treatment to the subgroup has the potential to enhance treatment effects [8, 
12-16]. The development and a priori implementation of classification methods for 
matching interventions of pain management programs to subgroups of patients may 
improve clinical outcomes. This is being examined in our ongoing randomized con-
trolled trial “Effectiveness of tailored pain management in patients with chronic back 
pain” (http://www.controlled-trials.com/ ISRCTN25592008/).  
 In this study, the sample consisted of selected persons who had suffered from a 
severe and disabling chronic back pain disorder for a long time and who fulfilled certain 
criteria (e.g. motivation, ability to understand German) and, therefore, possibly differ in 
important ways from people with chronic back pain in general thus limiting the general-
izability of the results. As the design of the study did not include a control group, the 
changes after the pain program cannot be solely attributed to the interventions. In this 
singe arm trial it is unclear if the different outcomes for the three subgroups represent 
different prognosis, response to generic aspects of care, or other factors. Another limi-
tation is the short-term measurement of score changes (between entry and discharge 
from the rehabilitation clinic after four weeks). Our future study uses standardized 
outcome measurements not only at the end of the experimental program but at follow-
up times that are long enough for the person with chronic back pain to modify behavior 
patterns and master effective strategies. When using a post- / pre-test difference to 
define improvement after an intervention, the possibility of regression towards the 
mean cannot be excluded. We aimed to minimize this effect by using only reliable 
measurement instruments that have been used previously with persons with chronic 
back pain. Regression to the mean was not the case in Multidimensional Pain Inventory 
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pain severity, Short Form-36 bodily pain, and Coping Strategies Questionnaire ability to 
decrease pain. In these three subscales the baseline scores of the dysfunctional sub-
groups were, compared to the adaptive copers and interpersonally distressed patients, 
the lowest. However, largest effect sizes in these three subscales were not measured in 
the dysfunctional subgroup but in the adaptive copers. Finally, all outcome variables 
were obtained from self-reported questionnaires, e.g. Multidimensional Pain Inventory 
general activities screening for perceived disability and not from observing physical 
performance.  
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Conclusions 
The findings of this study showed that the Multidimensional Pain Inventory subgroups 
previously identified in less disabled samples of chronic back pain patients are also 
evident in a highly disabled chronic back pain sample. The three subgroups identified 
(dysfunctional, interpersonally distressed, and adaptive copers) showed significant 
differences in score changes in pain, mental health, and coping outcomes following a 
four-week, standard, inpatient, interdisciplinary, pain management program. However, 
the pain management program led to small but not significant improvements in physi-
cal function and general activities. 
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management program based on the MPI 
Classification System: A pragmatic 
randomized controlled trial in patients with 
chronic back pain 
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Abstract 
 Objectives. Effects of conservative treatments in patients with nonspecific chronic 
back pain are modest. Prospective classification of these patients into homogeneous 
subgroups might be an important objective in order to tailor interventions and improve 
treatment outcomes. This study aimed to investigate the effects in improving pain and 
disability of a subgroup-specific, 4-week, inpatient interdisciplinary pain management 
program, compared to a standard pain management program in patients with chronic 
back pain in a rehabilitation setting. 
 Methods. A tailored pain management program based on the Multidimensional 
Pain Inventory (MPI) Classification System was compared to standard pain manage-
ment in a randomized controlled trial. The primary outcomes were self-reported pain 
and disability, measured at 4 and 12 weeks after randomization. Secondary outcomes 
were observed functional disability, anxiety and depression, pain catastrophizing, self-
efficacy and psychosocial aspects of pain.  
 Results. A total of 146 patients were included in this study. With the exception of 
reduction of minimum pain intensity after 4 weeks with a standard mean difference 
(SMD) = 0.43, 95% confidence interval (CI), 0.02 to 0.84; p = 0.034, no significant differ-
ences between intervention and control group were found. The secondary analysis, i.e. 
pairwise comparisons between the individual MPI subgroups and the control group, 
specified this difference in effect in favor of the control group compared to the MPI 
subgroup adaptive coper: SMD = 0.55, 95% CI, 0.02 to 1.08; p = 0.035 at the 12-week 
follow-up. None of the other comparisons for any of the outcomes and follow-up times 
was statistically significant.  
 Conclusions. The subgroup-specific pain management program based on the MPI 
Classification System for patients with chronic back pain was not more effective in im-
proving pain and disability than a standard pain management program. 
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Introduction 
Chronic pain of moderate to severe intensity occurs in 19% of adult Europeans, serious-
ly affecting the quality of their social and working lives [1]. As in the rest of Europe and 
most developed countries worldwide, low back pain is also the most prevalent health 
problem in Switzerland. The total economic burden of back pain to Swiss society varied 
in 2005 between 1.6 and 2.3% of the gross domestic product (4.8 to 6.6 billion Euros) 
[2]. Moreover, musculoskeletal pain disorders like back pain do not solely affect quality 
of life, but are also associated with a long-term increased risk of cancer and cardiovas-
cular-related mortality of 20 to 30% [3].  
 In trials with patients with chronic, nonspecific back pain, comparing exercise ther-
apy, behavioral therapy or multidisciplinary treatment with no-treatment, modest ef-
fects were found [4, 5]. In trials comparing two interventions, often no differences were 
identified [4]. Relative to a host of widely used conventional medical treatments, com-
prehensive interdisciplinary pain management programs offer the most efficacious and 
cost-effective, evidence-based treatment for patients with chronic back pain [6, 7]. 
However, back pain is nonspecific in about 90% of cases, which means that no relevant 
physical cause of the pain can be identified, and its origin remains unclear [7, 8].  
 The search for homogeneous subgroups of patients with nonspecific low back pain 
who respond best to subgroup-specific pain management interventions – for so many, 
the Holy Grail of low back pain research – has been on the international research agen-
da for over 18 years [7, 9-12]. Lack of prospective specification, inadequate sample size, 
inability to maintain statistical power, and the cumulative effect of sampling errors in 
trials designed to detect overall treatment effects complicate the interpretation of a 
posteriori subgroup analyses [13, 14]. Among other recommendations, studies investi-
gating treatment effect modifiers should limit their analyses to a small number of plau-
sible variables or subgroups that are nominated prior to the conduct of the trial [15, 
16]. Several, mainly physiotherapy exercise-based classification systems to subgroup 
low back pain patients with the intent to guide treatment, have been developed (for 
overview: reference [17]) and tested in several settings [18-20]. These trials showed 
large variations in methods for subgrouping, therapeutic interventions and outcome.  
 The Multidimensional Pain Inventory (MPI) Classification System, which reliably 
classifies back pain patients into three predominantly psychosocial subgroups, has been 
used by several research groups to show a posteriori significant effects for pain, mental 
health and coping [21-23]. So far, no randomized controlled trial has been conducted to 
evaluate the effects of tailored pain interventions to a priori classified MPI subgroups of 
patients with chronic back pain in a rehabilitation setting. 
 The aim of the present study was to examine the effectiveness of tailored pain 
management on pain and disability in patients with chronic nonspecific back pain classi-
fied according the Multidimensional Pain Inventory (MPI) Classification System, com-
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pared to general pain management. The secondary objective focussed on the explora-
tion of differences in effects between individual MPI subgroups and the control group. 
Methods 
Trial design 
This single blinded parallel group randomized controlled trial was designed to evaluate 
the effectiveness of a subgroup-specific pain program, compared to a standard pain 
program. The Local Research Ethics Committee of the Health Department in Aarau gave 
ethics approval on the 6th February 2009 (ref: 2008/033). The Ethics Committee of the 
Health Department in Zurich gave approval on the 12th March 2009 (ref: 15/09). All 
participants gave written informed consent according to the Declaration of Helsinki. 
Trial Registration was done at Current Controlled Trials Ltd c/o BioMed Central Ltd 
(http://www.controlled-trials.com/ ISRCTN25592008/). The acronym of this study is 
RCTcBPsub. 
Setting and participants 
The study was conducted at the rehabilitation clinic RehaClinic (locations Bad Zurzach 
and Braunwald, Switzerland), which is attended by severely disabled patients suffering 
from persistent musculoskeletal pain. The patients were participants in the Zurzach 
Interdisciplinary Pain Program. The program is a four-week, in-house, standardized, 
interdisciplinary pain management program. Detailed information on its concept and 
treatment goals have been published elsewhere [24]. All study participants were con-
secutively admitted and included in the study and 1) suffered from chronic nonspecific 
back pain (i.e. lumbar, thoracic, or pan vertebral pain syndrome without serious spinal 
pathology or nerve root pain) and had had pain for at least six months. Further inclu-
sion criteria were 2) ability to complete self-assessment questionnaires, understand the 
German language, no psycho-intellectual inabilities; and 3) provision of written, signed 
informed consent. Exclusion criteria were 1) severe somatic illness requiring specific 
treatment such as cancer, inflammatory rheumatic disease, neurological disease, and 
pain after a recent operation, and 2) manifest psychiatric disorder such as dementia, 
psychosis, suicidality. 
Randomization and allocation concealment 
Two computer-generated random number lists, one for the patients in RehaClinic 
Braunwald and one for RehaClinic Zurzach, generated by a researcher who was not 
involved in the conduct of the study (JBS), were used to allocate patients. To secure 
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highest possible equal distribution between the three MPI subgroups in the interven-
tion group and the control group, patients were randomly assigned by central block 
randomization (blocks of eight, that is two control patients and six intervention patients 
per block). After inclusion in the study, the study nurse (SL) received the group alloca-
tion by telephone by an independent secretary and assigned patients to the interven-
tions. The study nurse and the principal investigator were not involved in the assess-
ment, inclusion or treatment of the patients.  
Classification system 
The Multidimensional Pain Inventory Classification System classifies patients with 
chronic back pain into empirically derived subgroups according to their pattern of 
symptoms [21, 25-27]. Compared to other diagnostic groups and other examiner-based 
subgroup classification systems, it is substantially stable in classifying chronic back pain 
patients [28]. The Multidimensional Pain Inventory differentiates between three sub-
groups labelled as, dysfunctional, interpersonally distressed and adaptive copers [25]. 
The subgroup dysfunctional is characterized by severe pain, comprised life activities 
and enjoyment, reduced sense of control and high levels of emotional distress. The 
second subgroup, also marked with relatively high degrees of pain and affective distress 
but further characterized by low levels of perceived support from their significant oth-
ers, is labelled interpersonally distressed. The third subgroup (adaptive copers) consists 
of a set of patients with chronic pain who appear to be coping relatively well despite 
their long-standing pain. Compared to the two other subgroups, lower levels of pain, 
functional limitations and emotional distress characterize this profile [29]. The three 
subgroups have been replicated and validated in numerous studies (e.g. [21, 27, 30]). In 
this study, subgroups were defined by confirmatory cluster analysis using the prede-
fined three cluster solution according to the MPI Classification System [21, 25, 31]. The 
Multidimensional Pain Inventory (MPI) score patterns were depicted as graphs of the 
nine mean MPI baseline subscale scores and compared to the patterns described by 
Turk and colleagues using the rank orders of the three subgroups within one MPI sub-
scale. The therapists were allowed to overrule the MPI subgroup classification if they 
thought that the decision to overrule was appropriate. 
Interventions 
Over the course of treatment patients in both the intervention and control group re-
ceived on average four daily sessions of the following group therapies: cardiovascular 
training, relaxation therapy, participation in a pain coping group, humor therapy, in-
formation and education about the pathophysiology of pain mechanisms and manage-
ment of chronic disabling pain, movement analysis, occupational therapy and qigong / 
tai chi exercises. Individual treatment strategies were identified and discussed during 
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the interdisciplinary meetings of the pain management team (two hours per week for 
six patients). For both groups, subsequent ambulatory care was organized for the time 
after discharge from the clinic. The different components of the intervention and con-
trol group are described in the following two paragraphs (detailed intervention proto-
cols can be obtained upon request from the corresponding author). 
Tailored pain management group 
In addition to the group therapies mentioned above, patients in the intervention group 
received specific interventions, which were tailored to their subgroup classification. 
 Subgroup dysfunctional: The pacing problem of these patients was mainly underac-
tivity. Patients learned that it is safe to move, while restoring function by receiving 
feedback and positive reinforcement, treatment of depressive mood and additional 
stress management. 
 Subgroup adaptive copers: The coping problem of the patients in this subgroup 
mainly existed of denying or minimizing their problems and thus often presented a 
false positive picture [21, 31, 32]. Their pacing problem was mainly overactivity. Thera-
py focussed on activity pacing to moderate overactivity, use of stop-rules, body aware-
ness, and mental and physical relaxation techniques in stressful situations [33, 34]. 
 Subgroup interpersonally distressed: This subgroup of patients mainly expressed 
anxiety about how their pain affected other family members, regretted losing full work-
ing capacity and worried about financial consequences [35]. Systemic therapy (with 
pain patient and, if possible and desired, partner or spouse) focussed on encourage-
ment of well behaviors and reduction of negative responses, as well as higher levels of 
solicitous responses to pain behaviors of both the patient and their partner or spouse 
[36-39]. Exercise therapy focussed on identification and training of meaningful activi-
ties, which the patient could perform in future together with his partner or spouse.  
 The subgroup-specific intervention consisted of a combination of individual physio-
therapy, i.e. four-half hour sessions per week of graded exercise therapy, also called, 
graded activity [40-43] and individual psychotherapy, i.e. two-one-and-a-half hour ses-
sions per week of cognitive behavioral therapy or systemic therapy [44, 45]). Graded 
activity exercise developed by Lindstrom et al. consisted of two parts: baseline repeat-
ed measurements of functional performance and individual, sub-maximal, gradually 
increased exercise program with an operant-conditioning behavioral approach. The 
clinical psychologists applied counselling and exercise of the individual patient based on 
cognitive-behavioral principles or systemic therapy with the aim of modifying pain be-
havior of the patients and – for the patients classified in the subgroup interpersonally 
distressed – their partner or spouse. After initial assessment, the patients went through 
four further phases: collaborative reconceptualization of the patient’s view of pain; 
skills acquisition and skills consolidation, including cognitive and behavioral rehearsal; 
generalization, maintenance and relapse prevention; booster sessions and follow up.  
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General pain management group 
The patients in the control group absolved progressive resistance training and stretch-
ing exercises according to the recommendations of Hayden et al. [46, 47]. In individual 
physiotherapy sessions medical training therapy with or without training devices fo-
cussed on improvement of muscle strength, endurance and stretching of selected mus-
cle groups [48, 49]. The success of training was assured through systematic progression 
with exact quantification of the dose [50, 51]. This sports medicine approach introduces 
exercise based on the theoretical framework of exercise physiology. Progressive re-
sistance training was shown to improve the ability to generate force, which may carry 
over into an improved ability to perform daily activities. Central pain modulation during 
exercise therapy has been explained by activation of endogenous analgesia [52]. Indi-
vidual psychotherapy sessions were optional and, if selected, not primarily focussed on 
the management of their musculoskeletal pain syndrome as in the patients in the tai-
lored pain management group. 
Contrast between interventions 
The contrast between interventions was an important issue in this trial because both 
tailored and general pain management interventions were performed by physiothera-
pists and clinical psychologists and also contained a large basic module of group inter-
ventions for both groups. However, there were some important features that were 
responsible for the contrast. The systematic review of Hayden et al. [46] described 
general strategies for using exercise therapy to improve outcomes in chronic low back 
pain, while the graded activity training protocol prescribed the frequency, intensity and 
duration of the exercise therapy and graded activity in detail. The review by Hayden et 
al. generally recommended supervised exercise therapy encouraging activity/exercise. 
However, no further guidance was provided regarding the content of the exercise pro-
gram (type, intensity, frequency and duration of exercises) or regarding integrating 
behavioral principles. The physiotherapist was free in his decision to apply a pain-
contingent or time-contingent approach. In the tailored pain management training 
protocol the contents of the exercise therapy and operant conditioning were thorough-
ly described and the physiotherapists were trained to apply these skills in practice. The 
physiotherapist strictly followed a time-contingent approach. In order to avoid combin-
ing the different treatment elements, physiotherapists were trained only to deliver the 
one treatment element of their personal preference. For feasibility reasons, this subdi-
vision within the comparably small group of clinical psychologists was not made. 
Blinding 
In exercise therapy trials, neither health professionals nor patients can be blinded to 
the treatment. Therefore, this study does not meet the criterion of blinding of care 
provider and blinding of patients. However, before randomization the patients were 
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told that all treatments are effective, but that the exact effectiveness is not yet clear. 
The treatment providers (physiotherapists and clinical psychologists) were aware of 
which treatment they provided to the different subgroups of patients in the interven-
tion group and the patients in the control group. Other efforts to achieve a certain level 
of blinding within therapists and data researchers were a) interventions and measure-
ments were done by different therapists (the physical outcome measures 5-Minute 
Walk Distance test and Back Performance Scale were blindly assessed by a physiother-
apist who was not involved in the treatment of the patients and we asked the patients 
not to reveal information about their treatment to this physiotherapist); and b) an in-
dependent data manager (SL) collected and entered the data, recoded the patients to 
unique codes before handing the database to the analyzing researchers (MLV, FA). 
Intention-to-treat analysis was carried out independently and blinded for treatment 
allocation. 
Outcome measures 
Socio-demographic data and utilization of medical and therapeutic resources were 
recorded in a standardized way [53]. Medical records of the physicians in charge of our 
clinic (reports of the inpatient rehabilitation sent to the admitting physicians) were 
reviewed for data on further medical history. Comorbidities were examined with the 
Self-Administered Comorbidity Questionnaire [54]. 
Primary outcome variables pain severity and pain disability 
Pain severity was measured by the numeric rating scale (NRS) [55]. This self-report pain 
scale ranges from 0 (no pain) to 10 (worst conceivable pain). The patients indicated 
their current pain (pain at the moment of measurement), and their maximum and min-
imum pain during the last week. Pain disability was measured by the self-report 
Oswestry Disability Index (ODI) [56]. The ODI is a condition-specific questionnaire and 
consists of ten items to assess the extent of the patient’s back pain and difficulty in 
carrying out nine different activities of daily life: personal care, lifting, walking, sitting, 
standing, sleeping, sex life, social life and travelling. Each item is scored from 0 to 5, 
with higher values representing greater disability. The total score is multiplied by 2 and 
discussed in terms of points (0 to 100). We used the validated German version of the 
ODI, a translation and cross-cultural adaptation of the ODI version 2.1, which was test-
ed as a sensitive instrument for detecting clinical change [57, 58]. 
Secondary outcome variables 
Observed functional disability was measured with two physical performance tests. The 
Back Performance Scale (BPS) is a specific performance measure of observed mobility-
related activities, extensively validated for people with chronic back pain [59]. The BPS 
consists of five physical performance tests: The Sock Test, the Pick-up Test, the Roll-up 
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Test, the Fingertip-to-Floor Test, and the Lift Test. The 16-point BPS sum score ranges 
from 0 (= no activity limitation) to 15 (= major activity limitation) [60]. The 5-Minute 
Walk Distance test (5-MWD) is a performance based test, derived from the 12-Minute 
Walk Test by Butland and colleagues [61] and explicitly validated for patients with back 
pain [62]. Distance walked in 5 minutes is measured and reported in meters. A greater 
distance indicates a better performance. The Hospital Anxiety and Depression Scale 
(HADS) is a short self-rating of anxiety and depression (seven items each), these being 
two of the most important affective health dimensions for people with chronic muscu-
loskeletal pain [63]. It has been specifically developed and validated in non-psychiatric 
settings. We used the validated German version of the HADS [64]. Pain catastrophizing, 
a significant determinant of self-rated pain and disability, was measured with the Ger-
man version of the Pain Catastophizing Scale (PCS) [65, 66]. The PCS consists of 13 
items to assess the extent of the patient’s catastophizing thoughts and behaviors. Each 
item is scored on a five-point scale, with higher values representing greater catastro-
phizing. The total score is computed by summation of all items and ranges from 0 to 52 
points. The Coping Strategies Questionnaire (CSQ) is a self-report instrument designed 
to assess the active and passive coping strategies of individuals with chronic pain [67]. 
For this study we used the two one-item scales that assess participants’ subjective 
ability to control or decrease their pain. These two scales measure the perceived effec-
tiveness of participants' coping strategies and, as such, are a measure of self-efficacy. 
Using a 7-point Likert scale, patients rate from 0 to 6, with 0 signifying “no control/no 
ability to decrease pain” and 6 signifying “complete control/complete ability to de-
crease pain”. We used the validated German version of the CSQ which is a translation 
and cross-cultural adaptation of the original questionnaire [68]. To be able to evaluate 
the effect of the interventions in relation to the patient’s partner or spouse and be-
cause of lack of a different instrument measuring this social dimension, we used the 
three Multidimensional Pain Inventory (MPI) scales punishing responses, solicitous 
responses, and distracting responses [69, 70]. The psychometric properties of the Ger-
man version of the MPI are comparable to the original version [28]. 
Sample size 
Sample size calculations for this study were based on detecting an 18% (8 to 10 score 
points) difference on the Oswestry Disability Index at entry to the pain program, which 
has been identified as the minimum clinically important difference [58, 71]. According 
to power calculations (α = 0.05 and 1 – β = 80%), a sample size of 24 patients per 
treatment group provided 80% power to detect a clinically important difference of 8 
points between the intervention group and control group, assuming a common stand-
ard deviation of 12.0 [58, 72]. We expected a drop-out rate of 20% at most. This means 
that to obtain a total of 96 complete data sets at one year follow-up (two treatment 
arms with 72 and 24 patients) 120 patients had to be included in the study. However, 
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during recruitment, this number was revised to 140 study participants to compensate 
for a larger than anticipated loss at 3-months follow-up. 
Data analysis 
The primary analysis of the data was undertaken using the principle of intention-to-
treat. The patients were analyzed in the treatment group to which they were randomly 
allocated. Our intention-to-treat analysis included all participants: study completers, 
those who had missing data and those who were not fully compliant with the protocol. 
For missing data, imputation techniques carrying the last available score forward were 
used. In addition, a per-protocol analysis for the primary outcome was performed to 
estimate the impact on the effect of loss to follow up and treatment protocol devia-
tions. Deviations of the protocol were defined as either withdrawal from therapy within 
the four week stay at the rehabilitation clinic or not being treated according to the 
corresponding treatment allocation. 
 To determine statistically significant planned pairwise comparisons, clinical effec-
tiveness was examined with a Student’s t-test (normally distributed continuous data), a 
Chi-square test (categorized data) or a Wilcoxon test (not normally distributed continu-
ous data). The primary comparison was made between the intervention group as a 
whole (i.e. the overall effect of all three MPI subgroups) and the control group. The 
secondary analysis was made between the three MPI subgroups separately and the 
control group (the trial was prospectively sufficiently powered for these subgroup anal-
yses). Cohen’s Standardized Mean Difference d (SMD) for independent groups with 95% 
confidence intervals was calculated between baseline and 4 and 12 week follow up 
measurements. The SMD equals the difference of the score differences (baseline to 
follow up) of the means between intervention and control divided by the pooled stand-
ard deviation [73]. 
 For all tests, a p-value of less than 0.05 (two-tailed) was considered significant. All 
analyses were performed using version 21.0 of the statistical software package SPSS for 
Windows (SPSS Inc., Chicago, IL, USA). 
Results 
Figure 1 shows the flow of patients through the study. Patient recruitment started in 
March 2009 and patients were consecutively included until September 2012. A total of 
397 patients with chronic musculoskeletal pain were referred to the Zurzach Interdisci-
plinary Pain Program, of which 225 were eligible for participation. Seventy-nine pa-
tients did not meet the inclusion criteria. The most common reason for exclusion was 
insufficient understanding of the German language (n = 50). One hundred and forty-six 
patients met the inclusion criteria and were included in the study. The mean number of 
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treatment sessions (individual and group therapies) was similar in the intervention and 
control group. Eighteen physiotherapists and seven clinical psychologists participated in 
the trial. Training of the physiotherapists and clinical psychologists started in 2008 and 
refresher courses of the therapists were organised twice a year. 
 
 
Figure 1. Patient flow through the study 
Baseline comparisons and dropouts 
The mean age of study participants was 46 years (range 18-73), and 65% of 146 pa-
tients were women (Table 1). The patients in the intervention and control group were 
comparable in demographic and clinical characteristics, including their baseline scores 
for the primary outcomes severity of pain and pain disability. 
 
  
Assessed for eligibility (n = 225)
Excluded (n = 79) 
• Not meeting inclusion criteria (n=79) 
Analyzed after 12 weeks (n = 113) 
Discontinued intervention (n = 16) 
(clinical, n = 6; compliance, n = 7; language,  
n = 3)  
Allocated to intervention group (n = 113) 
• Received allocated intervention (n = 106) 
• Did not receive allocated intervention 
(n = 7) 
Discontinued intervention (n = 1) 
(clinical: n = 1)  
Allocated to control group (n = 33) 
• Received allocated intervention (n = 28) 
• Did not receive allocated intervention  
(n = 5)
Analyzed after 12 weeks (n = 33) 
Randomized (n = 146) 
Lost to follow-up after 12 weeks (n = 23) 
(compliance: n = 23)
Lost to follow-up after 12 weeks (n = 8) (compliance: 
n = 8)
Allocation 
Analysis 
Enrollment 
Follow-Up 
E l nt 
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Table 1. Patient characteristics of the sample groups at baseline 
Characteristic Intervention group 
(n = 113) 
Control group  
(n = 33) 
Demographic characteristic 
Female sex (%) 62.8 69.7
Age (y; m, min-max) 47.6 (18.0-73.4) 45.5 (21.8-67.2) 
School education (%) 
   No school education completed 2.7 0.0
   Elementary school 28.3 48.5
   Secondary school 62.8 51.5
   University entrance diploma 6.2 0.0
Employment status
   Paid work (h/wk; m±s) 16.8±19.2 20.8±19.3
   Household chores (h/wk; m, min-max) 11.3 (0.0-56.0) 9.3 (0.0-28.0) 
Sports (h/wk; %) 
   None 42.5 45.5
   > 2 23.0 12.1
Marital status (%)
   Single 25.7 15.2
   Married 64.6 75.8
   Other 9.7 9.1
Clinical characteristics 
Duration of symptoms (y; m, min-max) 10.1 (0.5-42.1) 8.6 (0.5-39.0) 
Co morbidities (%)
   None 20.5 28.1
   1-3 59.9 43.8
   >3 19.6 28.1
Smoking: yes (%) 40.7 48.5
Severity of pain (NRS score; m±s) 
   Current pain 6.3±2.1 6.2±2.0
   Maximum pain in last 7 days 7.9±1.7 7.6±1.6
   Minimum pain in last 7 days 4.4±2.3 5.3±2.4
Pain disability (m±s)
   Self-report (ODI score) 46.1±13.0 45.0±13.3
   Performance test (BPS score) 6.7±4.0 7.3±4.3
   Performance test (5-MWD test; meter) 320.6±126.1 307.3±128.3
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Characteristic Intervention group 
(n = 113) 
Control group  
(n = 33) 
Mental health 
   Depression (HADS-D score; m±s) 11.5±4.3 11.8±4.7
   Catastrophizing (PCS score; m±s) 51.0±22.4 55.0±26.4
Self-efficacy (m±s)
   CSQ item “control over pain” 2.6±1.2 2.4±1.2
   CSQ item “ability to decrease pain” 2.3±1.0 2.0±1.0
Treatment expectancy and credibility 
   CEQ expectancy (m±s) 61.3±21.4 59.4±22.6
   CEQ credibility (m±s) 53.9±20.2 52.5±22.8
Abbreviations: m, mean; s: standard deviation; NRS, Numeric Rating Scale (range from 0 to 10; 0=no pain, 
10=worst conceivable pain); ODI, Oswestry Disability Index (range from 0 to 100; 0=no disability, 
100=maximum conceivable disability); BPS, Back Performance Scale (range from 0 to 15; 0=best, 15=worst); 
HADS-D, Depression scale of Hospital Anxiety and Depression Scale (range 0 to 21; 0=no depression; 
21=maximum conceivable depressive mood; cut-off point of 9 out of 21 points for depression); PCS, Pain 
Catastrophizing Scale (range 0 to 100; 0=no catastrophizing; 100=maximum conceivable catastrophizing); 
CSQ, Coping Strategies Questionnaire (range 0 to 6; 0=least; 6=most/ best); CEQ, Credibility and Expectancy 
Questionnaire (range 0 to 100; 0=less; 100=most). 
Classification procedure 
Of the 113 patients randomly allocated to the intervention group, the MPI Classification 
System classified 27 patients as adaptive copers, 49 patients as interpersonally dis-
tressed, and 37 patients were classified as dysfunctional. Based on their clinical exami-
nation and observation of the patients, the therapists agreed with the subgroup classi-
fications and did not overrule the MPI Classification System.  
Treatment outcome: intention-to-treat analyses 
Primary outcomes 
For the Oswestry Disability Index, the tailored pain management group improved by 1.0 
point at 4-week follow up, and 1.7 point at 12-week follow up, respectively (Table 2). 
The improvements in the general pain management group at 1.3 and 2.3 points, re-
spectively, were comparable small. Between-group differences were at both time-
points non-significant. With the exception of minimum pain intensity after 4 weeks 
(standard mean difference (SMD) = 0.43, 95% confidence interval (CI), 0.02 to 0.84; p = 
0.034, in favor of the control group), no significant differences in pain between inter-
vention and control group could be measured. The secondary analysis, i.e. pairwise 
comparisons between the individual MPI subgroups and the control group, attributed 
this difference in reduction of pain in favor of the control group to the effect of the MPI 
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subgroup adaptive coper at 12 weeks follow up: SMD = 0.55, 95% CI, 0.02 to 1.08; p = 
0.035 (Table 3). 
 
Table 2. Effects of primary outcome variables pain severity and pain disability 
Variable 
(m±s) 
Intervention group
(n = 113) 
Control group
(n = 33) 
Between group difference 
(SMD, 95% CI) 
p 
NRS current pain     
   Baseline 6.3±2.1 6.2±2.0   
   Week 4 5.8±2.7 5.8±2.3 0.05 (-0.35 to 0.46) 0.803 
   Week 12 5.7±2.7 5.7±2.4 0.05 (-0.36 to 0.46) 0.804 
NRS maximum pain     
   Baseline 8.0±1.7 7.6±1.6   
   Week 4 7.6±2.0 7.5±2.3 0.11 (-0.30 to 0.51) 0.607 
   Week 12 7.4±2.2 7.4±2.1 -0.19 (-0.60 to 0.22) 0.352 
NRS minimum pain     
   Baseline 4.4±2.3 5.3±2.4   
   Week 4 4.0±2.5 4.2±2.4 0.43 (0.02 to 0.84) 0.034 
   Week 12 4.0±2.5 4.5±2.3 0.26 (-0.15 to 0.67) 0.208 
ODI pain disability     
   Baseline 46.1±13.0 45.0±13.3   
   Week 4 45.1±14.7 43.7±16.8 0.04 (-0.35 to 0.42) 0.859 
   Week 12 44.4±15.7 42.7±15.3 0.07 (-0.32 to 0.46) 0.740 
Abbreviations: m, mean; s, standard deviation; SMD, Cohen’s standardized mean difference d; 95% CI, 95% 
confidence interval; p, significance level between groups with t-test; NRS, Numeric Rating Scale (0=best; 
10=worst); ODI, Oswestry Disability Index (0=best; 100=worst). 
Secondary outcomes 
Within both groups small to medium effects were measured for the dimensions de-
pression, anxiety, catastrophizing, self-efficacy, observed functional performance, and 
responses of partner or spouse to patient pain behavior (Table 4). Most improvement 
occurred in reduction of catastrophizing: a mean of 5.6 points in the general pain man-
agement group, and 9.1 point in the standard pain management group. For all second-
ary outcome measures, no significant differences of effects between intervention and 
control at 4 and 12 week follow up were obtained.  
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Table 4. Effects found for secondary outcome variables 
 
Variable 
(m±s) 
Intervention 
group 
(n = 113) 
Control 
group 
(n = 33) 
Between
group difference 
(SMD, 95% CI) 
p 
HADS depression    
   Baseline 54.8±20.7 56.4±22.2  
   Week 4 58.6±23.6 59.2±24.0 0.08 (-0.31 to 0.48) 0.688 
   Week 12 56.2±26.4 59.2±25.3 -0.09 (-0.49 to 0.31) 0.660 
HADS anxiety    
   Baseline 52.0±21.2 50.0±24.0  
   Week 4 56.4±24.6 53.3±22.3 0.08 (-0.31 to 0.48) 0.688 
   Week 12 56.3±23.3 53.4±23.3 0.06 (-0.34 to 0.45) 0.777 
PCS total score    
   Baseline 51.0±22.4 55.0±26.4  
   Week 4 46.6±25.2 46.8±25.6 0.28 (-0.13 to 0.69) 0.172 
   Week 12 45.4±26.6 45.9±25.6 0.23 (-0.18 to 0.64) 0.267 
CSQ control pain    
   Baseline 2.6±1.2 2.4±1.2  
   Week 4 2.8±1.1 2.5±1.0 0.17 (-0.23 to 0.56) 0.407 
   Week 12 2.9±1.3 2.8±1.1 -0.01 (-0.41 to 0.39) 0.956 
CSQ decrease pain    
   Baseline 2.3±1.0 2.0±1.1  
   Week 4 2.6±1.0 2.3±1.2 0.01 (-0.38 to 0.41) 0.956 
   Week 12 2.5±1.3 2.5±1.0 -0.19 (-0.59 to 0.21) 0.341 
Back Performance Scale    
   Baseline 6.7±4.0 7.3±4.3  
   Week 4 5.2±4.0 6.2±4.8 -0.18 (-0.62 to 0.25) 0.401 
5 Minute Walk Distance test    
   Baseline 320±126 307±128  
   Week 4 358±129 333±155 0.17 (-0.25 to 0.59) 0.438 
MPI negative responses    
   Baseline 78.9±22.8 76.1±25.1  
   Week 4 78.4±22.7 79.0±22.7 -0.19 (-0.58 to 0.19) 0.665 
MPI solicitous responses    
   Baseline 57.3±27.9 59.3±21.8  
   Week 4 58.9±26.7 60.7±25.6 0.02 (-0.37 to 0.40) 0.728 
MPI distracting responses    
   Baseline 50.6±26.7 59.3±23.9  
   Week 4 53.3±26.2 57.7±22.3 0.29 (-0.10 to 0.68) 0.216 
Abbreviations: m, mean; s, standard deviation; SMD, Cohen’s standardized mean difference d; 95% CI, 95% 
confidence interval; p, significance level between groups with t-test; HADS, Hospital Anxiety and Depression 
Scale (range 0 to 100; 0=no depression/anxiety; 100=maximum conceivable depression/anxiety; PCS, Pain 
Catastrophizing Scale (range 0 to 100; 0=no catastrophizing; 100=maximum conceivable catastrophizing); 
CSQ, Coping Strategies Questionnaire (range 0 to 6; 0=least; 6=most/best); MPI, Multidimensional Pain Inven-
tory (range 0 to 100; 0=worst; 100=best). 
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Treatment outcome: per-protocol analysis 
Seventeen patients (that is, 11.6%) did not complete treatment during their 4-week 
stay at the rehabilitation clinic (Figure 1). Compared to one of the 33 patients (3.0%) in 
the standard pain management group, the greatest proportion of non-completers was 
recorded in the tailored pain management group, 16 of 113 (14.2%). Reasons for dis-
continued intervention were clinical (n = 6), language (n = 3), and compliance (n = 7). 
Loss to follow up after 12 weeks (tailored pain management group, 20.4%; general pain 
management group, 24.3%) was almost equally distributed. Percentages of discontin-
ued intervention or loss to follow up at 12 weeks were 33% for the adaptive copers, 
31% for the interpersonally distressed, and 41% for the subgroups dysfunctional (data 
not shown in detail). Baseline scores of the study completers compared to non-
completers (that is, patients with missing data at any time point) showed less duration 
of symptoms (completers, 10.6 y; non-completers, 7.9 y) and a lower percentage of 
women in the group of the study completers (62% versus 69%). All other characteristics 
did not substantially differ (Table 5). A total of 76 patients were evaluated in the per-
protocol analysis of the primary outcome pain severity and pain disability. No signifi-
cant differences of effects between intervention and control at 4 and 12 week follow 
up were obtained (Table 6).  
 
Table 5. Baseline scores of study completers compared to patients with missing data at any time point 
Characteristic Completers 
(n = 97) 
Non-completers 
(n = 49) 
p 
Gender, female (%) 62 69 0.369 
Age (y; m, min-max) 47.3 (18.1-73.4) 46.0 (21.0-78.6) 0.419 
School education (%)   0.599 
   No school education completed 2 2  
   Elementary school 32 35  
   Secondary school 60 61  
   University entrance 
   diploma 
6 2  
Co morbidities (%)   0.647 
   None 23 21  
   1-3 53 64  
   > 3 24 15  
Duration of symptoms (y; m, min-max) 10.6 (0.5-42.1) 7.9 (0.5-39.0) 0.264 
Pain disability (ODI; m±s) 45.8±13.0 45.9±13.0 0.924 
Pain severity (NRS current pain; m±s) 6.3±2.2 6.4±1.8 0.930 
Abbreviations: m, mean; s, standard deviation; ODI, Oswestry Disability Index (0=best; 100=worst); NRS, 
Numeric Rating Scale (0=best; 10=worst); p, significance level between groups. 
 
  
E F F E C T I V E N E S S  O F  A  S U B G R O U P - S P E C I F I C  P A I N  M A N A G E M E N T  P R O G R A M  
 141 
Table 6. Per-protocol-analysis: Effects of primary outcome variables pain severity and pain disability 
 
Variable 
(m±s) 
Intervention 
group 
(n = 68) 
Control group
(n = 8) 
Between group difference 
(SMD, 95% CI) 
p 
NRS current pain    
   Baseline 6.5±2.0 6.8±2.1  
   Week 4 6.0±2.8 6.9±2.3 -0.29 (-1.02 to 0.44) 0.437 
   Week 12 5.8±2.7 6.5±2.5 -0.21 (-0.95 to 0.52) 0.570 
NRS maximum pain    
   Baseline 8.0±1.5 7.6±1.6  
   Week 4 7.7±1.9 7.1±3.0 0.12 (-0.62 to 0.85) 0.756 
   Week 12 7.3±2.1 7.9±2.8 -0.22 (-0.96 to 0.51) 0.551 
NRS minimum pain    
   Baseline 4.5±2.3 5.8±2.0  
   Week 4 4.3±2.5 5.3±2.3 0.16 (-0.57 to 0.89) 0.665 
   Week 12 4.3±2.6 5.1±2.5 0.19 (-0.54 to 0.93) 0.605 
ODI pain disability    
   Baseline 46.6±12.6 46.4±19.3  
   Week 4 45.5±14.7 46.4±21.7 -0.11 (-0.84 to 0.62) 0.765 
   Week 12 44.6±16.2 42.0±21.8 0.20 (-0.53 to 0.94) 0.588 
Abbreviations: m, mean; s, standard deviation; SMD, Cohen’s standardized mean difference d; 95% CI, 95% 
confidence interval; p, significance level between groups with t-test; NRS, Numeric Rating Scale (0=best; 
10=worst); ODI, Oswestry Disability Index (0=best; 100=worst) 
Discussion 
The primary aim of the present study was to examine the effectiveness of a tailored 
pain management program on pain and disability in patients with chronic nonspecific 
back pain classified according to the Multidimensional Pain Inventory (MPI) Classifica-
tion System, compared to general pain management. This study failed to demonstrate 
that in a rehabilitation setting a subgroup-specific pain management program based on 
the MPI Classification System for patients with chronic back pain is more effective in 
improving pain and disability than a standard pain management program. 
 Interestingly, patients in both groups, in spite of intensive therapies based on best 
scientific knowledge and best clinical practice (over 110 h in total), made only small to 
moderate improvements in reduction of pain, disability, and the secondary outcomes. 
The effects were, at a group level, not clinically meaningful, although individual pa-
tients, in both groups, may have achieved significant improvement. 
 Another finding of interest was the problem of compliance. As in both groups no 
serious adverse events occurred, the discontinued interventions for clinical reasons and 
the three patients with difficulties in understanding the German language have to be 
attributed to exclusion criteria that were discovered too late. The six patients that were 
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non-compliant in the tailored pain management group may be explained by the fact 
that the main principle of graded activity exercise, progression of physical training on a 
time-contingent basis instead of a pain-contingent basis, was for some patients hard to 
tolerate. 
 To the knowledge of the authors, this is the first RCT evaluating the effects of sub-
group-specific interventions in pre-treatment classified chronic back pain patients ac-
cording the MPI Classification System. Therefore, the present study can only be com-
pared with RCTs evaluating the effects of tailored pain interventions based on other 
classification systems. The Treatment Based Classification system classifies patients in 
four treatment groups; a) direction-specific exercises, b) spinal joint manipulation or 
mobilization, c) trunk strengthening and stabilization exercises, and d) traction [74]. 
Fritz et al. compared this classification-based treatment approach with minimal physio-
therapy interventions according the clinical practice guidelines for acute work-related 
low back pain in 78 patients with acute low back pain (mean duration of symptoms of 
three days) [75]. Clinically meaningful and statistically significant improvements in pain 
disability (measured with Oswestry Disability Index) were obtained at 4- and 52-week 
follow-up (p = 0.023, resp. 0.044). In a similar setting with 123 patients with 
acute/subacute low back pain (mean pain duration of 15 days), Brennan et al. com-
pared matched to unmatched treatment interventions according to the same Treat-
ment Based Classification system. This study also showed significantly improved 
Oswestry Disability Index-scores at 4- and 52-week follow up (p = 0.030, and 0.006 
respectively). Apeldoorn et al. did a cross-validation of these two US-studies with 156 
subacute and chronic low back pain patients in the Netherlands (on average 5 months 
duration of current episode of low back pain) [19]. The positive results of the prior 
studies could not be replicated: the primary outcomes global perceived effect, pain 
disability (ODI), and pain severity (NRS) – as all secondary outcomes – were in both the 
intention-to-treat analysis, as well as in the per-protocol analysis non-significant. As in 
the present study, it might be more difficult to get increased effects in chronic back 
pain populations, compared to acute/subacute patients with back pain. Finally, based 
on the O’Sullivan Classification System [76], Vibe Fersum et al. compared the classifica-
tion-based cognitive functional therapy with traditional manual therapy and exercise 
[18]. This study showed significant improved Oswestry Disability Index-scores and NRS 
pain-scores at 12- and 52-week follow up (p < 0.001). However, these positive results 
may be biased by the fact that only 94 of 121 randomized patients were included in the 
final analysis. In the present study, even the per-protocol analysis did not show results 
in favor of the classification-based group.  
 Psychosocial coping style of the subgroup adaptive copers is controversially dis-
cussed in the literature. The question is whether these patients minimize their pain 
problems or truly better adjust to pain. The focus of the tailored interventions in the 
present study for this subgroup was on activity pacing to moderate overactivity, use of 
stop-rules, body awareness, and mental and physical relaxation techniques in stressful 
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situations. We elected this approach because of the low baseline disability scores (as 
compared to population norms). Compared to the baseline scores of the other two 
subgroups dysfunctional and interpersonally distressed, the adaptive copers perform 
better, but compared to healthy individuals they are also severely disabled. However, 
this treatment approach is in conflict with the observations made by Junghaenel et al. 
[77]. 
 In the present study it was not possible to use the MPI computer program devel-
oped by Rudy [78]. The reason for this was that it is based on a version of the MPI dif-
ferent from the one that has been translated and validated in German [69, 70, 79]. The 
MPI software classifies patients not just in the MPI subgroups dysfunctional, adaptive 
copers, and interpersonally distressed, but also refers to patients who cannot be classi-
fied into one of these three clusters as “anomalous” or “hybrid”. In the classification 
method used in the present study, subgroups were defined by confirmatory cluster 
analysis using the predefined three cluster solution according to the MPI Classification 
System. Without exception, all patients were assigned to one of the three subgroups 
with the clinical profile most likely to fit. Cluster analysis is a reproducible function in 
SPSS. When the total amount of clusters is defined, cluster analysis classifies all cases, 
and so, no unclassified cases exist. 
 The classification-based interventions in this study were not superior to standard 
pain management. Therefore, if the results of this study are to be replicated in other 
studies by different research groups in a comparable setting, the additional value of 
classification of patients with chronic back pain based on the MPI Classification System 
and the subsequent process of tailoring pain management interventions can be chal-
lenged. On the other hand, informed decision making is not solely based on best scien-
tific evidence, but also on clinical expertise of the health care professional and patient’s 
preferences and expectations [80]. Since the classification-based interventions were as 
equally effective as the interventions in the standard pain management group and 
credibility and expectancy of both patient and health care provider play an important 
role in the process of treatment [81, 82], subgroup classification and tailoring interven-
tions might be an alternative. 
 Pragmatic randomized controlled trials, like the present study, compare two or 
more (sets of) interventions which are believed to be clinically meaningful, and as they 
are delivered in clinical practice. In this trial both groups had a comprehensive range 
and number of group therapies. Most group therapies were performed based on a 
cognitive behavioral approach, and the pain coping group was led by a clinical psy-
chologist. This meant that the patients in the standard pain management group (indi-
vidual medical training therapy on the principles of exercise physiology by the physio-
therapist and optional individual psychotherapy, not focussing on pain coping strate-
gies) also received quite a lot of information on how to cope with different aspects of 
chronic back pain through these group therapies. This might have minimized contrast 
between interventions. 
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In this study, the sample consisted of selected persons who had suffered from a severe 
and disabling chronic back pain disorder for a long time and who fulfilled certain criteria 
(e.g. motivation, ability to understand German) and, therefore, possibly differ in im-
portant ways from people with chronic back pain in general thus limiting the generali-
zability of the results. Another limitation is the short-term measurement of effects 
(between entry and discharge from the rehabilitation clinic after four weeks and the 3-
month follow-up). Future analyses should use standardized outcome measurements at 
follow-up times of up to one year or longer that are long enough for the person with 
chronic back pain to modify behavior patterns and master effective strategies.  
 Subgrouping of patients with back pain may be less successful among patients with 
chronic symptoms and perhaps more meaningful in less disabled patients or patients 
with acute/subacute low back pain [18, 75, 83]. Classification of chronic back pain on 
the basis of psychosocial factors and pain coping patterns, as performed in this study, 
may be less effective. Future trials with chronic and highly disabled back pain patients 
might focus on classification systems based on mechanical loading strategies or modi-
fied movement strategies of the spine (for overview: [17]) or other biopsychosocial 
features as captured by the MPI Classification System.  
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Conclusions 
The subgroup-specific pain management program based on the Multidimensional Pain 
Inventory Classification System for patients with chronic back pain in this study was not 
more effective in improving outcomes for severity of pain and pain disability than a 
standard pain management program. 
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This final chapter discusses the main results of the thesis, methodological reflections 
and the possible impact of this research on physiotherapy and the interdisciplinary pain 
management of patients with chronic musculoskeletal pain disorders in Switzerland. 
Finally, I will discuss directions for future research.  
Main findings and limitations of this thesis 
Part I: Clinimetric studies 
Training and evaluation of pain coping strategies is a major goal of the Zurzach Interdis-
ciplinary Pain Program as well as of many other pain management programs. Tremen-
dous progress has been made in the last four decades in our understanding of how 
patients cope with the pain they experience (for overview: [1]). However, the concept 
of coping and its evaluation is still difficult and partly unknown [2]. One of the three 
objectives of this thesis was to test the clinimetric features of the self-reported meas-
urement tools Coping Strategies Questionnaire (CSQ) and the Multidimensional Pain 
Inventory (MPI) for outcome assessment and subgroup classification based on three 
different pain coping strategies. In Chapter 2 we demonstrated that the translation 
process, cross-cultural adaptation and testing of reliability of the CSQ proceeded with-
out major difficulties. However, its concurrent criterion-related validity and construct 
validity were low. Factor analysis in our and other studies revealed that only moderate 
percentages of the observed variance could be explained. Although modifications of 
the CSQ have been suggested [3-5], the original CSQ is still the most widely used pain 
coping questionnaire. So far, there is no gold standard assessment for pain coping. 
However, use of the widely applied outcome measures CSQ and MPI in chronic pain 
trials would permit pooling of data from different studies and provide a basis for mean-
ingful comparisons of treatments in terms of the clinical importance of their outcomes, 
particularly through systematic reviews [6]. Therefore, in spite of their deficits, we de-
cided to apply the CSQ and the MPI. In Chapter 3 we examined the test-retest reliability 
of the individual scales of the German MPI and – of high relevance for this thesis – the 
test-retest stability of the MPI subgroup classification in mainly chronic back pain pa-
tients. We demonstrated that test-retest reliability was moderate to good and compa-
rable to other language versions. MPI subgroup classification was substantially stable 
when compared to other diagnostic groups like fibromyalgia and other examiner-based 
subgroup classification systems like the Treatment Based Classification by Delitto and 
the O’Sullivan Classification System. We need to consider that in the studies of this 
thesis it was not possible to use the MPI computer program developed by Rudy for 
classification of patients [7]. The reason for this is that it is based on a different version 
of the MPI compared to the one that has been translated and validated in German [8-
10]. The MPI software classifies patients not just into the MPI subgroups dysfunctional, 
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adaptive copers, and interpersonally distressed, but also refers to patients who cannot 
be classified into one of these three clusters as “anomalous” or “hybrid”. Unfortunate-
ly, it is not documented in the manual how the classification of these non-classifiable 
patients is performed. In the classification method used in the present studies, sub-
groups were defined by confirmatory cluster analysis using the predefined three cluster 
solution according to the MPI Classification System. Cluster analysis is an exploratory 
method by which multiple sources of information are analyzed simultaneously to group 
individuals into clusters. Individuals within a cluster are similar to each other on the 
variables included in the statistical analysis and differ significantly from those in the 
other cluster groups. The MPI score patterns were depicted as graphs of the nine mean 
MPI subscale baseline scores and compared to the patterns described by Turk et al. 
using the rank orders of the three subgroups within one MPI scale [11, 12]. To assess 
whether a three-cluster solution was appropriate according to mathematical criteria, 
hierarchical cluster analysis according to the Ward method was performed [13]. The 
resulting diagram with the number of clusters and the course of the sum of residual 
squares did not favor a three-cluster solution. However, factor analysis revealed that a 
factor solution fitted best with three factors explaining up to 67% of the variance. Thus, 
the proposed “best feasible” (i.e. clinically characterized) empirically determined solu-
tion according to the subgroups defined by Turk et al. was chosen. Without exception, 
all patients were assigned to one of the three subgroups into which the clinical profile 
was most likely to fit. This means that an unknown number of patients without a doubt-
free pattern of symptoms and coping styles were assigned to and treated as an MPI 
subgroup that might have been entirely obvious. This may have biased the outcomes. A 
recent study reported that patients with unclear classifications were different from 
those with clear classifications [14]. Within this classification system the unclear pa-
tients were on average older, had a longer duration of back pain and less back pain 
related disability. Consequently, the research group suggested that future studies 
should investigate the decision process for patients who do not clearly fit into a sub-
group. In Chapter 4 we assessed the correlations between depression - the most com-
mon co-morbidity in patients with chronic musculoskeletal pain - and pain. It was re-
markable that the MPI pain severity scale and the HADS depression scale showed max-
imum overall correlation of 0.27 to 0.29, but analysis of the three MPI subgroups led to 
quite different pain-depression correlations. It was moderate in the subgroup interper-
sonally distressed (up to 0.57), weak in the subgroup dysfunctional (up to 0.26), and 
absent in the subgroup adaptive copers (down to –0.09). The strengths of the pain-
depression associations were too weak to state that a causal relationship between 
depression and pain would be true. However, in the MPI subgroup interpersonally dis-
tressed, the moderate association might be of importance for clinical care: chronic 
musculoskeletal pain could be treated by treating depression and vice versa. We im-
plemented this finding in the design of the interventions of the randomized controlled 
trial, see chapter 7. 
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Part II: Evaluation studies 
The second objective of this thesis encompassed the validation of the MPI subgroups by 
other assessment tools and exploration of differences in effects between a posteriori 
classified individual Multidimensional Pain Inventory subgroups after a standard pain 
management program. We examined this in Chapter 5 in patients with fibromyalgia 
and in Chapter 6 in patients with chronic back pain. The German version of the MPI 
obtained identically reliable and valid subgroups of fibromyalgia and back pain patients 
as derived with the original US version [12] and the Swedish version of the MPI [15, 16]. 
Furthermore, previous studies with chronic low back pain patients [17-19] and patients 
with fibromyalgia ([20, 21] showed overall disappointing effects of standard multidisci-
plinary treatments (“one size fits all”-approach), but subgroup analyses showed differ-
ences in outcome between MPI subgroups. In the low back pain studies mentioned 
before, most improvement on several scales was reported in the dysfunctional pa-
tients. Because the dysfunctional patients have at baseline the worst scores, this differ-
ence in treatment effect has to be at least partly explained by regression to the mean. 
In contrast, in our explorative studies we observed significant differences in pain reduc-
tion and improvement of mental health and coping across all three MPI subgroups. This 
led to the conclusion that differences in effects could not be completely explained by 
regression to the mean. However, we did not identify significant score changes be-
tween subgroups concerning disability, activities and physical functioning. This made us 
decide to use the back pain-specific Oswestry Disability Index in the randomized con-
trolled trial (chapter 7), instead of the generic physical activity scales of the Medical 
Outcome Studies Short Form 36. Limitations in both retrospective MPI-subgroup classi-
fication studies were the short-term measurement of effects (between entry and dis-
charge from the rehabilitation clinic after four weeks), multiple pairwise testing of sub-
scale scores of the MPI subgroups (partly compensated by the Bonferroni correction), 
and the lack of a control group. This made us decide to do a next study designed as a 
randomized controlled trial with longer follow-up intervals and predefined outcomes. 
 The primary objective of this thesis was to examine the effectiveness of tailored 
pain management in patients with chronic musculoskeletal pain, a priori classified ac-
cording the Multidimensional Pain Inventory Classification System, in order to improve 
patient care. The randomized controlled trial (Chapter 7) failed to demonstrate that in 
rehabilitation setting a subgroup-specific pain management program for patients with 
chronic back pain is more effective in improving pain and disability than a standard pain 
management program. Interestingly, patients in both groups, despite intensive thera-
pies and a magnitude of over 110 treatment hours in total, based on best scientific 
knowledge and best clinical practice, made only small to moderate improvements in 
pain, disability, self-efficacy, catastrophizing, psychosocial responses to pain, anxiety 
and depression. The effect sizes are comparable with other pain programs [22, 23], but 
the hypothesized additional value of the tailored interventions could not be deter-
mined. The effects were, at a group level, neither statistically significant nor clinically 
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meaningful, although individual patients, in both groups, may have made significant 
improvements. 
 To the knowledge of the authors, the trial described in this thesis is the first ran-
domized controlled trial evaluating the effects of subgroup-specific interventions in 
pre-treatment classified chronic back pain patients according to the MPI Classification 
System. Therefore, the present study can only be compared with randomized con-
trolled trials evaluating the effects of tailored pain interventions based on classification 
systems other than the MPI (Table 1a and Table 1b). The Treatment Based Classification 
system classifies patients in four treatment groups; a) direction-specific exercises, b) 
spinal joint manipulation or mobilization, c) trunk strengthening and stabilization exer-
cises, and d) traction [24]. Fritz et al. compared this classification-based treatment ap-
proach with minimal physiotherapy interventions according to the clinical practice 
guidelines for acute work-related low back pain in 78 patients with acute low back pain 
(mean duration of symptoms of 3 days) [25]. Clinically meaningful and statistically sig-
nificant improvements in pain disability (measured with Oswestry Disability Index) were 
obtained at 4- and 52-week follow ups. In a similar setting with 123 patients with 
acute/subacute low back pain (mean pain duration of 15 days), Brennan et al. com-
pared matched to unmatched treatment interventions according to the same Treat-
ment Based Classification system. This study also showed significantly improved inter-
group Oswestry Disability Index-scores at 4- and 52-week follow up. Compared to the 
studies by Fritz et al. and Brennan et al, the patients in our study were on average 9 to 
12 years older and had a much longer duration of symptoms (ten years versus 3 and 15 
days). On the other hand, baseline NRS pain intensity scores and ODI pain disability 
scores were comparable (6.5 and 5.2 versus 6.3, and 42.9 and 44.9 versus 46.1, respec-
tively). Apeldoorn et al. did a cross-validation of these two US-studies with 156 sub-
acute and chronic low back pain patients in the Netherlands (on average 5 months 
duration of current episode of low back pain) [26]. The positive results of the prior 
studies could not be replicated: the primary outcomes global perceived effect, pain 
disability (ODI), and pain severity (NRS) – as all secondary outcomes – were in both the 
intention-to-treat analysis, as well as in the per-protocol analysis not significant. Pa-
tients’ age and baseline pain intensity were almost identical to the patients in our 
study. In contrast, the participants in the study of Apeldoorn et al. were far less disa-
bled (baseline mean ODI pain disability scores of 18.1 versus 46.1). It might be more 
difficult to obtain increased effects in chronic back pain populations such as in our 
study compared to acute/subacute patients with back pain. However, acute/subacute 
low back pain takes a positive natural course in the majority of cases, which might 
complicate the analysis of the additional value of therapeutic interventions. Finally, 
based on the O’Sullivan Classification System [27], Vibe Fersum et al. compared classifi-
cation-based cognitive functional therapy with traditional manual therapy and exercise 
[28]. The objective of the O’Sullivan Classification System is the identification of mala-
daptive (pain provocative) spinal postures, movement patterns, and motor control 
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behaviors associated with low back pain and aims to implement behavioral interven-
tions that focus on cognitive and behavioral change. Compared to our study, the pa-
tients in this study were younger at baseline (41.0 versus 47.6 years), had less pain (NRS 
pain intensity of 4.9 versus 6.3), and, most of all, were less disabled (ODI pain disability 
score of 21.3 versus 46.1). The study by Vibe Fersum et al. showed significantly im-
proved Oswestry Disability Index scores and NRS pain-scores at 12- and 52-week follow 
up in the classification-based group compared to the group with traditional manual 
therapy and exercises. However, these positive results may be biased by the fact that 
only 94 of 121 randomized patients were included in the final analysis. Because 27 
randomized patients either did not start treatment or did not complete treatment, the 
authors decided that an intention-to-treat analysis was not indicated. 
 
Table 1a. Review of classification-based randomized controlled trials in back pain 
   Baseline characteristics  
of classification-based group 
Name of first 
author,  
publication date 
Classification 
system 
Setting Sample 
size 
Type of 
back pain 
Duration 
of  
symptoms 
Age 
(y;m±s) 
NRS pain 
intensity 
(m±s) 
ODI pain 
disability 
(m±s) 
Fritz JM  
et al. 2003 
TBC 5 outpatient clinics at 
University of Pittsburgh, 
Medical Center (USA) 
 78 acute 
(< 3 w) 
 3 d 35.9±10.3 6.5±1.7 42.9±15.7
Brennan GP  
et al. 2006 
TBC 3 outpatient clinics in 
Utah (USA) 
123 aute/subacute 
(< 90 d) 
15 d 38.4±10.0 5.2±2.1 44.9±11.2
Apeldoorn AT  
et al. 2012 
TBC 
(modified) 
21 physiotherapy clinics 
in Amsterdam (NL) 
156 subacute/ 
chronic 
 5 m 43.2±11.7 6.0±1.7 18.1±11.5
Vibe Fersum K  
et al. 2012 
 
OCS private physiotherapy 
practices, outpatient  
spine clinic in Bergen (N) 
121 chronic 61% > 5 y 41.0±10.3 4.9±2.0 21.3±7.5
Verra ML  
et al. 
MPI rehabilitation clinic, 
inpatients (CH) 
146 chronic 10 y 47.6±11.9 6.3±2.1 46.1±13.0
Abbreviations: m, mean; s, standard deviation; y, years; m, months; w, weeks; d, days; TBC, Treatment-Based 
Classification System by Delitto; OCS, O'Sullivan Classification System; MPI, Multidimensional Pain Inventory 
Classification System; NRS, Numeric Rating Scale (0=best; 10=worst); ODI, Oswestry Disability Index (0=best; 
100=worst). 
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The model of classification-based interventions is based on the identification of rela-
tively homogeneous subgroups of patients [29], with respect to psychosocial and be-
havioral baseline characteristics. This should lead to less variability in outcome after 
tailored interventions and larger effect sizes. By definition, effect sizes are determined 
by the score differences between two time points divided by the group standard devia-
tion at baseline. In other words, the smaller the standard deviation, the larger the ef-
fect size. Applying this to the randomized controlled trial in this thesis, we would expect 
to find smaller standard deviations and confidence intervals and subsequently larger 
within-subgroup and between-group effects after the tailored interventions. However, 
this was not the case. With a few exceptions, standard deviations and confidence inter-
vals of the MPI subgroups were as large as those in the non-subclassified control group. 
Obviously, the MPI Classification System was not able to classify the heterogeneous 
sample of patients with nonspecific back pain into three more homogeneous sub-
groups. New studies, published after the start of our trial, proposed a revised taxonomy 
and made suggestions on how to improve scoring and usefulness of the MPI [30-32]. 
These adaptations might improve the ability of the MPI Classification to increase ho-
mogeneity within subgroups. 
 Pragmatic randomized controlled trials, like the present study, compare two or 
more (sets of) interventions which are believed to be clinically meaningful when deliv-
ered in clinical practice. In the trial in this thesis both groups had a comprehensive 
range and number of group therapies. Most group therapies were performed with a 
cognitive behavioral approach, and the pain coping group was led by a clinical psy-
chologist. This meant that via these group therapies the patients in the general pain 
management group (i.e. individual medical training therapy on the principles of exer-
cise physiology by the physiotherapist and optional individual psychotherapy, not fo-
cused on pain coping strategies) received quite a lot of information on how to cope 
with different aspects of chronic back pain. For practical and ethical reasons we had to 
do the trial in this way. However, this might have minimized contrast between inter-
ventions. 
 Another finding of interest was the problem of adherence to treatment during the 
4-week stay at the rehabilitation clinic. As in both groups no serious adverse events 
occurred, the discontinued interventions for clinical reasons and the three patients with 
difficulties in understanding the German language might be attributed to exclusion 
criteria that were discovered too late. Six non-compliant patients in the tailored pain 
management group may have been due to the fact that the main principle of graded 
activity exercise, progression of physical training on a time-contingent basis instead of a 
pain-contingent basis, was for some patients hard to tolerate. 
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Implications for clinical practice 
Kamper et al. stated in 2010 that research up till then had failed to demonstrate the 
utility of any classification system with sufficient certainty to recommend implementa-
tion into clinical practice [33]. As shown, the classification-based interventions in the 
randomized controlled trial in this thesis were not superior to standard pain manage-
ment. Therefore, if the results of this study are to be replicated in other studies by 
different research groups in a comparable setting, the additional value of classification 
of patients with chronic back pain based on the MPI Classification System and the sub-
sequent process of tailoring pain management interventions might be challenged. On 
the other hand, informed decision-making is not solely based on best scientific evi-
dence, but also on clinical expertise of the health care professionals and patient’s pref-
erences and expectations [34]. Thus, because the classification-based interventions 
were equally as effective as the standard pain management group, and credibility and 
expectancy of both patient and health care provider play an important role in the pro-
cess of treatment [35, 36], subgroup classification and subsequent tailoring of interven-
tions might be an equivalent alternative. With complex treatments such as systemic 
therapy and graded activity exercise, the expertise of the pain therapist should also be 
borne in mind [33]. In the trial in this thesis the tailored interventions were performed 
by specially trained physiotherapists and clinical psychologists. 
 The psychosocial coping style of the subgroup adaptive copers has caused discus-
sion in the literature. The question is whether these patients minimize their pain prob-
lems or truly adjust better to pain. The focus of the tailored interventions in the ran-
domized controlled trial in the present thesis for this subgroup was on activity pacing to 
moderate overactivity, use of stop-rules, body awareness, and mental and physical 
relaxation techniques in stressful situations. We elected this approach because of the 
high baseline disability scores as compared to population norms as described in a pre-
vious study [37] and long-term clinical observations made by the pain therapists of the 
Zurzach Interdisciplinary Pain Program. Although, compared to the baseline scores of 
the other two subgroups dysfunctional and interpersonally distressed, the adaptive 
copers performed better, compared to healthy individuals the adaptive copers were 
also severely disabled and affected by their chronic pain syndrome. Aspects of endur-
ance behavior (synonym: overuse behavior), [38, 39] have been observed by the mem-
bers of the pain management team. However, our treatment approach for the sub-
group adaptive copers is in conflict with the observations made by Junghaenel et al. 
[40]. In observing patients’ pain behavior, they found strong support for the validity of 
the adaptive copers cluster in that patients’ positive adaptation was reliably corrobo-
rated by informants. They state that patients in the adaptive copers subgroup indeed 
fare better than dysfunctional and interpersonally distressed patients and that their 
positive adaptation cannot be merely attributed to a favorable self-report bias. After 
termination of the trial in this thesis, semi-structured interviews with the clinical psy-
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chologists who participated in the trial of the Zurzach Interdisciplinary Pain Program 
revealed that the pain therapists are still unanimously convinced that the adaptive 
copers largely deny their problems and wish to present a falsely positive picture of 
them. Consequently, it might seem that more research in this field is needed. 
 So far, there is no such thing as “magic healing” in chronic musculoskeletal pain. In 
line with the results of other trials investigating the effects of multimodal pain man-
agement programs, the interventions in the trials in this thesis led to small to moderate 
effects. We have to consider that the average age of patients participating in the pain 
management program was 46 years (with an average history of pain of 10 years) and 
variance of age in our studies was large (18-73 years). After completing the pain man-
agement program and at follow-up patients were not pain free and were still disabled 
by pain. This might imply that a currently unknown number of patients will have to deal 
with musculoskeletal pain for many more years or perhaps till the end of their lives. 
This indicates that in the near future, health care professionals in clinical care need to 
be informed about the specific needs of young adolescent pain patients (who will be 
diagnosed earlier), adults (as now) and also elderly pain patients (who still suffer from 
chronic disabling pain). The focus may have to shift from cure to (cost-)effective care. 
Recommendations for further research 
As discussed before at the beginning of this chapter and shown in Table 1a and Table 
1b, preliminary conclusions from the (non-systematic) review of RCTs analyzed in Table 
1a and Table 1b could be that subgrouping of patients with back pain may be less suc-
cessful in highly disabled patients with chronic symptoms and perhaps more meaning-
ful in less disabled patients or patients with acute/subacute low back pain [25, 28, 41]. 
Classification of chronic back pain on the basis of psychosocial factors and pain coping 
patterns, as performed in the studies in this thesis of real-world clinical care, may be 
more complex. Future trials with chronic and highly disabled back pain patients might 
focus on other bio-psycho-social features captured by the MPI Classification System, 
e.g. classification by pain mechanism [42, 43], or focus on classification systems based 
on, for example, mechanical loading strategies or modified movement strategies of the 
spine (for overview: [44]). The appropriate study designs for the different research 
questions relating to the treatment-based subgroups have to be carefully chosen [45], 
and interpretation of subgroup effects has to be done according to the latest recom-
mendations. These recommendations made by Hancock et al. are that subgroups 
should be identified using high-quality randomized controlled trials, the investigation 
should be limited to a relatively small number of potential subgroups for which there is 
a plausible rationale, subgroup effects should be investigated by formally analyzing 
statistical interactions, and findings of subgroups should be subject to external valida-
tion [46, 47]. Pair-wise comparisons in a case-control study design might reduce heter-
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ogeneity and demonstrate higher effects. Stratification of pain management according 
to the patient’s prognosis is another model. At this moment it has been successfully 
tested in one study in a heterogeneous sample of low back pain patients in primary 
care [48, 49]. Prognostic screening (low, medium, or high risk) with matched pathways 
(low risk patients were shown an educational video and given a back book; medium-risk 
and high-risk patients were referred for further physiotherapy-led treatment sessions) 
was associated with a small but significant reduction of disability at the four and twelve 
month follow-ups (ES = 0.32, and 0.19, respectively). Moreover, these stratified inter-
ventions were, compared with non-stratified current best practice in the United King-
dom, cost-effective (cost savings at twelve months of £240 versus £274 compared with 
the control group). Considering the immense economic costs of back pain to Swiss 
society of 1.6 to 2.3% of gross domestic product (€4.8 to €6.6 billion) [50], even small 
effects in these patients justify further research on this topic.  
 Another consideration might be the exploration of the most appropriate treatment 
settings for patients with chronic musculoskeletal pain disorders. In this thesis all stud-
ies were conducted in an inpatient rehabilitation setting. In contrast to Switzerland, 
most Western health insurance companies are not willing to pay the difference in costs 
between outpatient rehabilitation or primary care, and inpatient rehabilitation. In the 
near future, Swiss rehabilitation clinics have to clearly show what the additional value is 
of treating chronic musculoskeletal pain patients in an inpatient rehabilitation setting 
with a high intensity of treatment modalities, instead of in a less intensive outpatient 
setting. The solution for treatment of chronic musculoskeletal pain cannot be solely 
dependent on inpatient programs in rehabilitation clinics: the problem is simply too big. 
Health professionals in primary care (general practitioners and physiotherapists) are 
also important stakeholders. Future classification systems should focus on early identi-
fication, early diagnosis, and early subgroup-specific treatment of (sub-) acute patients 
at risk of developing a chronic pain condition. Kamper et al. suggested that a small 
number of variables (effect modifiers) to define meaningful subgroups have to be iden-
tified. Accordingly, treatment effects observed in sufficiently powered, well conducted 
trials might provide further evidence that certain subgroups of patients may respond 
better to tailored interventions. Finally, before broad implementation in clinical care, 
the results of single randomized controlled trials have to be replicated and also tested 
for the extent to which they will hold good outside the conditions of the original ran-
domized controlled trial [33, 47]. 
 Besides pain intensity, pain disability was the primary outcome of the randomized 
trial in chapter 7. We used the well-validated and responsive Oswestry Disability Index 
ODI). With this self-report questionnaire patients indicate what they think they are able 
to do. From a behavioral point of view we think this is decisive. After completion of the 
pain management program patients have to perform meaningful activities (work, train-
ing, household chores, outdoor activities, etc) by themselves. Their self-efficacy, moti-
vation and level of anxiety are crucial in their decision to perform activities or not. 
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Compared to the baseline scores, the ODI scores at the 4-week follow-up showed only 
small improvements: +2% in the classification-based group and +3% in the general pain 
management group. However, the 5-Minute Walk Test (a test in which the assessor 
rates the actual performance of the patient) revealed at the same 4-week follow-up 
+12% in the classification-based group, and +8% in the general pain management 
group. In other words, thinking what a patient is able to do is not always the same as 
what he or she actually can do [51-53]. Future trials should bear more witness of this 
clinical entity. 
 As a final point of interest, I would like to mention the difficulties of conducting the 
traditional intervention-control-group design of a randomized controlled trial in the 
context of musculoskeletal pain in a clinical setting. Besides the clear advantages of an 
RCT-design, limitations of the RCT study design have also been the subject of debate 
(e.g. [54]. For instance, prospective cohort studies with intra-individual control of ef-
fects in patients with chronic (i.e. stable) musculoskeletal pain disorders might be fea-
sible and meaningful alternatives. In a study at the RehaClinic with patients with hip 
and knee osteoarthritis we used the design of a naturalistic cohort study without con-
trol group [55]. The effects observed during the intervention were corrected by those 
observed during the waiting time prior to the intervention. Baseline scores were com-
pared to the normative data of healthy people, corrected for sex and age). Compared 
to an RCT, duration and costs of this study design were markedly shorter and lower. 
However, there is a lack of normative data for several assessments like the widely used 
questionnaires Multidimensional Pain Inventory and the Coping Strategies Question-
naire [56] and future research projects should focus on the search for these important 
data. 
Conclusions 
The German version of the Coping Strategies Questionnaire is a feasible and reliable 
outcome measure to be used in (large multicenter multinational) trials with German-
speaking patients to assess pain coping strategies in patients with chronic musculoskel-
etal pain. Also, the Multidimensional Pain Inventory (MPI) Classification System is sub-
stantially stable and can be recommended for specification of subgroups in interven-
tional studies in patients with chronic back pain. The cross-sectional study investigating 
the pain-depression relationship revealed that in the MPI subgroup interpersonally 
distressed, the moderate pain-depression association may have an impact on pain 
management, that is, pain could be treated by treatment of depression and vice versa. 
Moreover, the MPI subgroups previously described by other studies with less disabled 
samples of fibromyalgia and chronic nonspecific back pain patients are also evident in 
highly disabled samples. A posteriori cluster analysis revealed that the three MPI sub-
groups identified showed significant differences in pain severity, mental health and 
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coping outcomes following a standard inpatient pain management program. However, 
the tailored pain management program with subgroup-specific physiotherapy and psy-
chotherapy interventions based on the MPI Classification System for patients with 
chronic back pain was not more effective in improving pain and disability than a stand-
ard pain management program with non-matched interventions in a rehabilitation 
setting at 4- and 12-week follow-up. 
 With the results of the present thesis and the hitherto existing other publications 
on this topic it is at this moment probably too early to reject or accept the concept of 
sub classification of patients with chronic musculoskeletal pain. In accordance with the 
widely used Swiss proverb “Eine Studie ist keine Studie”, further research is necessary 
to confirm these results before definite recommendations can be made. Replication of 
the present randomized controlled trial by other research groups, in different settings, 
and with longer follow-up, and meta-analysis of existing trials is necessary. On the oth-
er hand, classification of chronic, highly disabled patients into psychosocial subgroups 
might turn out to be less promising than expected. Together with health professionals 
in diverse clinical settings, the research community might start looking for an alterna-
tive Holy Grail [57-59] in back pain research. As a current example of shifting emphasis 
back towards the biological part of chronic low back pain, Albert et al. demonstrated 
that an antibiotic protocol was significantly more effective than placebo in improving 
disability, reduction of lumbar pain, and a host of secondary outcomes [60]. 
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English summary 
The focus of this thesis is the validation and effectiveness of a classification-based pain 
management program in patients with chronic musculoskeletal pain in an inpatient 
rehabilitation setting in Switzerland. Chronic pain of moderate to severe intensity oc-
curs in 19% of adult Europeans. Chronic pain represents a substantial burden to indi-
viduals and their family and friends, employers, health care systems and society in gen-
eral. Although treatment effects are small to moderate, comprehensive interdiscipli-
nary pain management programs offer the most efficacious and cost-effective, evi-
dence-based treatment for patients with chronic back pain. In Switzerland, inpatient 
rehabilitation of chronic musculoskeletal pain is a commonly used treatment option. 
However, back pain is nonspecific in about 90% of cases, which means that no relevant 
physical cause of the pain can be identified. The search for classification systems identi-
fying homogeneous subgroups of patients with nonspecific low back pain who respond 
best to subgroup-specific pain management has been on the research agenda for over 
eighteen years. So far, the effects of a few classification-based interventions have been 
tested in different settings. These trials showed large variations in categorization meth-
od, therapeutic interventions and outcome. In this research project we tested the Mul-
tidimensional Pain Inventory (MPI) Classification System, which classifies back pain 
patients into three predominantly psychosocial subgroups based on patients’ pain cop-
ing behavior. All studies in this thesis were performed with patients participating in the 
Zurzach Interdisciplinary Pain Program (ZISP). The primary objective of this thesis is to 
examine the effectiveness of tailored pain management in patients with chronic muscu-
loskeletal pain classified according to the MPI Classification System, in order to improve 
patient care. The secondary objective encompasses the exploration of differences in 
effects between individual Multidimensional Pain Inventory subgroups. Finally, the 
third objective, as a prerequisite to achieve the first two objectives, is testing clinimet-
ric features of the measurement tools Coping Strategies Questionnaire and the Multi-
dimensional Pain Inventory Classification System. 
 The aim of the study described in Chapter 2 was to translate and cross-culturally 
adapt the American version of the Coping Strategies Questionnaire (CSQ) and to test 
the reliability and validity of the German version (CSQ-D). The training and evaluation 
of active, adaptive pain coping strategies is a major goal in pain management. There-
fore, the CSQ was translated and cross-culturally adapted following international guide-
lines. Reliability and validity were tested in 62 individuals with chronic musculoskeletal 
pain syndromes. For the concurrent criterion-related validity, the CSQ-D scales were 
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compared with the German Pain Coping Questionnaire (FESV-BW) and for the construct 
validity with the German Short Form 36 (SF-36). The translation process proceeded 
without major difficulties. In testing for reliability, the CSQ-D as a whole had a 
Cronbach’s alpha of 0.94 and an intraclass correlation coefficient of 0.89 (95% CI: 0.86-
0.98). The total CSQ-D score was correlated to the FESV-BW scales with scores of r = 
0.32-0.55 and with the SF-36 Mental Component Summary with scores of r = 0.32-0.53. 
In conclusion, the CSQ-D is a precisely translated and highly reliable instrument in the 
assessment of chronic pain coping strategies. Its concurrent criterion-related validity 
and construct validity are low. The main reason for the low level of agreement between 
the CSQ-D and the FESV-BW was revealed by factor analysis. The CSQ-D is recommend-
ed to be used in trials with German-speaking patients or large multicenter multinational 
trials to assess pain coping strategies in patients with chronic musculoskeletal pain. 
 Reliability of the German Multidimensional Pain Inventory (MPI) was only exam-
ined once in the past in a small sample. Previous international studies mainly involving 
fibromyalgia patients showed that retest resulted in 33-38% of patients being assigned 
to a different MPI subgroup classification. Chapter 3 presents the results of the cross 
validation study examining the reliability of the MPI and the stability of the MPI Classifi-
cation System of the empirically derived subgroup classification obtained by cluster 
analysis in chronic musculoskeletal pain. Participants were 204 persons with chronic 
musculoskeletal pain (82% chronic non-specific back pain). Subgroup classification was 
conducted by cluster analysis at 4 weeks before entry (= test) and at entry into the pain 
management program (= retest) using MPI scale scores. No therapeutic interventions in 
this period were conducted. Reliability was quantified by intraclass correlation coeffi-
cients (ICC) and stability by kappa coefficients (κ). Reliability of the MPI scales was least 
with ICC = 0.57 for the scale life control and further ranged from ICC = 0.72 (negative 
mood) to 0.87 (solicitous responses) in the other scales. At retest, 82% of the patients 
in the MPI cluster interpersonally distressed (κ = 0.69), 80% of the adaptive copers (κ = 
0.58), and 75% of the dysfunctional patients (κ = 0.70) did not change classification. In 
total, 22% of the patients changed MPI cluster group, mainly into the adaptive copers 
subgroup. In conclusion, test-retest reliability of the German MPI was moderate to 
good and comparable to other language versions. MPI subgroup classification is sub-
stantially stable in chronic back pain patients when compared to other diagnostic 
groups and other examiner-based subgroup classification systems. Therefore, the MPI 
Classification System can be recommended for reliable and stable specification of sub-
groups in observational and interventional studies in patients with chronic musculo-
skeletal pain.  
 The relationship between depression, a co morbidity with the highest prevalence in 
patients with chronic musculoskeletal pain, and chronic pain is controversial and the 
data on association show strong variation. Chapter 4 evaluates the consistency of 
chronic disabling pain and depression and aims to provide refined correlation and re-
gression data on the basis of categorical and continuous measures. Cross-sectional 
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assessment was based on standardized instruments that measure on a quasi-
continuous scale, the Short Form-36 (SF-36), the Hospital Anxiety and Depression Scale 
(HADS) and the MPI. Correlations between depression and pain were determined by 
the instruments’ scales, with and without correction for confounders, and within chron-
ic pain subgroups using multivariate regression analysis. In 273 chronic pain patients 
participating in the Zurzach Interdisciplinary Pain Program, the MPI pain severity scale 
and the HADS depression scale showed maximum overall correlations of 0.27 to 0.29 
(bivariate) and 0.30 (partial). The odds ratios for depression varied between 1.72 and 
2.10 for different pain levels. Distinguishing three subtypes of pain patients, the pain-
depression correlation was moderate in the MPI “interpersonally distressed” subgroup 
(up to 0.57) (characterized by relatively low support, high punishing, low solicitous, and 
low distracting responses), weak in the MPI “dysfunctional” subgroup (up to 0.26), and 
absent in the MPI “adaptive copers” subgroup (up to –0.09). Altogether, the strengths 
of the pain-depression association and the “dose-response” relationship were both 
weak – weaker than to be expected if the hypothesis of a causal relationship were true. 
In the MPI subgroup interpersonally distressed, the moderate association may have an 
impact on pain management, that is, pain could be treated by treatment of depression 
and vice versa. 
 Patients with non-specific musculoskeletal pain are not a homogeneous group but 
heterogeneous with regard to their bio-psycho-social impairments. As mentioned be-
fore, evaluation of effectiveness of classification-based pain management is the major 
objective of this thesis. The study presented in Chapter 5 aimed to replicate and vali-
date the empirically derived subgroup classification based on the MPI in a sample of 
highly disabled fibromyalgia patients. Second, it examined how the retrospectively 
identified subgroups differed in their response to a standard, interdisciplinary inpatient 
pain management program. Participants were 118 patients with fibromyalgia who ex-
perienced persistent pain and were highly disabled. Subgroup classification was con-
ducted by cluster analysis using MPI subscale scores at entry to the program. At pro-
gram entry and discharge, participants completed the MPI, SF-36, HADS, and the CSQ. 
Cluster analysis identified three subgroups in this highly disabled sample that were 
similar to those described by other studies using less disabled samples of fibromyalgia. 
The dysfunctional subgroup (DYS; 36% of the sample) showed the highest level of de-
pression, the interpersonally distressed subgroup (ID; 24%) showed a modest level of 
depression and the adaptive copers subgroup (AC; 38%) showed the lowest depression 
scores in the MPI (negative mood), SF-36 (mental health), HADS (depression), and CSQ 
(catastrophizing). Significant differences in treatment outcome were observed among 
the three subgroups in terms of reduction of pain severity (as assessed using the MPI). 
The effect sizes were 1.42 for DYS, 1.32 for AC, and 0.62 for ID (p = 0.004 for pair wise 
comparison of ID-AC and p = 0.018 for ID-DYS). These findings underscore the im-
portance of assessing patients’ differences in how they adjust to fibromyalgia. 
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 In a comparable design, the study described in Chapter 6 examined a sample of 173 
highly disabled patients with chronic back pain to find out how the three subgroups 
based on the MPI differed in their response to the standard inpatient Zurzach Interdis-
ciplinary Pain Program. Again, subgroup classification was conducted by cluster analysis 
using MPI subscale scores at entry into the program. At program entry and at discharge 
after four weeks, participants completed the MPI, the SF-36, the HADS, and the CSQ. 
Pairwise analyses of the score changes of the mentioned outcomes of the three MPI 
subgroups were performed using the Mann-Whitney-U-test for significance. Cluster 
analysis identified three MPI subgroups in this highly disabled sample: a dysfunctional, 
interpersonally distressed and an adaptive copers subgroup. The dysfunctional sub-
group (29% of the sample) showed the highest level of depression in SF-36 mental 
health (33.4 ± 13.9), the interpersonally distressed subgroup (35% of the sample) a 
modest level of depression (46.8 ± 20.4), and the adaptive copers subgroup (32% of the 
sample) the lowest level of depression (57.8 ± 19.1). Significant differences in pain re-
duction and improvement of mental health and coping were observed across the three 
MPI subgroups, i.e. the effect sizes for MPI pain reduction were: 0.84 (0.44 - 1.24) for 
the dysfunctional subgroup, 1.22 (0.86 - 1.58) for the adaptive copers subgroup, and 
0.53 (0.24 - 0.81) for the interpersonally distressed subgroup (p = 0.006 for pairwise 
comparison). Significant score changes between subgroups concerning activities and 
physical functioning could not be identified. In conclusion, MPI subgroup classification 
showed significant differences in score changes for pain, mental health and coping. 
These findings underscore the importance of assessing individual differences to under-
stand how patients adjust to chronic back pain.  
 In Chapter 7 we report on a randomized controlled trial examining the effective-
ness of tailored interventions in a priori classified patients with nonspecific chronic back 
pain.  
 The study aimed to investigate the effects in terms of improving pain and disability 
of a subgroup-specific, 4-week, inpatient interdisciplinary pain management program, 
compared to a standard pain management program in patients with chronic back pain 
in a rehabilitation setting. Before starting treatment and in order to match them to a 
subgroup-specific therapy based on physiotherapy and psychotherapeutic interven-
tions, the patients in the intervention group were classified according to the MPI Classi-
fication System. The primary outcomes were self-reported pain and disability, meas-
ured at 4 and 12 weeks after randomization; secondary outcomes were observed func-
tional disability, anxiety and depression, pain catastrophizing, self-efficacy and psycho-
social aspects of pain. Blinded intention-to-treat analysis was performed at 4 and 12 
weeks after start of treatment. A total of 146 patients were included in this study. With 
the exception of minimum pain intensity after 4 weeks (standard mean difference 
(SMD) = 0.43, 95% confidence interval (CI), 0.02 to 0.84; p = 0.034), no significant dif-
ferences between intervention and control group could be measured. The secondary 
analysis, i.e. pairwise comparisons between the individual MPI subgroups and the con-
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trol group, explained this difference in effect in favor of the control group to the MPI 
subgroup adaptive coper: SMD = 0.55, 95% CI, 0.02 to 1.08; p = 0.035 at 12 weeks fol-
low up. For all other comparisons for any of the outcomes at any of the follow ups 
there were no significant differences. The results of this study justify the conclusion 
that, in this study, a subgroup-specific pain management program based on the MPI 
Classification System for patients with chronic back pain was not more effective in im-
proving pain and disability than a standard pain management program. 
 Chapter 8 discusses the main results and methodological reflections of this thesis. 
Implications of the studies in this thesis for clinical care are discussed and recommen-
dations for future research projects are provided. Comparison with other randomized 
controlled trials evaluating effects of classification-based interventions in patients with 
back pain reveals mixed outcomes. In our randomized trial as well as in the studies that 
have been published so far, classification-based interventions do not automatically 
yield bigger effects. However, subgroup classification and tailored interventions might 
be at least an equivalent alternative to general pain management. Future research 
should search for more homogeneous subgroups and the behavioral pattern of the 
subgroup adaptive copers.  
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Deutsche Zusammenfassung 
Das Hauptziel dieser Dissertation ist die Untersuchung der Gültigkeit (Validität) und 
Wirksamkeit eines klassifikations-basierten Schmerzprogrammes bei Patienten mit 
chronischen, muskuloskelettalen Schmerzen in der stationären Rehabilitation in der 
Schweiz. Chronische Schmerzen mittlerer bis höherer Intensität kommen bei 19% der 
erwachsenen Europäer vor. Chronische Schmerzen sind eine erhebliche Belastung für 
den Betroffenen, seine Familie und Freunde, für die Arbeitgeber, die Gesundheitssys-
teme und die Gesellschaft im Allgemeinen. Obwohl die Behandlungseffekte klein bis 
mässig sind, bieten umfassende, interdisziplinäre Schmerzprogramme die wirksamste 
und kostengünstigste, evidenz-basierte Behandlung für Patienten mit chronischen Rü-
ckenschmerzen. In der Schweiz ist die stationäre Rehabilitation für Patienten mit chro-
nischen, muskuloskelettalen Schmerzen eine geläufige Behandlungsmöglichkeit. Rü-
ckenschmerzen sind jedoch in ungefähr 90% der Fälle unspezifisch, was bedeutet, dass 
keine einschlägige, körperliche Ursache der Schmerzen gefunden werden kann. Die 
Suche nach Klassifikationssystemen, die Patienten mit unspezifischen Rückenschmer-
zen in homogene Untergruppen unterscheiden, damit sie in einer untergruppen-
spezifischen Schmerzbehandlung besser behandelt werden können, steht seit mehr als 
18 Jahren auf der Forschungsagenda. Bis jetzt wurden die Effekte von nur wenigen 
klassifikations-basierten Interventionen in unterschiedlichen Therapiesituationen un-
tersucht. Diese Studien berichten von grossen Unterschieden in Klassifikationsmetho-
den, therapeutischen Interventionen und Resultaten. In diesem Forschungsprojekt 
haben wir das Multidimensional Pain Inventory (MPI) - Klassifikationssystem unter-
sucht. Basierend auf das individuelle Schmerzbewältigungsverhalten, gruppiert das 
MPI-Klassifikationssystem Patienten mit Rückenschmerzen in drei (hauptsächlich psy-
chosoziale) Untergruppen. Alle Studien in dieser Dissertation wurden mit Teilnehmen-
den des Zurzacher Interdisziplinären Schmerz-Programms (ZISP) durchgeführt. Das 
erste, primäre Ziel dieser Dissertation ist, mittels Untersuchung der Wirksamkeit der 
massgeschneiderten Schmerzbehandlung nachzuweisen, dass diese bei Patienten mit 
chronischen, unspezifischen, muskuloskelettalen Schmerzen die Patientenversorgung 
verbessern kann. Das zweite Ziel beinhaltet die Erkundung von Unterschieden bei den 
Effekten zwischen einzelnen MPI-Untergruppen. Das dritte Ziel, als Bedingung, die ers-
ten beiden Ziele erreichen zu können, ist die Testung der klinimetrischen Eigenschaften 
der beiden Messinstrumente Coping Strategies Questionnaire und MPI-
Klassifikationssystem. 
 In Kapitel 2 der Dissertation wurde das Ziel beschrieben, die amerikanische Origi-
nalversion des Schmerzbewältigungsfragebogens (Coping Strategies Questionnaire - 
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CSQ) zu übersetzen, transkulturell zu adaptieren und die Reliabilität und Validität der 
deutschen Version (CSQ-D) zu testen. Das Training und die Evaluation von aktiven, 
adaptierten Schmerzbewältigungsstrategien, ist eine der Hauptziele im Schmerz-
management. Deswegen wurde der CSQ nach den international geltenden Richtlinien 
übersetzt und transkulturell adaptiert. Die Reliabilität und Validität wurde bei 62 Pati-
enten mit chronischen, muskuloskelettalen Schmerzsyndromen getestet. Für die Tes-
tung der konkurrenten Kriteriumsvalidität wurden die Skalen der CSQ-D mit dem Fra-
gebogen zur Erfassung der Schmerzverarbeitung/Schmerzbewältigung (FESV-BW) und 
für die Konstruktvalidität mit den Skalen der deutschen Version des Fragebogens zur 
gesundheitsbezogenen Lebensqualität (SF-36) verglichen. Der Übersetzungsprozess 
erfolgte ohne Schwierigkeiten. Die Testung der Reliabilität ergab für den gesamten 
CSQ-D einen Wert für die interne Konsistenz (Cronbach’s alpha) von 0.94 und eine Int-
raklassen-Korrelation (ICC) von 0.89 (95% Vertrauensintervall: 0.86 bis 0.98). Der CSQ-D 
Gesamtscore korreliert mit den Skalen des FESV-BW mit Scores von r = 0.32 bis 0.55 
und mit r = 0.32 bis 0.53 für den SF-36 (psychische Summenskala PCS). Zusammenge-
fasst ist der Fragebogen CSQ-D ein sorgfältig übersetztes und hoch reliables Instrument 
für die Untersuchung von Bewältigungsstrategien bei chronischen Schmerzen. Die kon-
kurrente Kriterienvalidität und Konstruktvalidität ist mässig. Der Hauptgrund für die 
tiefe Übereinstimmung zwischen den CSQ-D und den FESV-BW wurde mittels Faktoren-
analyse eruiert. Der CSQ-D kann für Studien, die Schmerzbewältigungsstrategien von 
deutschsprachigen Patienten mit chronischen, muskuloskelettalen Schmerzen untersu-
chen oder für grosse internationale Multizenterstudien empfohlen werden.  
 Die Reliabilität der deutschen Version des Multidimensionalen Schmerzfragebo-
gens (Multidimensional Pain Inventory – MPI) wurde in der Vergangenheit erst einmal 
in einer kleinen Stichprobe untersucht. Frühere internationale Studien, mehrheitlich 
mit Patienten mit Fibromyalgie, zeigten ausserdem, dass beim Wiederholungsversuch 
33 bis 38% der Patienten einer anderen MPI-Untergruppe zugeteilt wurde. Kapitel 3 
präsentiert die Resultate der Vergleichsprüfung, die die Reliabilität der Skalen des MPI 
und die Stabilität des MPI-Klassifikationssystems bei Patienten mit chronischen, musku-
loskelettalen Schmerzen untersucht. Es nahmen 204 Patienten an der Studie teil (82% 
hatten chronische, unspezifische Rückenschmerzen). Die Klassifizierung in Untergrup-
pen wurde mittels Gruppenanalyse der Scores der MPI-Skalen, 4 Wochen vor Beginn 
(=Test) und beim Eintritt (= Wiederholungstest) ins Schmerzprogramm durchgeführt. In 
diesem Zeitraum wurden keine therapeutischen Behandlungen durchgeführt. Die Reli-
abilität wurde mittels Intraklassen-Korrelationskoeffizienten und die Stabilität mittels 
Kappa-Koeffizienten (κ) quantifiziert. Die Reliabilität der MPI-Skalen war mit einer Int-
raklassen-Korrelationskoeffizienten von 0.57 für die Skala Lebenskontrolle am gerings-
ten und variierte in den anderen Skalen von 0.72 (affektive Verstimmung) bis 0.87 (zu-
wendende Reaktionen der Hauptbezugsperson). Beim Wiederholungstest gab es keine 
Aenderung der ursprünglichen Untergruppen-Klassifikation bei 82% der Patienten in 
der MPI-Untergruppe "Interpersonally Distressed" (κ = 0.69), 80% der "Adaptive Co-
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pers" (κ = 0.58), und 75% der "Dysfunctionals" (κ = 0.70). Insgesamt wechselten 22% 
der Patienten ihre MPI-Untergruppenzuteilung und zwar hauptsächlich zur Untergrup-
pe "Adaptive Copers". Schliesslich kann man festhalten, dass die Test-Retest Reliabilität 
der deutschen Version des MPI mässig bis gut und vergleichbar mit Versionen in ande-
ren Sprachen ist. Verglichen mit anderen diagnostischen Gruppen und anderen Klassifi-
kationssystemen ist die Klassifikation in MPI-Untergruppen bei Patienten mit chroni-
schen Rückenschmerzen im Wesentlichen stabil. Deshalb kann das MPI-
Klassifikationssystem für Studien, zur zuverlässigen und stabilen Spezifizierung von 
Untergruppen bei Patienten mit chronischen, muskuloskelettalen Schmerzen empfoh-
len werden. 
 Der Zusammenhang zwischen depressiver Verstimmung (der Komorbidität mit der 
höchsten Prävalenz bei Patienten mit chronischen, muskuloskelettalen Schmerzen) und 
chronischen Schmerzen ist umstritten und die Daten betreffend Assoziation zeigen 
grosse Streuung. In Kapitel 4 wird die Übereinstimmung zwischen chronischen Schmer-
zen und Depression untersucht. Das Ziel war, auf der Basis von kategorialen und konti-
nuierlichen Messinstrumenten, verfeinerte Daten betreffend Korrelation und Regressi-
on zu generieren. Die Querschnittsuntersuchung basierte auf standardisierten Messin-
strumenten, die auf einer quasi-kontinuierlichen Skala messen: der SF-36, der HADS 
und der MPI. Korrelationen zwischen Depression und Schmerz wurden mittels der Ska-
len der Messinstrumente bestimmt, mit und ohne Korrektur für konfundierte Merkma-
le und mittels multivariater Regressionsanalyse innerhalb der Untergruppen von Pati-
enten mit chronischen Schmerzen. Die MPI-Skala "Schmerzstärke" und die HADS-Skala 
"Depression" wiesen bei 273 chronischen Schmerzpatienten, die am Zurzacher Interdis-
ziplinären Schmerz-Programm teilnahmen, maximale Gesamtkorrelationen von 0.27 bis 
0.29 (bivariat) und 0.30 (partial). Die Odds-Ratios für unterschiedliche Schmerzintensi-
täten in Depression, variierte zwischen 1.72 und 2.10. Bei der Unterscheidung von 
Schmerzpatienten in drei MPI-Untergruppen, war die Schmerz-Depression Korrelation 
in der MPI-Untergruppe „Interpersonally Distressed“ mässig (bis 0.57), in der MPI-
Untergruppe „Dysfunctional“ schwach (bis 0.26) und in der MPI-Untergruppe „Adaptive 
Copers“ nicht vorhanden (bis -0.09). Alles in allem waren das Ausmass der Schmerz-
Depression-Assoziation und die Dosis-Wirkungsbeziehung beide schwach, schwächer 
als man erwarten würde, wenn die Hypothese eines kausalen Zusammenhangs richtig 
wäre. Die mässige Assoziation in der MPI-Untergruppe „Interpersonally Distressed“ 
könnte eine Bedeutung für das Schmerzmanagement haben: Schmerzen können beein-
flusst werden mittels Behandlung der Depression und umgekehrt.  
 Patienten mit unspezifischen, muskuloskelettalen Schmerzen sind keine homogene 
Gruppe, sondern, wegen ihrer biopsychosozialen Beeinträchtigungen, sehr heterogen. 
Wie bereits vorher erwähnt, ist das Hauptziel dieser Dissertation die Untersuchung der 
Wirkung von klassifikation-basiertem Schmerzmanagement. Die Studie in Kapitel 5 
beabsichtigte, in einer Stichprobe mit schwerstbetroffenen Fibromyalgiepatienten, die 
empirisch abgeleitete Untergruppenklassifikation, basierend auf der MPI, zu wiederho-
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len und zu validieren. Zweitens wurde untersucht, wie die retrospektiv identifizierten 
Untergruppen sich in ihren Effekten nach einem standardisierten, interdisziplinären, 
stationären Schmerzprogramm unterscheiden. 118 Fibromyalgiepatienten mit anhal-
tenden Schmerzen und schweren Beeinträchtigungen bei der Ausführung ihrer Alltags-
aktivitäten nahmen an der Studie teil. Die Klassifikation in Untergruppen wurde mittels 
Clusteranalyse ausgeführt; dafür wurden die Mittelwerte der Skalen der MPI-
Untergruppen beim Eintritt ins Schmerzprogramm verwendet. Die Teilnehmenden 
füllten bei Eintritt und Austritt des Schmerzprogramms die Fragebögen MPI, SF-36, 
HADS und die CSQ aus. Die Clusteranalyse wies in dieser schwerstbetroffenen Stichpro-
be drei Untergruppen aus, die identisch mit denjenigen aus anderen Studien mit weni-
ger betroffenen Fibromyalgiepatienten beschrieben waren. Die Untergruppe "Dysfunc-
tional "(DYS; 36% der Stichprobe) wies das höchste Ausmass an Depression aus, die 
Untergruppe "Interpersonally Distressed "(ID; 24%) wies ein mässiges Depressionsni-
veau aus und die Untergruppe "Adaptive Copers" (AC; 38%) wies die tiefsten Punktwer-
te für Depression aus. Beurteilt wurden die Skalen MPI Affektive Verstimmung, SF-36 
Psychische Gesundheit, HADS Depression, und CSQ Katastrophisieren. Betreffend 
Schmerzlinderung (gemessen mit MPI-Skala Schmerzstärke) wurden signifikante Unter-
schiede im Behandlungsresultat zwischen den drei Untergruppen beobachtet. Die Ef-
fektstärken betrugen 1.42 für DYS, 1.32 für AC, und 0.62 für ID (p = 0.004 im Paarver-
gleich ID-AC und p = 0.018 für ID-DYS). Diese Ergebnisse betonen die Bedeutung der 
Beurteilung, wie unterschiedlich sich Patienten an Fibromyalgie anpassen.  
 In einer ähnlich aufgemachten Studie, beschrieben in Kapitel 6, wurde in einer 
Stichprobe mit 173 schwerstbetroffenen Patienten mit chronischen Rückenschmerzen 
untersucht, wie die drei MPI-Untergruppen unterschiedlich auf das standardisierte, 
stationäre Zurzacher Schmerz-Programm ansprachen. Auch hier wurde die Klassifikati-
on in Untergruppen mittels Clusteranalyse ausgeführt; dafür wurden die Mittelwerte 
der Skalen der MPI-Untergruppen beim Eintritt ins Schmerzprogramm verwendet. Die 
Teilnehmenden füllten bei Eintritt und Austritt des Schmerzprogramms die Fragebögen 
MPI, SF-36, HADS und die CSQ aus. Mittels Mann-Whitney-Tests für unabhängige Stich-
proben, wurden die Signifikanzniveaus im Paarvergleich der Veränderungen der Mit-
telwerte der vorhererwähnten Fragebögen bestimmt. Die Clusteranalyse ergab in die-
ser Stichprobe bei der Ausführung ihrer Alltagsaktivitäten drei MPI-Untergruppen: 
"Dysfunctional", "Interpersonally Distressed", und "Adaptive Copers". Die Untergruppe 
"Dysfunctional" (DYS; 29% der Stichprobe) wies das höchste Ausmass an Depression 
(gemessen mit dem SF-36 Psychische Gesundheit) aus (33.4 ± 13.9); die Untergruppe 
"Interpersonally Distressed" (ID; 35%) wies ein mässiges Depressionsniveau aus (46.8 ± 
20.4) und die Untergruppe "Adaptive Copers" (AC; 32%) wies die tiefsten Punktwerte 
für Depression aus (57.8 ±19.1). Betreffend Schmerzlinderung, Verbesserung der psy-
chischen Gesundheit und Schmerzbewältigung, wurden signifikante Unterschiede im 
Behandlungsresultat zwischen den drei Untergruppen beobachtet. Die Effektstärken für 
MPI-Schmerzlinderung betrugen 0.84 (0.44 – 1.24) für DYS, 1.22 (0.86 – 1.58) für AC, 
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und 0.53 (0.24 – 0.81) für ID (p = 0.006 im Paarvergleich). Betreffend Aktivitätsniveau 
und körperlicher Funktion konnten keine signifikanten Unterschiede im Behandlungsre-
sultat zwischen den drei Untergruppen beobachtet werden. Zum Schluss kann man 
festhalten, dass die retrospektive Klassifizierung in MPI-Untergruppen signifikante Un-
terschiede der Effekte für Schmerz, psychische Gesundheit und Schmerzbewältigung 
aufdeckte. Diese Resultate betonen die Bedeutung der Untersuchung, wie unterschied-
lich sich Patienten an chronische Rückenschmerzen adaptieren. 
 In Kapitel 7 werden die Resultate einer randomisiert kontrollierten Studie, die die 
Wirkung von massgeschneiderten Behandlungen bei a priori-klassifizierten Patienten 
mit chronischen, unspezifischen Rückenschmerzen untersucht, beschrieben. Das Ziel 
der Studie war die Untersuchung der Unterschiede in den Effekten betreffend Schmerz-
reduktion und Reduktion der funktionellen Behinderung bei Alltagsaktivitäten bei Pati-
enten mit chronischen Rückenschmerzen, die an einem Untergruppen-spezifischen, 4-
wöchigen, stationären, interdisziplinären Schmerzprogramm teilnehmen, im Vergleich 
mit einem Standard-Schmerzprogramm. Die Patienten in der Experimentalgruppe wur-
den vor Behandlungsbeginn mittels des MPI-Klassifikationssystems in Untergruppen 
eingeteilt: so konnten die Patienten einer Untergruppen-spezifischen Therapie, basie-
rend auf Physiotherapie und Psychotherapie, zugeteilt werden. Die primären Outcomes 
waren Schmerz und funktionelle Behinderung, gemessen mittels Fragebögen 4 und 12 
Wochen nach Randomisierung; sekundäre Outcomes waren beobachtete, funktionelle 
Behinderung, Angst und Depression, Schmerz Katastrophisieren, Selbstwirksamkeit und 
psychosoziale Aspekte von Schmerz. 4 und 12 Wochen nach Behandlungsbeginn wurde 
eine verblindete intention-to-treat-Analyse durchgeführt. Insgesamt wurden 146 Pati-
enten in diese Studie eingeschlossen. Mit Ausnahme von minimaler Schmerzintensität 
nach 4 Wochen (Standard Mean Difference (SMD) = 0.43, 95% Vertrauensintervall (CI), 
0.02 bis 0.84; p = 0.034) wurden keine signifikanten Unterschiede zwischen der Experi-
mentalgruppe und der Kontrollgruppe gemessen. Die sekundäre Analyse, das heisst, 
Paarvergleiche zwischen den individuellen MPI-Untergruppen und der Kontrollgruppe, 
erklärte diesen Unterschied im Effekt bei der Nachkontrolle nach 12 Wochen zu Guns-
ten der Kontrollgruppe im Vergleich mit der MPI-Untergruppe "Adaptive Copers": SMD 
= 0.55, 95% CI, 0.02 bis 1.08; p = 0.035. Alle anderen Vergleiche für alle Outcomes und 
alle Nachkontrollen ergaben keine signifikanten Unterschiede. Die Resultate dieser 
Studie rechtfertigen die Schlussfolgerung, dass ein Untergruppen-spezifisches 
Schmerzprogramm, basierend auf dem MPI-Klassifikationssystem, für Patienten mit 
chronischen Rückenschmerzen in dieser Studie nicht effektiver betreffend Schmerzre-
duktion und Reduktion der funktionellen Behinderung war als ein Standard-
Schmerzprogramm. 
 In Kapitel 8 werden die Hauptresultate und methodologischen Überlegungen die-
ser Thesis besprochen. Die Konsequenzen der Studien dieser Thesis für das klinische 
Patientenmanagement werden diskutiert und es werden Empfehlungen für zukünftige 
Forschungsprojekte gemacht. Vergleiche mit anderen randomisierten, kontrollierten 
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Studien, die die Effekte von klassifikations-basierten Interventionen untersucht haben, 
zeigen unterschiedliche Resultate. Sowohl in unserer randomisierten Studie als auch in 
den anderen bis dato publizierten Studien, führen klassifikations-basierte Interventio-
nen nicht automatisch zu grösseren Effekten. Untergruppen-spezifische Interventionen 
könnten jedoch wenigstens eine ebenbürtige Alternative zum allgemeinen Schmerz-
management sein. In weiteren Forschungsprojekten sollten homogenere Untergruppen 
und das Verhaltensmuster der Untergruppe „Adaptive Copers“ untersucht werden. 
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Nederlandse samenvatting 
De focus van dit proefschrift is de validering en het testen van de effectiviteit van een 
op een classificatiesysteem gebaseerd revalidatieprogramma bij patiënten met chroni-
sche pijn aan het bewegingsapparaat in een derdelijns setting (revalidatie kliniek) in 
Zwitserland. Chronisch pijn met matige tot sterke intensiteit komt bij 19% van de vol-
wassenen in Europa voor. Chronisch pijn vormt niet alleen een grote belasting voor het 
individu en zijn sociale omgeving, maar ook voor de gezondheidszorg, werkgevers en de 
maatschappij in het algemeen. Hoewel de behandeleffecten klein tot bescheiden zijn, 
zijn uitvoerige interdisciplinaire pijnprogramma’s waarschijnlijk het meest kosteneffec-
tief voor patiënten met chronische rugklachten. In Zwitserland is therapie in een revali-
datie instelling bij patiënten met chronische pijnklachten aan het bewegingsapparaat 
een gangbare behandeloptie. Rugklachten zijn echter in ongeveer 90% van de gevallen 
niet-specifiek, hetgeen betekent dat er geen lichamelijke oorzaak voor de pijn gevon-
den worden kan. De zoektocht naar classificatie systemen, die in staat zijn om homoge-
ne subgroepen van patiënten met niet-specifieke rugklachten te onderscheiden die het 
beste reageren op een subgroep-specifieke pijnbehandeling, staat al meer dan 18 jaar 
op de internationale onderzoeks agenda. Tot nu toe zijn de effecten van slechts aan 
paar op classificatie-gebaseerde interventies in verschillende settings onderzocht. Deze 
interventies brachten een grote variatie in indelingen, therapeutische interventies en 
resultaten aan het licht. In dit project hebben we het Multidimensional Pain Inventory 
(MPI) classificatie systeem onderzocht, dat rugpatiënten - op basis van hun omgang 
met de pijnklachten indeelt in drie voornamelijk psychosociale subgroepen. Alle onder-
zoeken in dit proefschrift werden met patiënten uitgevoerd die deelnamen aan het 
Zurzach Interdisciplinaire Pijnprogramma (ZISP) uit. De voornaamste doelstelling van dit 
proefschrift bestond uit het onderzoeken van de effectiviteit van de subgroep-
specifieke behandeling van patiënten met chronische pijnklachten aan het bewegings-
apparaat die geclassificeerd worden met het MPI classificatie systeem. Zo zou de toe-
komstige behandeling van patiënten eventueel geoptimaliseerd kunnen worden. De 
tweede doelstelling betrof het onderzoeken van verschillen in effecten tussen de indi-
viduele MPI-subgroepen. Tenslotte bestond het derde doel – als voorwaarde om de 
eerste twee doelstellingen te bereiken – uit het testen van de klinimetrische eigen-
schappen van de Coping Strategies Questionnaire (CSQ) en de MPI. 
 Het trainen en evalueren van actieve, geadapteerde strategieën in de omgang met 
pijn (coping) is een van de prioriteiten in de behandeling van pijnklachten. Het doel van 
het onderzoek dat in hoofdstuk 2 beschreven wordt was het vertalen en transcultureel 
aanpassen van de Amerikaanse versie van de CSQ en het testen van de betrouwbaar-
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heid en de validiteit van de Duitse versie (CSQ-D). De CSQ werd volgens de internatio-
nale richtlijnen vertaald en transcultureel aangepast. De betrouwbaarheid en validiteit 
werden bij 62 individuen met chronische pijnklachten aan het bewegingsapparaat on-
derzocht. Om de concurrente criterium validiteit te testen werden de schalen van de 
CSQ met die van de German Pain Coping Questionnaire (FESV-BW) vergeleken en voor 
de constructvaliditeit met de schalenschalen van de German Short Form-36 (SF-36). Het 
vertaalproces verliep zonder noemenswaardige moeilijkheden. Voor de betrouwbaar-
heid had de CSQ-D als geheel een Cronbach’s alpha van 0.94 en een intraclass correlatie 
coëfficiënt van 0.89 (95% betrouwbaarheidsinterval: 0.86 tot 0.98). De totaalscore van 
de CSQ-D correleerde met de schalen van de FESV-BW met scores van r = 0.32 tot 0.55 
en met de SF-36 Mental Component Summary met scores van r = 0.32 tot 0.53. Conclu-
derend, de CSQ-D is een goed vertaald en betrouwbaar meetinstrument voor het on-
derzoeken van de omgang met pijn. Deconcurrente criterium validiteit en constructva-
liditeit waren laag. De voornaamste reden voor het lage niveau van overeenstemming 
tussen de CSQ-D en de FESV-BW kon met behulp van factoranalyse aangetoond wor-
den. De CSQ-D kan aanbevolen worden voor onderzoek met Duitstalige patiënten of 
grote internationaal multicenter onderzoek, waarin de omgang van patiënten met pijn 
wordt geëvalueerd. 
 De betrouwbaarheid van de Duitse versie van de MPI (MPI-D) is in het verleden 
slechts eenmaal in een kleine steekproef onderzocht. Eerdere internationale onder-
zoeken voornamelijk met patiënten met fibromyalgie , toonden aan dat 33-38% van de 
patiënten bij de hertest aan een andere MPI-subgroep waren toegewezen. Hoofdstuk 3 
presenteert de resultaten van een crossvalideringsstudie die de betrouwbaarheid van 
de MPI en de stabiliteit van het MPI-classificatiesysteem bij patiënten met chronische 
pijnklachten aan het bewegingsapparaat onderzocht. De deelnemers aan het onder-
zoek waren 204 personen met chronische pijn (82% had chronische niet-specifieke 
rugklachten). Met behulp van de scores van de MPI-schalen 4 weken voor deelname 
aan het pijnprogramma (= test) en bij het begin van het pijnprogramma (= hertest) 
werd via cluster analyse de classificatie in subgroepen uitgevoerd. In deze periode wer-
den geen therapeutische interventies uitgevoerd. De betrouwbaarheid werd met be-
hulp van intraclass correlation coefficients (ICC) en de stabiliteit met behulp van kappa 
coefficients (κ) gekwantificeerd. De betrouwbaarheid van de MPI-schalen was voor de 
schaalschaal life control het laagst met een ICC van 0.57 en varieerde in de andere 
schalen tussen ICC = 0.72 (‘negative mood’) en 0.87 (‘solicitous responses’). Bij de her-
test veranderden in het MPI-cluster Interpersonally Distressed 82% van de patiënten (κ 
= 0.69), 80% van de Adaptive Copers (κ = 0.58), en 75% van de Dysfunctionals (κ = 0.70) 
hun oorspronkelijke classificatie niet. Bijeengeteld wisselden 22% van de patiënten bij 
hertest van MPI cluster groep, voornamelijk in richting van de subgroep Adaptive Co-
pers. Concluderend, de test-hertest betrouwbaarheid van de Duitse versie van de MPI 
was matig tot goed en vergelijkbaar met versies in anderen talen. Vergeleken met an-
dere diagnosegroepen en andere classificatiesystemen is de classificatie van patiënten 
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met chronische rugklachten in MPI-subgroepen vrij stabiel. Daarom kan het MPI classi-
ficatiesysteem worden aanbevolen om op betrouwbare wijze onderscheid te maken in 
subgroepen ten behoeve van observationeel en interventieonderzoek bij patiënten met 
chronische pijnklachten van het bewegingsapparaat.  
 De relatie tussen depressie, een comorbiditeit met de hoogste prevalentie bij pati-
enten met pijnklachten van het bewegingsapparaat, en chronisch pijn is omstreden en 
de cijfers betreffende deze associatie laten veel variatie zien. In hoofdstuk 4 wordt de 
samenhang tussen chronisch pijn en depressie onderzocht. Het doel was om met be-
hulp van categoriale en continue meetinstrumenten verfijnde data te genereren om 
correlatie en regressieanalyses te kunnen uitvoeren. Een cross-sectioneel onderzoek 
werd uitgevoerd met gebruikmaking van gestandaardiseerde instrumenten, die op een 
quasi-continue schaal meten: te weten de SF-36, de Hospital Anxiety and Depression 
Scale (HADS) en de MPI. Correlaties tussen depressie en pijn in de MPI-subgroepen 
werden met behulp van de subschalen van deze meetinstrumenten bepaald, met en 
zonder correctie voor confounders, en met behulp van multivariate regressie analyse. 
Correlaties tussen de MPI-schaal ‘pain severity’ en de HADS-schaal depressie resulteer-
den bij 273 pijn patiënten die aan het Zurzach interdisciplinaire pijnprogramma deel-
namen in correlaties van 0.27 tot 0.29 (bivariaat) en 0.30 (partieel). De odds ratios voor 
depressie varieerden voor de verschillende pijnniveaus tussen 1.72 en 2.10. De pijn-
depressie correlatie was matig in de MPI-subgroep Interpersonally Distressed (tot 0.57), 
laag in de subgroep Dysfunctional (tot 0.26) en afwezig in de MPI-subgroep Adaptive 
Copers (tot -0.09). Alles wel beschouwd waren de pijn-depressie associatie en de dosis-
response relatie laag, lager als men zou kunnen verwachten als de hypothese van een 
causale samenhang waar zou zijn. Voor de MPI-subgroep Interpersonally Distressed zou 
de matige associatie gevolgen kunnen hebben voor de behandeling van pijn: pijn zou 
via de behandeling van depressie beïnvloed kunnen worden en omgekeerd.  
 Patiënten met niet-specifieke pijnklachten van het bewegingsapparaat zijn geen 
homogene groep, maar zeer heterogeen wat betreft hun biopsychosociale problemen. 
Zoals reeds eerder vermeld was de evaluatie van de effectiviteit van een op classificatie 
gebaseerd pijnprogramma de hoofddoelstelling van dit proefschrift. Het onderzoek dat 
in hoofdstuk 5 beschreven wordt had tot doel de empirisch ontwikkelde MPI-classifi-
catie in een steekproef met fibromyalgiepatiënten met veel beperkingen te herhalen en 
te valideren. Ten tweede werd onderzocht in hoeverre de retrospectief geïdentificeer-
de subgroepen na behandeling in een standaard pijnprogramma verschilden voor wat 
betreft hun effecten. De deelnemers aan dit onderzoek waren 118 patiënten met fi-
bromyalgie die aanhoudende pijnklachten en substantiële beperkingen in de uitvoering 
van hun activiteiten van het dagelijks leven ervoeren. De classificatie in subgroepen 
werd met behulp van cluster analyse uitgevoerd, waarbij de scores van de MPI schalen 
werden gebruikt. Bij begin en aan het einde van het pijnprogramma vulden de deelne-
mers aan het onderzoek de vragenlijsten MPI, SF-36, HADS en CSQ in. Met behulp van 
clusteranalyse werden in deze steekproef drie subgroepen onderscheiden, die identiek 
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waren met subgroepen die in steekproeven met fibromyalgie patiënten met minder 
beperkingen beschreven werden. De subgroep Dysfunctional (DYS; 36% van de steek-
proef) had het hoogste niveau van depressie, de subgroep Interpersonally Distressed 
(ID; 24%) had een matig niveau van depressie en de subgroep Adaptive Copers (AC; 
38%) had de laagste depressie-scores in de MPI (schaal negative mood), SF-36 (mental 
health), HADS (depressie), en CSQ (catastroferen). Tussen de drie subgroepen werden 
voor wat betreft reductie van de MPI-pijnintensiteit significante verschillen in behande-
lingsresultaat gemeten. De effect sizes waren1.42 voor de MPI-subgroep DYS, 1.32 voor 
AC, en 0.62 voor ID (p = 0.004 in de paarvergelijking ID-AC en p = 0.018 voor ID-DYS). 
Deze resultaten onderstrepen de betekenis van het onderzoeken van de verschillen 
tussen patiënten in aanpassing aan het ziektebeeld fibromyalgie.  
 In een vergelijkbaar onderzoek dat in hoofdstuk 6 beschreven staat werden 173 
patiënten geïncludeerd met veel beperkingen ten gevolge van chronische rugpijn. Het 
doel hier was om uit te vinden in hoeverre de drie MPI-subgroepen verschillende effec-
ten lieten zien op het standaard pijnrevalidatieprogramma in Zurzach. Ook hier werd de 
classificatie in subgroepen met behulp van cluster analyse uitgevoerd, waarbij de scores 
van de MPI schalen gebruikt werden. Bij begin en einde van het pijnprogramma na vier 
weken vulden de deelnemers aan het onderzoek de vragenlijsten MPI, SF-36, HADS en 
CSQ in. Met behulp van de Mann-Whitney-U-test werden paarsgewijze tussen de ver-
anderingen in scores van de hiervoor genoemde meetinstrumenten in de MPI-subgroe-
pen uitgevoerd. De clusteranalyse identificeerde in deze steekproef drie subgroepen: 
een Dysfunctional, een Interpersonally Distressed en een Adaptive Copers subgroep. De 
subgroep Dysfunctional (DYS; 29% van de steekproef) had het hoogste niveau van de-
pressie in de SF-36 psychische gezondheid (33.4 ± 13.9), de subgroep Interpersonally 
Distressed (ID; 35%) had een matig niveau van depressie (46.8 ± 20.4) en de subgroep 
Adaptive Copers (AC; 32%) had de laagste depressie-scores (57.8 ± 19.1). Tussen de drie 
subgroepen werden significante verschillen in pijnreductie, verbetering van de psychi-
sche gezondheid en omgang met de pijnklachten geobserveerd. De effect sterktes (ef-
fect sizes) voor MPI pijnreductie bedroegen 0.84 (0.44 – 1.24) voor de subgroep Dys-
functional, 1.22 (0.86 – 1.58) voor de subgroep Adaptive Copers en 0.53 (0.24 – 0.81) 
voor de subgroep Interpersonally Distressed (p = 0.006 voor de paarvergelijking). Wat 
betreft activiteiten en lichamelijke functie konden tussen de subgroepen geen signifi-
cante verschillen aangetoond worden. Concluderend, de classificatie in MPI-sub-
groepen liet significante verschillen in effecten wat betreft pijn, psychische gezondheid 
en omgang met pijn zien. Deze resultaten onderstrepen het belang van het evalueren 
van de verschillen in hoe patiënten zich aanpassen aan chronische rugklachten. 
 In hoofdstuk 7 rapporteren we over een gerandomiseerd gecontroleerde studie die 
de effecten van subgroep-specifieke interventies bij a priori geclassificeerde patiënten 
met niet-specifieke rugklachten onderzocht. De doelstelling van dit onderzoek was het 
meten bij patiënten met chronische rugklachten van de verschillen in pijnreductie en 
het verbeteren van de uitvoering van activiteiten in het dagelijks leven na een sub-
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groep-specifiek, 4-weeks, interdisciplinair pijnrevalidatieprogramma, vergeleken met 
een standaard-pijnrevalidatieprogramma. Voor begin van de behandeling werden de 
patiënten in de experimentele groep geclassificeerd volgens het MPI-classificatie-
systeem, met het doel ze subgroep-specifieke fysiotherapie en psychotherapie aan te 
bieden. De primaire uitkomstmaten waren pijn en functionele beperkingen bij de uit-
voering van activiteiten in het dagelijks leven (disability) - gemeten middels vragenlijs-
ten - en werden 4 en 12 weken na de randomisatie gemeten; secundaire uitkomstma-
ten waren geobserveerde functionele beperkingen, angst en depressie, pijn catastrofe-
ren, zelfwerkzaamheid, en psychosociale aspecten van pijn. 4 en 12 weken na randomi-
satie werd een geblindeerde intention-to-treat analyse gedaan. In totaal werden 146 
patiënten gerekruteerd. Met uitzondering van de daling van de minimale pijnintensiteit 
na 4 weken (standard mean difference (SMD) = 043, 95% betrouwbaarheidsinterval 
(CI), 0.02 tot 0.84; p = 0.034) konden er geen significante verschillen tussen de experi-
mentele groep en de controle groep vastgesteld worden. De secundaire analyse – een 
paarsgewijze vergelijking tussen de individuele MPI-subgroepen en de controle groep – 
verklaarde dit verschil in effect 12 weken na randomisatie ten gunste van de controle 
groep in vergelijking met de MPI-subgroep Adaptive Copers (SMD = 0.55, 95% CI, 0.02 
tot 1.08; p = 0.035). Voor alle andere vergelijkingen met alle andere meetinstrumenten 
waren er geen significante verschillen. De resultaten van dit onderzoek rechtvaardigen 
de conclusie, dat subgroep-specifieke pijnbehandeling gebaseerd op het MPI classifica-
tiesysteem bij patiënten met chronische rugklachten niet effectiever is in pijnreductie 
en verbetering van het functioneren, dan een standaard-pijnrevalidatieprogramma.  
 In hoofdstuk 8 worden de voornaamste resultaten en methodologische overwegin-
gen besproken. De implicaties van de onderzoeken beschreven in dit proefschrift voor 
de klinische patiëntenzorg worden bediscussieerd en er worden aanbevelingen voor 
toekomstig onderzoek gedaan. Een vergelijking met andere gerandomiseerde gecontro-
leerde studies die de effecten van op classificatie-gebaseerde interventies onderzoch-
ten gaf een gemengd beeld. Zowel in ons onderzoek als ook in andere studies die tot 
dusver gepubliceerd werden, leiden op classificatie-gebaseerde interventies niet auto-
matisch tot grotere effecten. Niettemin kunnen subgroep classificatie en subgroep-
specifieke interventies op zijn minst een gelijkwaardig alternatief bieden voor algemene 
pijnbehandeling zijn. Toekomstige onderzoeken zouden homogenere subgroepen moe-
ten zoeken en tevens het gedragspatroon van de patiënten in de MPI-subgroep Adapti-
ve Copers moeten nagaan. 
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